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IntroDuCtIon
Since the 1970s clinical practice guidelines have obtained a prominent position in 
western medicine and health care. Guidelines are meant as an instrument to reduce 
variation in processes and are originating from the industry. The reason guidelines entered 
the health care setting was the explicit belief that many, if not most, professionals were 
(are) working suboptimally through not practising with the best evidence available to 
their particular discipline or specialisation. By standardising care according to the best 
available scientific evidence inappropriate practice variation is reduced and health care 
professionals are supported in offering the most optimal treatment. In the beginning 
guidelines were based on consensus between experts and during the ‘90s guidelines 
became evidence based. Nowadays clinical practice guidelines are considered to be 
one of the most important tools for quality improvement and quality assurance in health 
care. As defined by the prominent Institute of Medicine (IOM) from the USA, clinical 
practice guidelines are “systematically developed statements to assist practitioner and 
patient decisions about appropriate health care for specific clinical circumstances.1” 
Besides the obviously large number of advocates, clinical practice guidelines also have 
many critics in and outside the health care professions. They argue that guidelines lead to 
“cookbook medicine” and to “de-skilling”, resulting in a diminishing quality of care and 
autonomy of the health care professional.2 Advocates counter these arguments by stating 
that guidelines permit room for individual fine-tuning, that deviations from guidelines 
are allowed (if motivated), and that formalising a professional group’s knowledge base 
will strengthen the profession’s autonomy rather than threatening it. An area that has 
received less attention in such discussions is the “specific clinical circumstances” 
mentioned in the IOM’s definition. Besides the disease-specific characteristics, the 
“specific clinical circumstances” usually refer to the age and gender of the patient. 
However, because of globalisation and the worldwide migration during the last 50 
years, the western world became increasingly multicultural giving a new dimension 
to the discussion on (the validity of) guidelines. The concept of standardisation seems 
to be in contrast with the increasing diversity in the population. Although the concept 
of standardisation and guidelines explicitly state that professionals can autonomously 
deviate from the guidelines, guidelines base their recommendations on the average 
patient. An important issue in this is the characterisation of this average patient. 
Guidelines being evidence based it is obvious that the average patient is the average 
patient studied in the scientific evidence. In guidelines RCTs are considered to be the 
most powerful evidence (besides meta-analyses) and study participants in RCTs are not 
seldom formed by white, middle-aged men. So, the average patient in the guidelines 
could also be best described as being the white middle-aged man. The question arises 
whether recommendations based on the average patient can be applied to all subgroups 
of patients. Physicians can of course deviate from guidelines for individual patients, but 
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is there not reason for structural deviation from guidelines in specific subgroups, i.e. 
specific ethnic minority groups. Examples of reasons to assume that health care should 
address the patient’s ethnicity as an important determinant are considerable in number. 
For instance, it seems that some specific diseases are especially found in specific ethnic 
groups, like sickle cell anaemia in people of African descent.3 Another important issue 
could be the religious background of the patient. Giving a blood sample for analysis 
or taking pills during the Ramadan could be very problematic.4 Furthermore, insulin 
derived from pigs or cows is not a treatment option in Muslims or Hindus. The relevance 
for medical treatment of these examples of ethnic differences is obvious. However, it is 
not clear whether these or other existing differences should be discussed in guidelines. 
The consequences of ethnic variation in patients are most evident in general practice 
in deprived neighbourhoods. In the Netherlands the population of some deprived 
neighbourhoods exists for more than 80% of ethnic minorities. Some GPs in deprived 
neighbourhoods have patient populations with patients from more than 60 different 
ethnic origins. Furthermore, because in the Netherlands the GPs are the gatekeepers 
of the health care system and they are therefore the first physician somebody who 
seeks care sees, the consequences in care for ethnic minorities are most manifest in 
general practice. 
Central aim and outline of this thesis
The central question of this thesis is whether guidelines should pay more attention to 
ethnic differences. Because this study was performed in the Netherlands it focussed 
on the guidelines of diabetes mellitus type 2, hypertension and asthma in adults of the 
Dutch College of General Practitioners. The choice for these three conditions was made 
because of their prevalent and chronic character, these conditions have guidelines of 
the Dutch College of General Practitioners for many years, and there were indications 
that ethnic differences probably could be important in some of these conditions. The 
guidelines of the Dutch College of General Practitioners have an important position in 
Dutch general practices. The development process is shaped according to the principles 
of evidence based medicine and is well structured and executed. The development 
process is often considered as an (international) example of the way evidence based 
guidelines should be developed.5 That is also why the guidelines are highly valued by 
the general practitioners.6 In order to assess the need for ethnic diversity in guidelines it 
is especially interesting to focus on the best practice regarding guidelines. 
The main question was divided into five sub questions: 
1.  Is there any reason or evidence for paying attention to ethnic differences in 
these chronic conditions (chapter 2, 3, and 4)? Chapter 2 presents the results of 
an systematic review of the scientific literature on differences in the prevalence 
of diabetes mellitus type 2, other cardiovascular risk factors, and cardiovascular 
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disease between Turkish and Moroccan immigrants compared with the indigenous 
population in North Western European countries. Chapter 3 presents the results of 
a comparison of the attention given to ethnic differences in primary care guidelines 
from the USA, the UK, Canada, and the Netherlands. Chapter 4 focuses further on 
the guidelines of the Dutch College of General Practitioners and shows results of the 
comparison of statements about relevant ethnic differences between the guidelines 
and their supporting evidence.
2.  Does the GP’s treatment differ between patients of different ethnic origin? This 
question is answered in chapter 5 in which results are presented of a retrospective 
analysis of patient files. 
3.  Is the GP’s adherence to guidelines associated with the ethnic background of their 
patient? Chapter 6 provides an answer by presenting the results of a prospective 
study in which the adherence to guidelines was determined in specific contacts 
with patients.
4.  Are there any ethnic differences in the association between treatment and clinical 
outcome of treatment? Chapter 7 shows the result of an analysis of the association 
between adherence to guidelines and the clinical outcome of treatment.
5.  What is the opinion of GPs with many ethnic minorities in practice, regarding 
the usefulness of the current guidelines in the treatment of ethnic minorities? 
This question is addressed to in chapter 8 by presenting the results of qualitative 
interviews with the participating GPs.
referenCes 
1.  Field MJ, Lohr ML. Clinical practice guidelines: directions for a new program. 
Washington DC: National Academy Press, 1990.
2. Berg M. Problems and promises of the protocol. Soc Sci Med 1997;44:1081-8.
3.  Lehmann, H. Sickle cell anemia 35 years ago: reminiscence of early African studies. 
Am J Pediatr Hematol Oncol 1984;6:72-6.
4.  Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S, et al. Diabetes and 
Ramadan: Review of the literature. Diabetes Res Clin Pract. 2006;73:117-125.
5.  Fleuren MAH. Waarom worden standaarden in de praktijk niet gevolgd en wat valt 
eraan te doen? Huisarts Wet 1998;41:511-4.
6.  Thomas S. De positie van standaarden en adviezen van het Nederlands Huisartsen 
Genootschap. Ned Tijdschr Geneeskd 1994;138:2638-40.
Prevalence of type 2 diabetes mellitus, 
other cardiovascular risk factors, and 
cardiovascular disease in Turkish and 
Moroccan immigrants in North West 
Europe: a systematic review.
Uitewaal PJM, Manna DR, Bruijnzeels MA, 
Hoes AW, Thomas
2
 Preventive Medicine 2004; 39: 1068-1076.
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AbstrACt
background: The prevalence of diabetes, other cardiovascular risk factors, and 
cardiovascular morbidity and mortality varies between immigrant groups in Western 
societies, but epidemiological data on these topics are scarce for Turks and Moroccan 
immigrant living in North West Europe.
Methods: Medline and Embase were systematically searched for studies containing 
data on the prevalence of diabetes, cardiovascular risk factors, and cardiovascular 
morbidity and mortality in Turkish or Moroccan immigrants living in Northwestern 
European countries.
results: Eighteen studies were identified. Corresponding findings were a high prevalence 
of type 2 diabetes in Turkish and Moroccan immigrants, a high prevalence of smoking 
among Turkish men, and a very low prevalence of smoking in Moroccan women compared 
to the indigenous population. Because of lack of valid studies, no definite conclusions 
could be drawn for in particular blood pressure and lipids. One German study showed 
exceptionally lower cardiovascular mortality rates in Turkish immigrants.
Conclusion: The reviewed studies yielded insufficient evidence for a good quality 
comparison of the cardiovascular risk profile between Turkish and Moroccan immigrants 
and indigenous populations. Diabetes mellitus was more prevalent in Turkish and 
Moroccan immigrants, smoking more prevalent in Turkish males, and very rare in 
Moroccan females.
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IntroDuCtIon
The prevalence of diabetes and other cardiovascular risk factors, and the incidence 
cardiovascular disease, varies between ethnic groups 1–4 and is influenced by genetic, 
environmental, social, and cultural factors 5–10. This has been well described for ethnic 
minority groups of Black African or South Asian descent living in Western countries 11–17, 
but for other large ethnic minority groups living in West European countries, knowledge 
on these topics is limited. The largest foreign nationality in the European Community 
by far is Turkey, with over 3 million Turkish immigrants. Most Turkish immigrants live 
in Germany (about 2 million), but also in the Netherlands they form the largest ethnic 
minority group with 330,000 persons. Moroccan immigrants form one of the largest 
ethnic minority groups in France (500,000 persons), Belgium (125,000 persons), and 
the Netherlands (280,000 persons). 
Studies have shown that populations in European Mediterranean countries (Italy, 
Portugal, France, Yugoslavia, Greece, and Spain) have a lower mortality rate from 
ischemic heart disease compared to northern European countries 18,19. Although Turkey 
and Morocco are also Mediterranean, a Turkish study reported that coronary death 
rates in Turkey can be ranked among the highest in Europe 20. It is, however, unknown 
whether cardiovascular risk factors and the cardiovascular death rates are influenced by 
migration of Turks and Moroccans to western European countries.
Given the increasing number of elderly among the Turkish and Moroccan immigrant 
populations, it is important to have some prognosis concerning cardiovascular morbidity 
and mortality in these groups soon. 
To gain insight on this topic, we performed a systematic review to establish the prevalence 
of diabetes and other cardiovascular risk factors in Turkish and Moroccan immigrants 
in western European countries, and to determine what is known about cardiovascular 
mortality in these groups.
MethoDs
study selection
Analogue searches were made in Medline (1985–2002) and Embase (1985–2002) using 
the terms shown in Box 1. Articles were selected if the title or abstract made clear that 
the paper reported original prevalence data on diabetes and other cardiovascular risk 
factors (including hypertension, lipids, smoking, obesity), and cardiovascular morbidity 
and mortality on samples of Turkish or Moroccan adults living in a North West European 
country. Studies based on children and published studies before 1985 were excluded.
In addition, we checked the reference lists from selected publications to collect missed 
publications. We also used the references of a recent report by the Dutch National 
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Institute for Public Health and the Environment 21, which investigated Dutch reports on 
cardiovascular risk factors in ethnic minorities in the Netherlands.
The selection was independently performed by two persons (PU and DM). In all cases 
of disagreement, consensus was reached.
box 1
ethnic groups
1.  Turks OR Turkish OR ‘‘Moroccan*’’ OR Arabs OR Arab OR ‘‘North African*’’ 
North West European
2.  Netherlands OR Dutch OR Belgium OR Belgian OR ‘‘German*’’ OR Denmark OR Danish OR UK 
OR English OR France OR ‘‘French*’’ OR Sweden OR Swedish OR Norway OR Norwegian OR 
Finland OR ‘‘Finn*’’ OR ‘‘North Europ*’’
3. #1 AND #2 
Diabetes mellitus type 2
4.  ‘‘Diabetes mellitus’’, ‘‘Non-insulin-dependent’’ [MESH] OR NIDDM OR ‘‘Noninsulin dependent’’ 
OR ‘‘Non insulin dependent’’ OR ‘‘Non insulindependent’’ OR ‘‘Non-insulin-dependent’’ OR 
‘‘Non-insulin dependent’’ OR ‘‘Type II diabetes’’ OR ‘‘Type 2 diabetes’’ OR ‘‘Diabetes type 2’’ OR 
‘‘Diabetes type II’’
Epidemiology
5.  ‘‘Vital Statistics’’ [Mesh] OR Mortality OR Prevalence OR Incidence OR Morbidity Risk factors
6.  Smoking OR Smoking [MESH] OR Cholesterol OR Lipids [MESH] OR ‘‘Lipid*’’ OR ‘‘Cardiovascular risk 
factor*’’ OR ‘‘Risk factors’’[MESH] OR Hypertension [MESH] OR Hypertension OR ‘‘Blood pressure’’
Cardiovascular disease
7.  ‘‘Cardiovascular Diseases’’[MESH] OR ‘‘Vascular disease’’ OR ‘‘Coronary artery disease’’ OR 
‘‘Coronary disease’’ OR ‘‘Coronary heart disease’’ OR ‘‘Myocardial infarction’’ OR Cardiovascular 
OR ‘‘Cerebrovascular accident’’ [Mesh] OR Stroke OR ‘‘CVA’’ OR ‘‘Transient ischemic attack’’ OR 
‘‘TIA’’ OR ‘‘Cerebral hemorrhage’’ OR ‘‘Carotid stenosis’’
8. #4 OR #5 OR #6 OR #7
9. #3 AND #8
10. (Limits: Adult: 19+ years; text word)
study selection and data extraction
The following methodological characteristics of the cross-sectional studies with 
prevalence data on diabetes and cardiovascular risk factors were evaluated: study 
population, sampling method (random versus nonrandom), sample size by ethnic group, 
age of the studied groups, response rate, and the methods used to identify patients and 
measuring cardiovascular risk factors and mortality.
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First author  study population sampling Age range sample size  response Available data Method of
& publication   method (years) by ethnic  rate (%)  data collection
year    group
Bleeker 22  Amsterdam,   random  12– 69  T  1269  58 diabetes,   patient interview
 Rotterdam,Utrecht,     M  1266   hypertension,
 Gouda (NL)   I  1221  smoking
Brussaard 23 Amsterdam,  random  24– 58  T 50  15  cholesterol  actively measured
 Utrecht,     M  25
 Twente (NL)   I  79
CBS 24  general population   random  all ages  T  5306  83  hypertension,  patient interview
 (NL)   I  15,860  obesity
Dijkshoorn 25  population   random  35– 74  T  774  71  diabetes, obesity,  patient interview
 Amsterdam (NL)   M  686   smoking
    I  903
Dijkstra 26 diabetes patients  no samplinga  not given  T  59  NR  ischematic heart  actively measured
 admitted to hospital    I  185   disease
 (NL)
Health survey  population    random  16– 75  T  287  43  diabetes,   patient interview
the Hague 27  the Hague (NL)   M  147   hypertension,
    I  867  smoking
Köycü 28  population  random  18– 64 T  149  66  hypertension,   actively measured
 Amsterdam (NL)   I  881   obesity, smoking
Middelkoop 29  14 general   no samplinga  40– 55  T  44  NR  hypertension,   derived from
 practices (NL) (women not   M  40   obesity, smoking  medical records
  studied)   I  1961
Porsch 30  25 general    no samplingb  > 35  T  480  NR  hypertension,   actively measured
 practices (D)   I  NS   obesity, smoking
Reijneveld 31  population    random  16– 64  T  118  61  smoking  patient interview
 Amsterdam (NL)   M  176
    I  2448
Swinkels 32  general population   random  >16  T  3371  83  smoking  patient interview
 (NL)c   I  9634
Uniken-  population    random  16– 69  T  248  67  diabetes,   patient interview
Venema 33 Rotterdam (NL)   I  241  hypertension
Weide 34  103 general   no samplinga  18– 65  T  1165  NR  cardiovascular   derived from
 practices (NL)   M  853   disease medical records
    I  1471
Weijers 35  population of   no samplinga  28– 84  T  1728  NR  diabetes  actively measured
 one borough    M  2021
 in Amsterdam (NL)   I  8249
Weijers 36  diabetes patients  no samplinga  20– 90  Md  113  NR  cardiovascular   actively measured
 admitted to     I  603  disease
 hospital (NL)
NR = not reported, NS = not studied
a All identified patients were included, no estimation was made of the proportion of non-identified patients.
b Nonrandom: patients voluntarily underwent a health check-up and were not compared with the indigenous population.
c Data derived from the CBS study.
d Including other North African groups.
tAble 1
Characteristics of 14 studies from the Netherlands (NL) and Germany (D) with data on the prevalence of diabetes, 
cardiovascular risk factors, and cardiovascular disease in Turkish (T) and Moroccan (M) immigrants and the 
indigenous (I) population
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results
The searches on Medline and Embase yielded 354 papers. From these papers, 20 were selected 
based on title or abstract; there was a disagreement on 1 of the 20 papers (95% agreement). 
Ten of these studies had original prevalence data and were included in this review. Checking 
the references lists yielded an additional eight studies. Thus, finally, 18 publications were 
reviewed. Of these 18 reports, 16 had data on Turkish and 10 on Moroccan individuals. 
Of the 18 selected studies, 12 were cross-sectional studies with prevalence data 
on diabetes and cardiovascular risk factors, 4 studies had data on incidence of 
cardiovascular disease, and 2 on cardiovascular mortality. Eleven studies were based 
in community settings and five in general practice or hospital. Most studies were 
specifically designed to focus on the prevalence of diabetes or other cardiovascular 
risk factors compared with the general or indigenous population. One study was 
designed to describe the use of a sentinel practice network, and two studies to 
describe differences in diabetes-related complications between various groups. One 
study did not compare prevalence data 30, and one study used data on the indigenous 
population from other studies as a comparison 14. 
Table 1 22–36 shows that all studies, except one 30, were conducted in the Netherlands. 
Methods to establish the Turkish and Moroccan descent included name analysis 24,28,32, 
country of birth 30, registered as having the Moroccan nationality 22, data from the 
municipal register (country of birth and parents’ country of birth) 25,27,31– 36, and as 
reported by the GP 29. The method was not mentioned in one study 26. The age range 
varied widely between studies. Response rates ranged from 43% 27 to 83% 24. In six 
studies, the response rates were not mentioned, probably because data were extracted 
from an existing database. 
Smoking behavior was assessed with self-reports. Prevalence of hyperglycemia was 
determined by self-reports in three studies 22,25,27 or blood samples 30,35. The presence 
of hypertension was assessed by self-reports in three studies 22,24,27, blood pressure 
measurement 22,24, or medical record 24. The lipid profile measurement was performed 
by taking blood samples 28–30. The presence of coronary heart disease was assessed by 
selfreports 25,27, from medical records 34, or based on ECG registrations 30.
Prevalence of diabetes
Five studies had data on the prevalence of diabetes (Table 2). In four studies with an 
indigenous comparison group, the prevalence of diabetes was 1.3–2.8 times higher 
in Turks and 1.9–3.2 times higher in Moroccans. The available data did not show a 
clear gender difference. In the only German study 30, the age-standardized diabetes 
prevalence rate in Turks was 7.8% in men and 9.9% in women, which was comparable 
with the prevalence of diabetes in Turks in Dutch studies, but 30% lower than the 
prevalence in German women (compared to Turkish women).
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first author  Method of   turks    Moroccans   Indigenous   P value for difference
 data collection          turks/Moroccan versus
  Men Women  All  Men  Women  All Men Women All  indigenous population
Prevalence of diabetes
Bleeker 22  self-reported  –  –  5a  5  5  5  –  –  0.5a  NR
Dijkshoorn 25  self-reported  –  –  3.8  –  –  3.8  –  –  2.0  NR
The Hague 27  self-reported  –  –  4  –  –  7  –  –  3  NR
Porsch 30  actively screened:  7.8  9.9  –     NCIP 
 fasting plasma        
 (criteria not given)       
Weijers 35  actively screened   12.3  9.9  10.9  11.9  14.2  121.4  4.0  3.6  3.8  P < 0.001
 whole blood glucose 
 (WHO criteria ’85)
Prevalence of hypertension
Bleeker 22  self-reported  –  –  4a  7  9  8  –  –  5a  NR
CBS 24  self-reported  3 3  3  NS    3  3  3  NR
The Hague 27  self-reported  –  –  10 –  –  8  –  –  11  NR
Köycü 28  actively screened  15  22  17  NS    NR    NR
Middelkoop 29  data derived from,  17  –  –  –  –  –  9  –  –  not statistically
 medical records           significant
 (hypertension defined
 as DBP >95)
Porch 30  actively screened,  12.2  10.3  –  NS   NS
 hypertension defined 
 as SBP >160 or 
 DBP >95 m
Prevalence of smoking
Bleeker 22  self-reported  56  21  40  34  2  17  49  38  43a  NR
Dijkshoorn 25  self-reported  –  –  45 –  –  19  –  –  42  NR
The Hague 27  self-reported  49  30  –  27  3  –  39  31  31  NR
Köycü 28  self-reported  60  34  52  NS 50  48  49  NR
Middelkoop 29  data derived  73  –  –  54  –  –  42  –  –  T– I: P < 0.05
 medical records
Porsch 30  self-reported  42  13  –  NS   NS
Reijneveld 31  self-reported  69  28  49  23  1  14  44  47  45  NR
Swinkels 32  self-reported  58  22  42  NS   44  37  41  NR
CBS 24  self-reported,  10  20  –  NS   4  5  –  NR
 criterion obesity:
 BMI >30
Dijkshoorn 25  self-reported,  –  –  54  –  –  36  –  –  30  NR
 criterion obesity:
 BMI >25
Köycü 28  actively screened,  60  60  –  NS   NS
 criterion not defined 
 (increased BMI)
Middelkoop 29 derived from the   30  –  –  17  –  –  13  –  –  T– I: P < 0.05
 medical record,  
 criterion obesity: 
 BMI >30
Porsch 30  actively screened,  21  48  –  NS   NS
 criterion obesity: 
 BMI >30
NCIP = not compared to the indigenous population, NS = not studied, NR = not reported, BMI = body mass index, 
DBP = diastolic blood pressure, SBP = systolic blood pressure, T– I = Turks versus Indigenous population.
a Data on the Turkish and Dutch comparison groups originate from the CBS study24.
tAble 2
Findings from 14 studies with data on the age- and gender-adjusted prevalence of diabetes, hypertension, smoking, 
and overweight or obesity in Turkish (T) and Moroccan (M) immigrants and indigenous (I) inhabitants in the 
Netherlands and Germany
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Prevalence of cardiovascular risk factors
Hypertension
Five studies had data on the prevalence of hypertension in Turks and two in Moroccans 
(Table 2). The prevalence of hypertension in these studies varied widely. Three studies, 
using self-reported data, revealed no clear differences in the prevalence of hypertension 
between the Turkish, Moroccan, and the indigenous sample 22,24,27. One study with a 
small sample of Turkish males (using data from the medical record) showed a higher 
prevalence of hypertension in Turks, although the difference was not statistically 
significant 29. Two studies, with blood pressure measurements, did not directly compare 
the prevalence of hypertension with the indigenous population, but one of these studies 
compared blood pressure levels between Turks and Dutch, and showed a higher mean 
blood pressure level in both Turkish men and women aged over 30 years 28.
Plasma lipids
One Dutch study showed lower total cholesterol levels in Turkish persons than in the 
native Dutch population (mean total cholesterol in Turks, 4.8 mmol/L vs. 5.4 in Dutch) 28, 
whereas a German study showed comparable total cholesterol levels in Turks and 
Germans (mean level 6.1 mmol/L) 30. HDL-cholesterol levels in Turkish males were 
lower in both the Dutch and German studies compared to the indigenous population 
(mean HDL-cholesterol in Turkish Dutch males, 0.96 mmol/L vs. 1.20 mmol/L in Dutch 
males 28, and 0.93 mmol/L in Turkish Germans 30). One study compared total cholesterol 
levels in a small female Turkish (n = 50) and Moroccan (n = 25) group with Dutch 
indigenous females. The mean cholesterol level was 5.0 mmol/L in Turkish, 5.3 mmol/L 
in Moroccan versus 5.5 mmol/L in Dutch females ( P < 0.05 between the Turkish and 
Dutch females). In Turkish and Moroccan females, 8% had a cholesterol level >6.5 
mmol/L versus 13% in Dutch females (NS) 23.
Smoking
The prevalence of smoking was reported in seven studies (Table 2). The differences in the 
prevalence of smoking between men and women varied considerably between the ethnic 
groups. All studies show a higher prevalence of smoking in Turkish men (range, 42–73%) 
compared to Dutch men (range, 39 – 50%) 22,27 – 29,31,32. The lowest prevalence was found 
in Moroccan women (range, 1–3%) 22,27,31. The prevalence in other women ranged from 
13% to 34% in Turkish 22,27,28,30–32 and from 31% to 48% in Dutch women 22,27,28,31,32. 
Obesity
The prevalence of overweight and obesity was reported in five studies (Table 2). In 
three of these reports, the prevalence was compared with the indigenous population. 
Overweight or obesity was more prevalent in Turks 24,25,29, equally or more prevalent 
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in Turkish women than in men. Differences between Moroccans and the indigenous 
population (two reports) were less clear 25,29.
Cardiovascular disease and mortality 
Table 3 shows the results of six studies with data on the prevalence of cardiovascular 
disease: four studies in the general population 25,27,30,34 and of two studies in type 2 
diabetes patients admitted to hospital 26,36. The prevalence of cardiovascular disease was 
comparable in Turkish immigrants and the Dutch or German indigenous population 25,27,30,34. 
In Turkish diabetes patients, ischemic heart disease was found less often than in 
    turks  Moroccans  Indigenous P value  study
      population
Cardiovascular disease (general population)
 Self-reported (%)  28  17  21  NR  Dijkshoorn 25
 Self-reported heart disease (%)  2  1  3 NR  The Hague 27
 Self-reported stroke (%)  1  0  1  NR  The Hague 27
 Diagnosed by GP [OR (95% CI)]  0.85 0.46 reference  –  Weide 34
    (0.25– 0.82)  (0.55– 1.32)
 Diagnosed (ECG) (men, women) (%)  10.4, 6.5   10.5, 7.2 NR  Porscha 30
Cardiovascular disease (in diabetes patients)
 Diagnosed (ECG) (%)  –  1.1  9.0  P < 0.001  Weijers 36
    9  –  29  P < 0.02 Dijkstra 26
 (age-adjusted odds ratio)  0.19   reference  Dijkstra 26
	 	 	 	 (0.06– 0.65)
Mortality	from	cardiovascular	disease	in	the	Netherlands,	Germany	and	France
Cardiovascular mortality
 (percentage of
 all-cause mortality)
 Netherlands  25– 44 years (m, f)  28, 19   22, 16  NR  Mackenbach 37
  45– 64 years (m, f)  48, 40   44, 28  NR
 Germany  25– 64 years (m, f)  34, 27
 France  25 years and above      Khlat 38
  disease of the circulation    18, 26
  system (m, f) of which:
   ischemic heart disease (m, f)   7, 5
   cerbrovascular disease (m, f)   4, 8
   other vascular disease (m, f)   8, 14
Cardiovascular Mortality
 (death rates per 100,000)
 Germany  25– 44 years (m, f)  76, 41   107, 44   Razum 39
  45– 64 years (m, f) 789,498   1338,747
Mortality risk (relative risk)a
 France  Disease of the circulatory    0.71, 1.13  reference  P < 0.01,  Khlat 38
  system (m, f) of which:    P < 0.01
   schemic heart disease (m, f)   0.65, 0.93  reference  P < 0.01, NS
   cerebrovascular disease (m, f)   0.60, 0.98  reference  P < 0.01, NS
   other vascular disease (m, f)   0.83, 1.35  reference  P < 0.01, 
       P < 0.01
m, f = male, female, NR = not reported, NS = not statistically significant.
a Data on the German comparison group originate from a different study.
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Data from the nine studies with data on the prevalence of cardiovascular disease and cardiovascular mortality in 
Turkish and Moroccan immigrants and indigenous inhabitants in the Netherlands, Germany, and France 
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Dutch diabetes patients (9% vs. 23%; P < 0.02) 26. Compared to the indigenous 
population, all available data show lower prevalence of cardiovascular disease in 
Moroccans 25,27,34. Three studies compared cardiovascular mortality in Turks 37,39 
or Moroccans 38 with the indigenous population in the Netherlands, Germany, and France.
Cardiovascular mortality as a percentage of the overall mortality was higher in Turkish 
immigrants in the Netherlands, particular in Turkish females 37. Such a higher percentage 
in cardiovascular mortality in females was also found in the German population 39. 
However, age-adjusted cardiovascular disease mortality rates in Germany were 43% 
lower in Turkish men than in German men (period between 1981 and 1994), and in 
Turkish women, the cardiovascular mortality rates were 21% lower than in German 
women (period between 1993 and 1994) 39. The French study showed that Moroccan 
men had a lower mortality risk than men in the general population, but Moroccan 
women had a higher mortality risk compared to the French general population 38.
Two reports had data on stroke in Turks or Moroccans and the indigenous population 27,38, 
and no clear differences between the groups were observed.
DIsCussIon
The reviewed studies proved only a limited number of valid estimates of cardiovascular 
risk in Turks or Moroccans immigrants versus the indigenous population. Available 
evidence shows that diabetes mellitus is more prevalent in both Turkish and Moroccan 
immigrants; smoking more is prevalent in Turkish males and less prevalent in Moroccan 
females. In addition, HDL-cholesterol seems lower in Turkish men, and the prevalence 
of obesity is higher in Turkish men and women. Data on cardiovascular death rates are 
rare: in one study, the rate was strikingly lower in Turkish German immigrants compared 
to the German population.
 
study quality 
To assess study quality, important indicators of quality are the methods to measure 
cardiovascular risk, the response rate and sample size. In most studies, measurements 
were based on self-reports and are therefore inadequate for assessing the ‘‘true’’ 
prevalence of hyperglycemia or diabetes, hypertension, and hypercholesterolemia, 
and the presence of cardiovascular disease. The response rate was often low (less than 
70%) in five studies, and not even mentioned in five other studies. Therefore, response 
could have biased the results. In addition, the study sample size in about 50% of the 
studies was less than 250 persons, and due to the population structure of immigrant 
groups, the proportion of elderly immigrants in all study samples was very small. 
Because risk factors are related to aging 40,41, larger numbers of elderly immigrants are 
needed in a study to allow valid conclusions to be drawn.
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Prevalence of diabetes and other cardiovascular risk factors 
Type 2 diabetes is more frequent among Turkish and Moroccan immigrants than 
among Europeans. A higher frequency of type 2 diabetes among immigrants was also 
reported in many other studies 8,10,42,43. This phenomenon can be explained by genetic 
susceptibility, which is unmasked by environmental factors such as nutritional factors, 
obesity, physical inactivity, and stress 10,43. Obesity is strongly associated with type 2 
diabetes 44,45, and the high prevalence of diabetes may be caused by a high prevalence 
of obesity in Turks and Moroccans 46,47. 
The prevalence of smoking in Turkish male immigrants is comparable to the reported 
prevalence among Turks in Turkey (58% versus 51%) and higher than in the indigenous 
population (44%). The prevalence of smoking in Turkish female immigrants is, however, 
higher than reported among Turkish females in Turkey (24% vs. 11%) 40. This might be 
explained by an unfavorable influence of Westernization on smoking behavior among 
Turkish women, but in particular, not in Moroccan female immigrants, since smoking 
is rare in the latter group. However, this difference might also be due to selection of the 
migrant population. 
For total cholesterol and hypertension, the picture remains unclear. Studies including 
measurements in large samples in Turkish or Moroccan immigrants are rare and produce 
contrasting results.
Cardiovascular disease and mortality 
In one of the few available studies, the cardiovascular mortality rate in Turkish 
immigrants in Germany (both men and women) was lower than the rate in the 
German indigenous population, particular in men, while the proportion of all-
cause mortality attributable to cardiovascular disease was somewhat higher in 
Turkish men and evidently higher in Turkish women. The combination of a higher 
contribution of cardiovascular disease to mortality in Turkish immigrants and 
lower cardiovascular death rates can only be explained by an even lower overall 
mortality in Turks, particular in Turkish women, compared to the indigenous 
population. Low overall mortality rates in immigrants are found in Germany 48 
and were also reported among Turkish and Moroccan immigrants in the 
Netherlands 49,50, in Sweden 51, and North African immigrants in France 52. Lower 
mortality rates among immigrants are often explained by ‘‘the healthy migrant 
effect’’, implying that migrants represent a relatively healthy selection from a 
population. The fact that in a French study, North African women had a higher 
risk of dying from a cardiovascular disease and a similar overall mortality risk 
is probably partly attributable by a lack of such a positive selection, since the 
reason for migration was not related to work 52. Other explanations for low overall 
mortality rates in migrants are also possible. 
Firstly, the studied populations are not fixed but are largely extended by newcomers 53. 
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Data on the Turkish population in Germany show a 27% increase of the Turkish 
population between 1981 and 1994, but the same data show that a large number (over 
40%) of Turkish immigrants aged 35 years and older left Germany in this same period 39. 
Thus, low mortality rates in immigrants could be the result of loss to follow-up. 
Secondly, data on remigration are not given to the national registration authorities, 
resulting in overestimations of the immigration population (i.e., the denominator 
of the mortality rate), resulting in lower mortality rates. Indeed, by trying to adjust 
for such an overestimation of the immigrant population, the mortality rates in 
immigrant Turks in Sweden increased 51. A very recent report (September 2003) 
from Sweden showed higher relative risk of cardiovascular disease in Turks 
compared to Swede [in men, 1.44 (95% CI 1.24–1.66); in women, 1.52 (1.23–
1.88)] 54. This finding gives further prove that the CVD rates in Turkish immigrants 
are possibly underestimated. 
search limitations 
The first step was a search in MEDLINE, and EMBASE yielded 354 papers of which 20 
were selected. Most of the not-selected articles contained no original prevalence data 
on diabetes or cardiovascular risk factors or involved other groups than the Turks or 
Moroccans. With the second step, we searched the selected reports to collect missed 
publications. This, however, concerns earlier reports; therefore, recent publications (from 
2002) may have been missed. Furthermore, by using a Dutch report investigating other 
Dutch reports on cardiovascular risk as source for identifying relevant publications, the 
chance for a Dutch study to be selected for this review is larger than studies from other 
countries. This could have led the to over-presentation of Dutch studies in this review. 
However, this potential overpresentation of Dutch studies probably did not effect our 
main conclusions on diabetes and smoking because the different studies reviewed all 
had similar conclusions. 
We conclude that in other minority groups in Western societies, type 2 diabetes in 
Turkish and Moroccan immigrants is more prevalent than among the indigenous 
population, and smoking is more prevalent in Turkish men and rare in Moroccan 
women. The available data on the prevalence of the other cardiovascular risk factors 
(hypertension and lipid profile) and cardiovascular disease in these groups are, 
however, insufficient to allow definite conclusions. More studies using objective 
screening methods (such as ECG and blood samples) and well-standardized 
criteria for the diagnosis of cardiovascular disease are needed. The finding of lower 
cardiovascular mortality rates in a single study in Turkish men requires confirmation 
from future studies.
2STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
PrEvalEncE of tyPE 2 dIabEtES MEllItuS...
referenCes
1  Khattar RS, Swales JD, Senior R, Lahiri A. Racial variation in cardiovascular morbidity 
and mortality in essential hypertension. Heart 2000;83:267– 71.
2  Chaturvedi N, Jarrett J, Morrish N, Keen H, Fuller JH. Differences in mortality and 
morbidity in African Caribbean and European people with non-insulin-dependent 
diabetes mellitus: result of 20-year follow-up of a London cohort of a multinational 
study. BMJ 1996; 313:848– 52.
3   Anonymous, U.K. Prospective Diabetes Study Group. The incidence of myocardial 
infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes 
(U.K. Prospective Diabetes Study 32). Diabetes Care 1998;21:1271– 7.
4   Balarajan R. Ethnicity and variations in mortality from coronary heart disease. Health 
Trends 1996;28:45– 51.
5  Joffe B, Zimmet P. The thrifty genotype in type 2 diabetes: an unfinished symphony 
moving to its finale? Endocrine 1998;9:139– 41.
6  Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk 
factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross-
sectional study. BMJ 1999;319: 215– 20.
7  Sundquist J, Winkleby M. Country of birth, acculturation status and abdominal 
obesity in a national sample of Mexican–American women and men. Int J Epidemiol 
2000;29:470–7.
8   Zimmet P. Type 2 (non-insulin-dependent) diabetes—An epidemiological overview. 
Diabetologica 1982;22:399– 411.
9   Cappucio FP, Cook DG, Atkinson RW, Strazullo P. Prevalence, detection, and 
management of cardiovascular risk factors in different ethnic groups in South 
London. Heart 1997;78:555–63.
10  Abate N, Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabetes 
Complications 2003;17:39 –58.
11  Magnus MH. Cardiovascular health among African-Americans: a review of the health 
status, risk reduction, and intervention strategies. Am J Health Promot 1991;5:282– 90.
12  Cappuccio FP. Ethnicity and cardiovascular risk: variations in people of African 
ancestry and South Asian origin. J Hum Hypertens 1997; 11:571– 6.
13  Burden AC. Blood pressure control and cardiovascular risk in patients of Indo-Asian 
and African-Caribbean descent. Int J Clin Pract 1998; 52(6):388– 94.
14  Brancati FL, Kao WH, Folsom AR,Watson RL, Szklo M. Incident type 2 diabetes 
mellitus in African-American and white adults: the Atherosclerosis Risk in 
Communities Study. JAMA 2000;283:2253– 9.
15 Burden AC. Diabetes in Indo-Asian people. Practitioner 2001;245: 445– 51.
16  Cooper RS, Rotimi CN, Kaufman JS, Owoaje EE, Fraser H, Forrester T, et al. Prevalence 
of NIDDM among populations of the African Diaspora. Diabetes Care 1997;20:343–8.
28 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 2
17  Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK 
higher or lower than that in European white adults? A review of cross-sectional data. 
J Hum Hypertens 2002;16:739– 51.
18  Menotti A, Blackburn H, Kromhout D, Nissinen A, Adachi H, Lanti M. Cardiovascular 
risk factors as determinants of 25-year all-cause mortality in the seven countries 
study. Eur J Epidemiol 2001;17:337– 46.
19  Kunst AE, Groenhof F, Mackenbach JP, The EU Working Group on Socio-economic 
Inequalities in Health. Occupational class and causespecific mortality in middle 
aged men in 11 European countries: comparison of population-based studies. BMJ 
1998;316:1636– 42.
20  Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 
2001;156:1–10.
21  Leest LATM, Dis SJ, Verschuren WMM. Hart-en vaatziekten bij allochtonen in 
Nederland (Cardiovascular disease in non-Western immigrants in the Netherlands), 
The Dutch National Institute of Public Health and Environmental Protection. 
Bilthoven: RIVM; 2002. RIVM publication 261858006/2002.
22  Bleeker JK, Reelick NF. De gezondheid van Marokkanen in de randstad (Health in 
Moroccans living in the urban agglomeration of Western Holland). Rotterdam: Area 
Health Authority, community interventions sector Health Promotion; 1998.
23  Brussaard JH, Brants HAM, Erp-Baart van AJM, Hulshof KFAM, Kistenmaker C. 
De voeding bij allochtone bevolkingsgroepen. Deel 3. Voedingsconsumptie en 
voedingstoestand bij Marokkaanse, Turkse en Nederlandse 8-jarigen en hun 
moeders. Zeist: TNO Nutrition and Food research; 1999. TNO-rapport V99.855.
24  Centraal Bureau voor de Statistiek en Koninklijk Instituut voor de Tropen. 
Gezondheidsenqueˆte Turkse ingezetenen in Nederland, 1989/90 (Health 
interview survey Turkish inhabitants in the Netherlands). Den Haag: CBS Statistics 
Netherlands; 1991.
25  Dijkshoorn H. Amsterdamse Gezondheidsmonitor (Amsterdam periodic health 
interview survey). Amsterdam: Amsterdam Area Health Authority; 2002, cluster EDG.
26  Dijkstra S, Klok M, Hoogenhuyze van D, Sauerwein HP, Berghout A. Ischaemic 
heart disease in Turkish migrants with type 2 diabetes mellitus in the Netherlands: 
wait for the next generation? Neth J Med 2002;60:21– 4.
27  Stadsenquête Den Haag 2001 (City health interview survey the Hague 2001) The 
Hague: Bestuursdienst Gemeente Den Haag, Municipality; 2001, p. 1– 87.
28  Köycü B, Kara T, Camlidag O, Aydinli R, Verschuren WMM, Motfrans van GA. 
Risicofactoren voor hart-en vaatziekten bij Turken in Amsterdam en in Ankara (Risk 
factors for cardiovascular disease in Turks in Amsterdam and Ankara), Ned Tijdschr 
Geneeskd 1997; 141:881–8.
29  Middelkoop BJC, Bohnen AM, Duisterhout JS, Hoes AW, Pleumeekers HJCM, Prins 
A. Rotterdam general practitioners report (ROHAPRO): a computerised network of 
29STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
PrEvalEncE of tyPE 2 dIabEtES MEllItuS...
general practices in Rotterdam, The Netherlands. J Epidemiol Community Health 
1995;49: 231– 3.
30  Porsch-Oezcueruemez M, Bilgin Y, Wollny M, et al. Prevalence of risk factors of 
coronary heart disease in Turks living in Germany: the Giessen study. Atherosclerosis 
1999;144:185– 98.
31  Reijneveld SA. Reported health, lifestyles, and use of health care of first-generation 
immigrants in the Netherlands: do socio-economic factors explain their adverse 
position? J Epidemiol Community Health 1998;52:298– 304.
32  Swinkels H. Smoking and drinking behaviour of Turkish inhabitants of the 
Netherlands, 1989/1990. Maandber Gezondh.stat (CBS) 1992; 7:5–17.
33  Uniken Venema P. Toen ik hier kwam was ik kerngezond; de gezondheid van Turkse 
in Nederland (I was healthy when I came here; the health situation of Turks in the 
Netherlands). Phd thesis, Erasmus University Rotterdam, 1989.
34  Weide MG, Foets M. Migranten in de huisartspraktijk: andere klachten en diagnosen 
dan Nederlanders (Migrants in general practice: different from the Dutch in 
complaints and diagnosis), Ned Tijdschr Geneeskd 1998;142:2105– 9.
35  Weijers RNM, Bekedam DJ, Oosting H. The prevalence of type 2 diabetes and 
gestational diabetes mellitus in an inner city multi-ethnic population. Eur J Epidemiol 
1998;14:693–9.
36  Weijers RNM, Goldschmidt HMJ, Silberbusch J. Vascular complications in 
relation to ethnicity in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 
1997;27:182– 8.
37  Mackenbach JP. Ziekte en sterfte onder Turken in Nederland (Morbidity and mortality 
among Turks in the Netherlands), Ned Tijdschr Geneeskd 1992;136:1044– 9.
38  Khlat M, Courbage Y. Mortality and causes of death of Moroccans in France, 1979–
91. Population: an English selection. Population 1996; 8:59–94. 
39  Razum O, Zeeb H, Gerhardus A. Cardiovascular mortality of Turkish nationals 
residing in West Germany. Ann Epidemiol 1998;8: 334–41.
40  Satman I, Yilmaz T, Segül A, et al. Population-based study of diabetes and risk 
characteristics in Turkey. Diabetes Care 2002; 25:1551– 6.
41  Nanas S, Pan WH, Stamler J, et al. The role of relative weight in the positive 
association between age and serum cholesterol in men and women. J Chronic Dis 
1987;40:887– 92.
42  Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, 
including Europeans, in a British inner city. Diabetes Care 2001;24:1377– 83.
43  Hara H, Egusa G, Yamakido M, Kawate R. The high prevalence of diabetes mellitus 
and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los 
Angeles. Diabetes Res Clin Pract (Suppl.) 1994;24:S37–42.
44  Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for 
clinical diabetes mellitus in women. Ann Intern Med 1995;122:481– 6.
30 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 2
45  Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from 
a national cohort of US adults. Am J Epidemiol 1997;146:214– 22.
46  Erem C, Yildiz R, Kavgaci H, Karahan C, Deger O, Can G, et al. Prevalence of 
diabetes, obesity and hypertension in a Turkish population (Trabzon city). Diabetes 
Res Clin Pract 2001;54: 203–8.
47  Kadiri EQ. Le diabete non insulino-dependant a` safi. Dossiers population et Sante´, 
vol. 2. Rabat: Royaume du Maroc Ministere de la Sante´ Publique; 1994.
48  Razum O, Zeeb H, Akgün S, Yilmaz S. Low overall mortality of Turkish residents in 
Germany persists and extends into a second generation: merely a healthy migrant 
effect? Trop Med Int Health 1998;3:279– 303.
49  Uitenbroek DG, Verhoeff AP. Life expectancy and mortality differences 
between migrant groups living in Amsterdam, The Netherlands. Soc Sci Med 
2002;54:1379– 88.
50  Middelkoop BJC, Koolwijk van AFM. Sterfte naar etniciteit en sociaal-economische 
positie: gunstige cijfers voor de Hagenaars van mediterrane afkomst (Mortality 
according to ethnicity and social economic position: favourable data in Hague 
inhabitants of Mediterranean descent), Epidemiol Bull 2002;37:15–24.
51  Ringbäck Weitoft G, Gullberg A, Hjern A, Rose´n M. Mortality statistics in immigrant 
research: method for adjusting underestimation of mortality. Int J Epidemiol 
1999;28:756– 63.
52  Darmon N, Khlat M. An overview of the health status in France, in relation to their 
dietary practices. Public Health Nutr 2001; 4:163– 72.
53  Centraal Bureau voor de Statistiek en Koninklijk instituut voor de Tropen. 
Bevolkingstrends, 1e kwartaal 2003 (Population trends) Voorburg: Statistics 
Netherlands CBS; 2003
54  Gadd M, Johansson S-E, Sundquist J, Wandell P. Morbidity in cardiovascular disease 
in immigrants in Sweden. J Intern Med 2003; 254:236– 43.
Ethnic specific recommendations in 
clinical practice guidelines: a first 
exploratory comparison between 
guidelines from the USA, Canada, the 
UK, and the Netherlands.
Manna DR, Bruijnzeels MA, 
Mokkink HGA, Berg M.
3
Quality and Safety in Health Care 2003; 12: 353-358
32 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 3
AbstrACt
objectives: To investigate whether clinical practice guidelines in different countries 
take ethnic differences between patients into consideration and to assess the scientific 
foundation of such ethnic specific recommendations.
Design: Analysis of the primary care sections of clinical practice guidelines.
setting: Primary care practice guidelines for type 2 diabetes mellitus, hypertension, and 
asthma developed in the USA, Canada, the UK, and the Netherlands.
Main outcome measures: Enumeration of the ethnic specific information and 
recommendations in the guidelines, and the scientific basis and strength of this evidence.
results: Different guidelines do address ethnic differences between patients, but to a 
varying extent. The USA guidelines contained the most ethnic specific statements and 
the Dutch guidelines the least. Most ethnic specific statements were backed by scientific 
evidence, usually arising from descriptive studies or narrative reviews.
Conclusion: The attention given to ethnic differences between patients in clinical 
guidelines varies between countries. Guideline developers should be aware of the 
potential problems of ignoring differences in ethnicity.
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IntroDuCtIon
Over the past 20 years clinical practice guidelines have become an increasingly 
popular tool for implementation of scientifically based clinical information to improve 
the quality of health care. Many countries have produced such guidelines, mainly via 
specialist and/or general practice organisations. As defined by the Institute of Medicine 
(USA), clinical practice guidelines are “systematically developed statements to assist 
practitioner and patient decisions about appropriate health care for specific clinical 
circumstances”.1 These statements should be based on the best available scientific 
evidence and practical knowledge; however, the increasing number of clinical 
guidelines has stimulated discussion about their value.2–6 
An area that has received less attention in such discussions is the “specific clinical 
circumstances”. Besides the disease specific characteristics, the “specific clinical 
circumstances” usually refer to the age and sex of the patient. However, with the 
increase in migration to western countries during the last 50 years, these western 
countries have increasingly become moremulticultural and physicians are increasingly 
confronted with patients from diverse ethnic groups. In some of these groups particular 
diseases can be more prevalent or more severe, and this may also determine the 
patient’s clinical circumstance.7–10 Ignorance of ethnic differences between patients 
could lead to inferior quality of care for ethnic minorities. Many potentially avoidable 
procedures such as amputations, avoidable hospital admissions and readmissions, 
avoidable pain from cancer, untreated disease, and deaths are associated with a lower 
quality of care for ethnic minorities.11 12 The question as to whether ethnicity should 
be a specific clinical circumstance systematically taken into consideration in clinical 
practice guidelines has not yet been fully addressed. The aim of the present study was 
to investigate whether clinical practice guidelines in different countries take ethnic 
differences between patients into consideration, and the scientific basis and strength of 
such ethnic specific recommendations. 
MethoDs
The clinical guidelines for three prevalent and chronic health problems—type 2 diabetes 
mellitus, hypertension, and asthma—used in four western countries were examined between 
2000 and July 2001. These particular health problems were selected because of the relatively 
high impact of these diseases in western countries and because of the expected differences 
between members of different ethnic groups. For these three health problems primary care 
guidelines from national organisations in the USA, Canada, the UK, and the Netherlands 
were analysed (n=13; one guideline per disease from each country except the Dutch 
asthma guidelines which consisted of two separate guidelines, one for diagnostics and one 
34 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 3
for treatment). The USA guidelines were developed by the National Heart, Lung and Blood 
Institute (asthma 1997; hypertension 1997) and the American Diabetes Association (2001),13–15 
the Canadian guidelines by the Canadian Medical Association (asthma 1999; 
hypertension 1999; diabetes 1998),16–18 the British guidelines by the British Thoracic 
Society (1997), the British Hypertension Society (1999), and Diabetes UK (2000),19–21 
and the guidelines used by Dutch general practitioners (GPs) were developed by the Dutch 
College of General Practitioners (asthma 2001; hypertension 1997; diabetes 1999).22–25 
Because some guidelines covered the whole spectrum of care and others focused on 
primary care only, we studied only the primary care sections of the different guidelines. 
Each guideline was carefully examined (by DRM) and any ethnic specific statement and/or 
recommendation made was marked and noted. This procedure was repeated (by MAB) and 
an inter-rater agreement was calculated. Consensus was reached in all cases of disagreement. 
The identified statements were then organised into the following coherent themes:
• epidemiology (including aetiology);
• diagnostics (including screening);
• treatment (including therapy);
• patient education;
• (content of) medical record;
• (overall) cultural sensitivity.
The statements were designated either as merely empirical information/facts or as 
specific recommendations in the guidelines. The underlying scientific evidence for each 
box 1 
Categories of strength of evidence of statements in clinical guidelines (developed by the north of 
england evidence-based guideline development project)
Ia: Evidence from meta-analysis of randomised controlled trials
Ib: Evidence from at least one randomised controlled trial
IIa: Evidence from at least one controlled study without randomisation
IIb: Evidence from at least one other type of quasiexperimental study
III:  Evidence from descriptive studies, such as comparative studies, correlation studies and case 
controlled studies
IV:  Evidence from expert committee reports or opinions or clinical experience of respected 
authorities, or both.
IV*: Narrative reviews
*Narrative reviews could not be properly categorised into the categories of the North of England 
evidence-based guideline development project. For this reason we added IV* to the existing 
categories.
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ethnic specific statement was collected by checking all the references mentioned in 
the guideline for the specific statements; by reading the evidence, the strength of the 
evidence was then graded according to an adjusted version of the schemes of the North 
of England guideline development project (box 1).26
results
The overall inter-rater agreement was good. Forty seven segments of text regarding 
ethnic differences were identified in the guidelines, of which 42 were identified by both 
authors (inter-rater agreement: 89%). All 47 were included in the analysis.
Category type of statement  statement about ethnic differences  Country  evidence  strength
Epidemiology  Empirical  Higher prevalence  USA  Fujimoto (1987)27  III
    Zimmet (1992)28  IV*
    Harris (1995)29  IV*
   CAN  Dean (1992)30  III
    Delisle (1993)31  III
    Fox (1994)32  III
    Harris (1997)33  III
    Harris (1997)34  III
    Dean (1998)35  IV
    Tuomilehto (1992)36 IV
   UK  No reference  –
   NL  Berghout (1995)37  III
    Bongers (1995)38  III
    Querido (1995)39  III
    Reitsma (1995)40  IV*
Diagnostics  Recommendation  Testing for diabetes at younger   USA  Harris (1995)29†  IV*
  age or more frequently CAN  No reference  –
 Recommendation  Screening if patient is 45 years (or older)  NL  Berghout (1995)37†  III
  and member of ethnic group  Bongers (1995)38†  III
    Querido (1995)39†  III
    Reitsma (1995)40†  IV*
 Recommendation  Aggressive screening for complications  CAN  No reference  –
 Recommendation  Community based screenings programs  CAN  Delisle (1993)31†  III
  should be established  Harris (1997)33†  III
 Recommendation  Primary prevention programs initiated   CAN  Delisle (1993)31†  III
  by Aboriginal communities should   Harris (1997)33†  III
  be encouraged
 Recommendation In identifying patients the higher   UK  No reference  –
  prevalence should be remembered
Patient education  Recommendation  Nutrition recommendations should   USA  No reference  –
  consider cultural and ethnic background CAN  No reference  –
Medical record  Recommendation  Medical history and management plan   USA  No reference  –
  should consider important cultural factors
Cultural sensitivity  Recommendation  Respect for unique cultural issues  CAN  No reference  –
*Narrative reviews.
†There was no reference mentioned for this particular statement in the guideline, but because this statement is based on information 
about risk factors (high prevalences), it is probably based on the evidence about a higher prevalence in certain ethnic groups.
tAble 1
Guidelines on diabetes mellitus type 2: comparison between countries on ethnic specific statements 27–40
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ethnic specific information in diabetes guidelines 
Table 1 gives the analysis of the diabetes guidelines. All four guidelines made an 
empirical statement about a higher prevalence of diabetes among certain ethnic groups. 
The US, Canadian and, to a lesser extent, the UK and Dutch guidelines had some 
additional statements (related mainly to diagnostics/screening) about the consequences 
of this higher prevalence. The statements in the Canadian guideline were presented 
in a separate section dedicated to diabetes among their aboriginal population, except 
the recommendation to obtain insight into the ethnic and cultural influences on the 
nutrition of the patient.
Category  type of statement  statement about ethnic differences  Country  evidence  strength
Epidemiology  Empirical  Higher prevalence, more severe and    USA  Klag (1997)41  IIb
  higher risk for complications  Burt (1995)42  III
    Fang (1996)43  III
    Singh (1996)44  III
    Havas (1996)45  IV*
    Hall (1997)46  IV*
   UK  Balarajan (1991)56  III
    McKeigue (1991)57  III
    Cappuccio (1997)8  III
    Williams (1995)58  IV
Treatment  Empirical  Difference in response to  USA  Townsend (1990)47  Ib
  pharmacological treatment  SOLVD (1991)48  Ib
    Materson (1993)49  Ib
    Chen (1993)50  IIa
    Chen (1995)51  IIa
   UK  Materson (1993)49  Ib
 Empirical  Hypertension is sensitive to dietary salt    USA  Weinberger (1996)52  IV*
  restriction in black subjects UK  No reference  –
 Empirical Lifestyle modifications are   USA  No reference –
  particularly important
 Recommendation  Black subjects require multi-drug therapy  USA  Burt (1995)42†  III
  because of more severe hypertension  Hall (1997)46†  IV*
 Recommendation  Achieve goal blood pressure of below   USA  Burt (1995)42†  III
  140/90 mm Hg  Hall (1997)46†  IV*
 Recommendation  Emphasis on glucose tolerance, lipids and   UK  McKeigue (1991)57  III
  increased coronary risk  Williams (1995)58  IV
 Recommendation  Good blood pressure control important in  UK  No reference  –
  South Asians with diabetes
 Recommendation  Aspirin and/or statin treatment may be   UK  No reference  –
  indicated for South Asians at high risk 
  of CHD
 Recommendation  The start of drug therapy should be    CAN  No reference  –
  influenced by black race
Patient education  Empirical  Requirement of more focused education  USA  Enas (1996)53  III
    Howard (1996)54  III
    Winkleby (1996)55  III
    Havas (1996)45  IV*
 Recommendation  Advice to reduce fat and refined sugar   UK  No reference  –
  intake and to increase exercise
*Narrative reviews.
†There was no reference mentioned for this particular statement in the guideline, but because this statement is based on information 
about risk factors (high prevalences), it is probably based on the evidence about a higher prevalence in certain ethnic groups.
tAble 2
Guidelines on hypertension: comparison between countries on ethnic specific statements8 41–58
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scientific basis of ethnic specific information in diabetes guidelines
For diabetes the different guidelines used different sources of evidence (research papers) 
for their ethnic specific statements. The evidence was mainly type III (descriptive) 
prevalence studies and all addressed their own national situation. 
ethnic specific information in hypertension guidelines
Table 2 presents the analysis of the hypertension guidelines. The Dutch guideline 
contained no ethnic specific statements, the Canadians had only one such statement 
(albeit an important one), and the US and UK reported more extensively (in separate 
paragraphs) about ethnic differences. The guidelines made empirical statements about 
(1) a higher prevalence, more severe hypertension, and a higher risk of complications in 
certain ethnic groups; (2) the difference in response to pharmacological treatment; and 
(3) the higher sensitivity to dietary salt restriction among black subjects. These empirical 
statements led to different treatment recommendations in the respective guidelines.
scientific basis of ethnic specific information in hypertension guidelines
For epidemiology the evidence was primarily from type III (descriptive) studies or 
narrative reviews, while the evidence for the differential response to pharmacological 
treatment was mainly from randomised controlled trials. One study (type Ib) was used 
as evidence in both the US and UK guidelines. 
ethnic specific information in asthma guidelines
In the asthma guidelines (table 3) one empirical statement about the ethnic variability 
of lung function was found in both the US guideline (in a separate paragraph) and 
in the Dutch guideline. The US guideline also stressed the importance of a culture 
sensitive approach to the patient. The Canadian guideline made no ethnic specific 
statements, and the UK guideline had only one minor remark about the failure of 
attending education programmes.
scientific basis of ethnic specific information in asthma guidelines
Almost all evidence in the guidelines for asthma were based on type III (descriptive) studies.
DIsCussIon
The results of this study show that clinical guidelines from the four western countries 
do contain ethnic specific information and recommendations, but to a varying extent. 
The Dutch guidelines contained only a few empirical facts and only once made an 
additional specific recommendation based on these facts. The other three guidelines 
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Category  type of statement  statement about ethnic differences  Country  evidence  strength
Epidemiology  Empirical  Hospitalisation and death rates highest   USA  CDC (1996)59  III
  among black subjects
Diagnostics  Empirical  Lung function varies across ethnic groups  USA  Woolcock (1972)60  III
    Hsu (1979)61  III
    Wall (1982)62  III
    Coultas (1988)63  III
    Crapo (1988)64  III
    Marcus (1988)65  III
    Coultas (1994)66  IV*
   NL  Quanjer (1983)74  IV*
    Quanjer (1993)75  IV*
Patient education  Empirical  Failure of attending education programs is  UK  Fitzgerald (1994)73  IV
  associated with minority ethnic group
 Recommendation  Asthma education in native language and  USA  Manson (1988)67  III
  sensitive to patient’s culture  Pachter (1993)68  III
    Pachter (1995)69  III
    Risser (1995)70  III
    Kleinman (1978)71  IV
    Woloshin (1995)72  IV
Medical record  Recommendation  Sociocultural beliefs should be an item   USA  No reference  –
  in medical history
*Narrative reviews.
tAble 3
Guidelines on asthma: comparison between countries on ethnic specific statements59–75
added more recommendations to the empirical facts, only for hypertension in the case 
of the UK, only for diabetes in the case of Canada, but for all three health problems in 
US guidelines. The US guidelines therefore gave the most attention to ethnic differences 
by presenting empirical facts as well as formulating specific recommendations.
Because most of the statements about ethnic differences in the different guidelines 
were based on differences in epidemiology (prevalences), the scientific evidence used 
consisted mainly of descriptive studies or narrative reviews and addressed their national 
situation. The US guidelines tended to use more evidence.
This is a first exploratory study of the attention given in clinical practice guidelines to 
ethnic differences. We focused on guidelines from only four western countries and 
thereby narrowed our scope considerably. Although our comparison is useful, it would be 
interesting to broaden it in further research by including guidelines from other countries 
with a relatively large group of subjects from ethnic minorities. 
It is difficult to give an explanation for the difference in focus on ethnic differences in 
the guidelines found in this study because the guidelines are produced and used in 
the complex environment of a healthcare system. Ethical, economic, legal, political, 
and cultural aspects are involved which vary in the different countries. Because of 
historical developments, countries may have their own specific way of approaching 
ethnic differences. The USA and Canada, for example, have a long history of being 
multicultural societies with relatively large groups of native inhabitants and other 
subgroups. In the UK and the Netherlands, however, ethnic minorities are a more 
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recent phenomenon resulting from labour and colonial migrants. These differences in 
historical background have led to political and cultural differences in facing questions 
concerning minority groups. Whereas the USA places both cultural and political 
emphasis on differences in ethnic identities, other countries do this to a lesser extent, 
resulting in other normative values. All these aspects could impact on the process of 
guideline development—for example, on the composition of the panel developing 
the guidelines which, in turn, could influence the process of decision making in the 
selection of relevant evidence and in the content of the guidelines.6 76–80 Although 
guidelines are considered to be products of evidence-based medicine and therefore 
primarily based on available scientific evidence, they always contain (either explicit 
or implicit) normative values of (individual) panel members.
Another factor to consider is the possibility that, because mainly local/national evidence 
was used to develop the ethnic specific recommendations, panel members in one 
country may consider that data are only applicable to ethnic groups in the country 
where the research was conducted. But do Afro-Americans in the USA differ from black 
subjects in the Netherlands and the UK; and do South Asians living in the USA differ 
from those in the UK, Canada or the Netherlands? As far as the medical differences 
discussed in this paper are concerned, the answer is probably not, because it is often 
reported that the higher prevalence and severity of diabetes and hypertension in certain 
ethnic groups and the differences in response to drugs result, at least in part, from 
genetic differences and the migration process.82 83
The above considerations raise interesting questions as to whether cultural differences 
between countries can explain different normative values between groups of guideline 
developers resulting in more or less ethnic specific recommendations in the guidelines, 
and whether health information about certain minority ethnic groups is applicable to 
similar groups in other countries. Since disease or health specific data on white subjects 
are accepted worldwide, it is legitimate to question why this does not apply to scientific 
data on differences between other ethnic groups. Future research should try to find the 
answers to these questions. 
The development of guidelines is a complicated process in which many heterogeneous 
considerations are weighed against each other. Guidelines must be feasible and as clear, 
understandable and unambiguous as possible, given current healthcare practices. There 
will always be some reluctance about changes in current practice, and in describing 
exceptions and, for example, ethnic differences.Nevertheless, ethnic differences are 
present in all western societies and this issue can expect a higher priority in future 
research and health care. However, at present, the proportion of ethnic minorities in 
deprived neighbourhoods in the UK and the Netherlands is very large and, for the 
care in those underprivileged areas, ethnic specific recommendations in guidelines can 
already help practitioners in their daily practice and therefore should be implemented 
as soon as possible. If clinical recommendations do not accept the existence of 
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clinically relevant ethnic differences in, for example, prevalence/complications and 
response to pharmacological treatment, suboptimal or even harmful practices may 
occur.84 This also applies to the need for ethnic specific education and counselling and 
sensitivity towards differences in cultural values and norms, particularly when a positive 
clinical effect has been proved. By disregarding scientific evidence, the guideline may 
provide inaccurate information and thereby compromise the quality of care84; and 
by disregarding scientific evidence, the higher morbidity and mortality and the higher 
risk of complications with hypertension and diabetes will continue or even get worse 
because, in the Netherlands, for example, members of the ethnic minority groups are 
relatively young and will therefore be faced with more morbidity in the future.
ConClusIons
Differences in the attention given to ethnic differences between patients in clinical 
practice guidelines exist between countries.Whatever the explanations may be for 
these differences, guideline developers should be aware of the potential problems for 
patients from ethnic minority groups. Ethnic differences should play an important part 
in both screening the available evidence and in the development of the guideline—for 
example, the composition of the expert panel. With the increasing movement of people 
between countries, this aspect will become even more important in the future.
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AbstrACt
objective: To assess whether ethnic differences were present in the scientific foundation 
of GP-guidelines and whether these ethnic-specific remarks resulted in ethnic specific 
information in the guidelines.
Design: Content analysis
Method: The used scientific foundation for the guidelines about type 2 diabetes mellitus 
(DM2), asthma in adults and hypertension was collected and carefully screened. 
Relevant ethnic-specific information was written down and compared to the content 
of the guidelines.
results: Different relevant ethnic differences were mentioned in the scientific foundation. 
Differences in prevalence, onset and complications were stated. The foundation 
for asthma mentioned differences in lung-volume and for hypertension mentioned 
differences in prevalence, onset, complications, and response to pharmacological 
treatment and dietary salt restriction. The DM2-guideline mentioned a higher prevalence 
of diabetes in Hindustanic people and recommended earlier screening. The asthma 
guidelines mentioned that the lung volume is dependent of ethnicity. The hypertension 
guideline did not mention any ethnic-specific information
Conclusion: A limited number of ethnic differences in the scientific foundation were 
taken over in the guidelines. Possible explanations could be normative values from 
guideline developers about the adaptation of evidence in guidelines and the possible 
political or social reluctance against distinctions based on ethnicity. However, a possible 
consequence is an ineffective or sub-optimal care for ethnic minorities. Especially GPs 
in multicultural neighbourhoods, with a relatively large ethnic population, benefit from 
guidelines which pay attention to ethnic differences between patients.
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thE dutch collEgE of gEnEral PractItIonErS’ guIdElInES...
IntroDuCtIon
Since the 1960s the Netherlands has increasingly changed into a multicultural society. 
More than 9 percent of the Dutch population currently belongs to an ethnic minority group 
and the forecast is that this will increase to 15 percent by 2015. 1 Many multicultural, 
deprived neighbourhoods in large cities contain numbers of ethnic minority inhabitants 
that often exceed the corresponding number of native inhabitants. This increase in 
ethnic minorities has led to situations in which general practitioners in multicultural 
neighbourhoods are increasingly faced with ethnically diverse patient populations. 
Compared to the native populations, such populations show differences in, among 
other things, the incidence and prevalence of certain diseases as well as complications, 
responses to medical therapy, experience of sickness, sickness behaviour, ideas about 
the origin of diseases, and often also differences in a linguistic sense 2,3. Such differences 
may, as a result of communication problems and cultural differences between ethnic 
minority patients and (native) general practitioners, lead to a reduction in the quality of 
health care, manifesting itself in incorrect diagnoses, increased workload for GPs, lower 
patient compliance and the incorrect or unnecessary use of health care provisions. 4,5
Official guidelines of medical treatment are important and universally accepted 
instruments that GPs have at their disposal in support of their daily practices. Such 
guidelines, as developed for Dutch GPs by the Dutch College of General Practitioners 
(NHG), have proved effective instruments in quality improvement. 6 By issuing these 
guidelines, the NHG aims to provide greater support for GPs as well as to reduce 
unacceptable differences in GP treatment. We hypothesise that, in order to achieve 
the same effective support for daily GP practice in multicultural districts, guidelines 
will have to take into account the ethnically diverse patient populations of GPs. Earlier 
research showed that the NHG refers relatively infrequently to ethnic differences in 
its standards, compared with, in particular American, but also British and Canadian 
guidelines. 7 Such infrequency may have various causes. We examined, first, whether 
ethnic differences between patients are, in fact, referred to in the scientific evidence 
gathered by the NHG in substantiation of its guidelines and, second, whether such 
references are traceable in the guidelines.
reseArCh MethoD
Of the four NHG standards concerning the chronic diseases diabetes mellitus type 2 
(1999), hypertension (1997) and asthma in adults (2001), we examined the professional 
literature which was referred to as the guidelines’ scientific justification.8-11 The asthma 
standard consists of two parts: one diagnostic part and one treatment part. (Text) books were 
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tAble 1 
terms indicating ethnicity in relation to which the scientific justification in the four nhG guidelines 
was screened* 
‘race’, ‘racial’
‘ethnic’, ‘ethnicity’
‘blacks’, ‘whites’ 
‘African-Americans’, ‘Indian patients’, ‘Asians’, et cetera
‘minority’
‘migrant’
‘native’, ‘non-native’
‘immigrant’
‘culture’, ‘cultural’
* The Dutch equivalents of these terms were also used in the screening process. 
excluded from the analysis (n=58), leaving original research documents, review articles, 
(consensus) guidelines, doctoral theses and editorials. (n=528). Each manuscript examined 
was carefully screened for terms referring to ethnicity (as indicated in table 1). Each time 
a term was used, the text was marked. Since most references to ethnic differences were 
limited to largely irrelevant comments -- varying from a research population containing 
a certain ethnic subgroup about which the analysis subsequently had nothing further 
to say, or references to ethnicity-based adjustments in analyses, to marginal comments 
on ethnic differences in introductions or discussions – and since such references were 
consequently not usable as a form of scientific justification for standards, a distinction was 
made between relevant and irrelevant comments. A comment was marked as relevant 
if it was, first, based on empirical research (in which expert consensus was also being 
assumed to be empirical substantiated) and, second, if it compared an ethnic minority 
group with a native/dominant group. Subsequently, the text of the standard was read and 
the comments in the literature were compared with those in the standard. 
results
Table 2 shows the number of manuscripts used as scientific justification for the four 
standards plus the number that was eventually screened. Five manuscripts referred to 
could not be found. 523 manuscripts, accounting for nearly 90 percent of the scientific 
justification, were screened. In just over 7 percent of works screened, relevant information 
on ethnic differences was found. That information is summarised in table 3. 
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 Diabetes  Asthma hypertension
total number of manuscripts 187 (100%) 207 (100%) 191 (100%)
Excluded manuscripts* 14  (9%) 33 (16%) 11 (6%)
Undiscovered manuscripts 1 2 2
Screened manuscripts 172 (92%) 173 (84% ) 178 (93%)
Manuscripts containing   62 (36%) 25 (14%) 43 (24%)
some ethnic information
Total number of manuscripts  15 (9%)  7 (4%) 16 (9%)
containing relevant 
ethnic information**
* (text) books excluded 
** A comment was deemed ‘relevant’ if it was based on empirical evidence (judgements of experts being assumed to be similarly 
based on empirical evidence) and if it compared an ethnic minority group with a native/dominant group.
tAble 2
The number of manuscripts (%) used as a scientific justification for four NHG guidelines
 Justification Guideline
Diabetes mellitus type 2
Higher prevalence  + +
Earlier onset  + -
Higher risk of serious complications  + -
Three-yearly screening  - +
hypertension
Higher prevalence + -
Higher chance of serious complications  + -
Higher sensitivity to reduced salt intake  + -
Differential effects of medicines + -
Earlier onset  + -
More ‘aggressive’ treatment required  + -
Asthma
Difference in lung function + +
Higher incidence and degree of seriousness + -
Higher hospitalisation rate and mortality  + -
in black persons (in the US)
tAble 3
The most important ethnic differences referred to in the scientific justification of four NHG guidelines and in the 
standards themselves
Diabetes mellitus type 2
The relevant comments on ethnic differences in the literature relating to the diabetes 
standard concerned higher prevalence 12-21, earlier onset 12-14 and a more serious course 
of the disease, combined with higher incidence of complications or risk factors such as 
micro-albuminuria 22-24, diabetic nephropathy 22, insulin resistance 15 and (abdominal) 
obesity, in different ethnic groups.15,16
52 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 4
The literature with relevant ethnic differences included three Dutch studies. 12-14. A case-
control study showed that the prevalence of type 2 diabetes was four times higher and 
that the onset of cardiovascular disease occurred eight years earlier in Asian patients. 12 
The researchers in question concluded that, as a result of insulin resistance, type 2 
diabetes is a key contributory factor in the early onset of cardiovascular disease in 
Hindustani patients (in the Netherlands). A patient file study at three GP practices 
showed a higher prevalence of diabetes than expected in Surinamese and Moroccan 
patients. The average age of the patients was also lower.13 The last Dutch manuscript 
examined concluded that in Hindustani patients the prevalence of diabetes is higher, 
onset is earlier and complications are more serious.14
Two non-Dutch guidelines used by the NHG standard as scientific justification also 
stressed ethnic differences. One American consensus guideline referred to Afro-American 
patients as being less inclined than white patients to monitor their glucose levels one or 
more times per day.25 One expert panel reported that healthy persons in ethnic risk groups 
should be screened earlier and more often.17 Finally, two review articles concluded that 
black type 1 diabetes patients showed an increased risk of mortality and amputation.18,26
The NHG standard refers to the higher incidence of diabetes in Hindustani patients and 
advises three-yearly screening for Asian patients older than 45 years of age.  
hypertension
All ethnicity-related comments in the hypertension guideline evidence concerned black 
patients and can be summarised under the following three main headings. The first is higher 
prevalence, earlier onset, and a greater risk of and more serious complications.27-31 The 
second main heading concerns the reduced effectiveness of beta blockers compared to 
diuretics and calcium antagonists, which, among other things, was demonstrated in double-
blind, randomised clinical trials.30-38 Finally, there is the higher positive effect on the blood 
pressure of reduction in the intake of table salt (sodium chloride) in the diet.30,39 
In regard to these three subjects, guidelines and expert reports used as scientific justification 
of the NHG guideline contained a number of comments and recommendations on the 
treatment of hypertension in black patients. A Canadian guideline regards membership 
of “the black race” as a risk factor in the development of hypertension.40 Diuretics are a 
preferred form of medication, whereas monotherapy with beta blockers or ACE reducers 
has proved less effective.30,31 As a result of the higher prevalence of serious hypertension it is 
advised that black patients should be treated with multiple medications, while GPs should 
not hesitate to use the strongest medicines.30 One last comment is included in a review of 
The Women’s Caucus on hypertension among US women: “Ethnicity has a significant effect 
on the onset of hypertension, as well as on the selection of antihypertensive medication 
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and responses to treatment. That is the reason why a universal algorithm for the treatment 
of hypertension, which ignores patients’ ethnicity, is no longer appropriate”.27 In addition, 
the authors state that, because black female patients clearly benefit from an aggressive 
treatment of hypertension, such treatments, accompanied by screening and tracing (case 
finding), may constitute a key public health care measure for this group.27
The researchers of the San Antonio Heart Study state that treatment strategies which 
simultaneously reduce hypertension and increase insulin sensitivity are to be strongly 
preferred, especially in persons with a significant risk of developing type 2 diabetes 
(including certain ethnic groups).41 Finally, the researchers calculated different specific 
predictive values for routine blood pressure measurement for white and black patients 
(men and women), which could be used in screening for hypertension.42
The NHG hypertension guideline does not mention ethnic differences between patients. 
Asthma
The relevant references in the literature concerning the asthma guideline relate to two 
subjects. First, the fact that ethnicity codetermines the lung capacity and, consequently, 
the reference values for peak expiratory flow.43-48 Second, the prevalence and seriousness 
of asthma is higher for some ethnic groups, and increased asthma-related mortality 
rates in the United Stated occur predominantly in the black patient group.44-49 It is, 
however, supposed that environmental factors and lower social-economic status rather 
than ethnicity are the main determinants in these cases.44
The NHG ‘asthma in adults’ guideline mentions that lung function reference values 
depend, among other things, on the country of origin.  
DIsCussIon
Our inventory shows that the scientific justification of the NHG guidelines refers to 
several relevant ethnic differences between patients. However, the NHG guidelines 
adopt the scientific evidence to different degrees. For example, the guideline for diabetes 
mellitus type 2 and asthma in adults include important differences, in one case leading 
to a specific recommendation in the diabetes guideline, whereas the NHG hypertension 
guideline makes no reference to ethnic differences, despite the considerable attention 
paid to such differences in the scientific justification. 
The discussion emerging from these results raises two questions: first, given the information 
that is currently available, do NHG guidelines make sufficient reference to ethnic differences; 
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and, second, when should scientific evidence be mentioned in guidelines? NHG guidelines 
consist of carefully considered, well-founded judgements, which, as a matter of logic, can 
only be formulated after the provision of several sources of evidence by various studies. 
Thus, evidence needs to be solid before being included in the guidelines. The impression 
emerged that what the NHG was waiting for was solid Dutch evidence. This was shown, for 
example, by the higher incidence reported for Hindustani patients in the diabetes guideline, 
which was based on Dutch studies. The fact that, in the comment that lung function depends 
on ethnic origin in the NHG standard ‘COPD en astma bij Volwassenen: diagnostiek’ 
[diagnostics for COPD and asthma in adults] no further reference is made to Dutch specific 
ethnic subgroups, seems to confirm our impression, given that the information contained in 
the comment is based on a non-Dutch source. 
Whereas the ethnicity-specific evidence available in the Netherlands for the most important 
ethnic groups is rather limited, the contrary is certainly the case internationally; for example, 
in the United States and United Kingdom, as is also shown by the guidelines issued in those 
countries.7 The guidelines in question show that the considerable problems of hypertension 
among black patients and diabetes among South-Asian (e.g. Hindustani) patients have 
often been demonstrated in research, which is reflected in the guidelines. Research in the 
countries referred to also demonstrates the reduced effectiveness of certain antihypertensive 
medicines (in controlled as well as randomised studies), as well as highlights the positive 
effect of reduced intake of table salt on blood pressure. In our view, such clinical information 
is relevant and deserves to be included in medical guidelines. The same consideration 
applies to the earlier onset and more unfavourable prognoses for diabetes in Hindustani 
patients, besides the higher prevalence referred to in the guideline. 
Why should evidence from other countries not be used in Dutch guidelines? After all, the 
evidence found in white populations abroad is universally applied to the white (or even 
the entire) population in the Netherlands. What, in fact, is the difference between an Afro-
American patient in the United States and a Creole Surinamese or Ghanaian patient in the 
Netherlands in relation to the differences noted? Or between a South-Asian patient in Britain 
or Canada and an Hindustani or Pakistani patient in the Netherlands? In our view, such 
differences are marginal in relation to properties that are attributable to specific population 
groups and that may be important for effective medical treatment. Ignoring such sources of 
evidence is a waste of the wealth of information that has been gathered worldwide, while it 
may well result in Dutch general practice having to run after the facts. 
 
A different type of explanation is provided by Wiersma, who offers us a behind-the-scenes 
glimpse of guideline development.50 He describes how specific recommendations for women 
in relation to cholesterol screening were considered socially unfeasible and unpromotable in 
the doctor-patient contact, and therefore were not included in the NHG cholesterol guideline 
(despite demonstrable clinical differences, based on solid evidence). Given the social debate 
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surrounding ethnic differences in health care, the situation might be analogous: perhaps the 
differentiated approach to different population groups was similarly considered unfeasible 
or undesirable. If so, the entire course of guideline development would seem to consist of 
stages in which various normative decisions are or need to be taken.51 In view of the evidence 
and the need for attention to ethnic differences, these differences should receive a place 
in the guideline development process besides criteria such as age and sex. This might, for 
example, be achieved through selection of the expert panel, which usually consists of general 
practitioners with more than average knowledge of, or interest in, the relevant disease. The 
inclusion of an additional general practitioner who is reasonably well-informed about, and 
takes a higher than average interest in, ethnic differences or who works in a multicultural 
neighbourhoods, might in itself act as a considerable awareness-raising factor in this area.52
Health care workers in multicultural neighbourhoods, in particular, are constantly 
faced with all the differences that exist between various ethnic groups (including the 
native Dutch population).3 Consequently, the tendency towards a greater focus on 
ethnic differences that is noticeable in Dutch health care research seems only logical. 
In fact, the diabetes and asthma guidelines have already taken the first steps towards 
a narrower focus on the differences in question, and it is expected that the revised 
version of the NHG Hypertension guidelines, which is to be published this year, will 
follow the same route. Given the importance of this approach in view of the continuing 
multiculturalisation of the Netherlands, we would advocate a more proactive attitude 
by the NHG in these matters. Greater justice could be done to the required quality of 
care in an increasingly diverse population through a combination of various factors: by 
being more sensitive to potential ethnic differences in the development of guidelines 
for medical  procedures; by including in working groups general practitioners who 
work with ethnic minorities on a daily basis; by looking over the borders to see what 
information is already available; and by including ethnic differences in the structural 
development of guidelines (assigning them equal status with age and sex). 
ConClusIon
NHG guidelines are generally regarded as precious instruments in the Dutch medical 
world. They have been a mainstay for general practitioners in their daily practices for 
years. However, the attention paid to clinically relevant ethnic differences has as yet 
been limited, despite the international evidence for the existence of such differences. 
Given the fact that general practitioners in multicultural districts, in particular, might 
benefit considerably from guidelines that incorporate the multicultural character of 
patient populations -- with the associated diagnostic consequences, information, 
treatment and attitudes in relation to patients from ethnic minorities --  it would be 
wise to include such international evidence in the development of NHG standards. 
 
56 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 4
referenCes
1  Sociaal en Cultureel Planbureau. Sociaal en Cultureel Rapport 1998. Rijswijk: 
Sociaal en Cultureel Planbureau/Elsevier bedrijfsinformatie; 1998.
2  Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-
drug therapy for hypertension in men. A comparison of six antihypertensive agents 
with placebo. The Department of Veterans Affairs Cooperative Study Group on 
Antihypertensive Agents. N Engl J Med 1993;328(13):914-21.
3 Bruijnzeels MA. De Multiculturele huisartspraktijk. Migrantenstudies 2001:73-84.
4  Manna DR, Bootsma AH, Lamberts SWJ, Mackenbach JP. Samenhang tussen etniciteit 
en verwijsreden bij nieuwe patiënten op de polikliniek Inwendige Geneeskunde 
van het Academisch Ziekenhuis Rotterdam-Dijkzigt, 1997. Nederlands Tijdschrift 
voor Geneeskunde 2000;144(37):1785-89.
5  Wieringen van JCM, Harmsen JAM, Bruijnzeels MA. ‘Intercultural communication 
in general practice’. Eur J Publ Health 2002;12(1):63-8.
6  Rutten GEHM, Thomas S. NHG-standaarden voor de huisarts. Utrecht: 
Wetenschappelijk Uitgeverij Bunge; 1993.
7  Manna DR, Bruijnzeels MA, Mokkink HGA, Berg M. ‘Ethnic specific 
recommendations in clinical practice guidelines. An international comparison’. 
Submitted. 2002.
8  Geijger RMM, Thiadens HA, Smeele IJM, Sachs APE, Bottema BJAM, Van Hensbergen 
W, et al. NHG-standaard COPD en Astma bij Volwassenen: Diagnostiek. Huisarts 
Wet 2001;44(3):107-17.
9  Geijger RMM, Van Hensbergen W, Bottema BJAM, Van Schayck CP, Sachs APE, 
Smeele IJM, et al. NHG-Standaard Astma bij Volwassenen: Behandeling. Huisarts 
Wet 2001;44(4):153-64.
10  Rutten GEHM, Verhoeven S, Heine RJ, De Grauw WJC, Cromme PVM, Reenders 
K, et al. NHG-standaard Diabetes Mellitus type 2 (eerste herziening). Huisarts Wet 
1999;42(2):67-84.
11  Walma EP, Grundmeijer HGLM, Thomas S, Prins A, Van den Hoogen JPH, Van 
der Laan JR. NHG-Standaard Hypertensie (eerste herziening). Huisarts Wet 
1997;40(12):598-617.
12  Bongers I, Westendorp R, Stolk B, Huysman H, Vandenbroucke J. Vroegtijdige 
coronaire hartziekten samengaand met diabetes mellitus type II bij personen van 
Hindoestaanse afkomst. Ned Tijdschr Geneeskd 1995;139(1):16-8.
13  Querido J. De prevalentie van diabetes mellitus type II in een achterstandsbuurt. 
Huisarts Wet 1995;38:250-4.
14  Berghout A, Dijkstra S. Diabetes mellitus type II bij Hindoestanen; nieuwe 
verschijningsvormen van oude ziektebeelden. Ned Tijdschr Geneeskd 1995;139(1):3-7.
15 Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334(9):574-9.
5STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
thE dutch collEgE of gEnEral PractItIonErS’ guIdElInES...
16 Krentz AJ. Insulin resistance. BMJ 1996;313:1385-9.
17  Anonymous. Report of the expert committee on the diagnosis and classification of 
diabetes mellitus. Diabetes Care 1997;20(7):1183-97.
18  Finch C, Zimmet P. Mortality from diabetes. Diabetes Annual 1988;4:1-14.
19  Greenhalgh P. Shared care for diabetes. A systematic Review. Royal College of 
General Practitioners, Occasional paper 67. London; 1994.
20  Zimmet P. Type 2 (non-insulin-dependent) diabetes - an epidemiological overview. 
Diabetologia 1982;22:399-411.
21  Wilson P, Keavan M, Kannel W. Epidemiology of diabetes in the elderly. The 
Framingham Study. Am J Med 1986;80:(suppl 5A) 3-9.
22  Alzaid A. Micro-albuminuria in patients with NIDDM: an overview. Diab Care 
1996;19:79-89.
23  Gilbert R, Cooper M, McNally P, O’Brien R, Taft J, Jerums G. Microalbuminuria: prognostic 
and therapeutic implications in diabetes mellitus. Diab Med 1994;11:636-45.
24  Stehouwer C, Jager A, Donker A. Microalbuminurie bij essentiële hypertensie: van 
beperkte betekenis voor het aanwijzen van patiënten met een hoog risico voor 
complicaties. Nederlands Tijdschrift voor Geneeskunde 1997;141:1649-53.
25  American Diabetes Association. Consensus statement. Self monitoring of blood 
glucose. Diabetes Care 1994;17:81-6.
26  Reiber G. The epidemiology of diabetic foot problems. Diabetic Med 1996;13 
(suppl 1):S6-S11.
27  Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, et al. Hypertension in 
women: what is really known? The Women’s Caucus, Working Group on Women’s Health 
of the Society of General Internal Medicine. Ann Intern Med 1991;115(4):287-93.
28  Bennet NE. Hypertension in the elderly. Lancet 1994;344:447-9.
29  Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern 
Med 1983;98(5 Pt 2):855-9.
30  Anonymous. The fifth report of the Joint National Committee on Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 
1993;153(2):154-83.
31  Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, Myers MG. Report of the 
Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment 
of essential hypertension. Can Med Assoc J 1993;149:575-84.
32  Freis ED, Reda DJ, Materson BJ. Volume (weight) loss and blood pressure response 
following thiazide diuretics. Hypertension 1988;12:244-50.
33  Veterans Administration Cooperative Study Group. Comparison of propanolol 
and hydrochlorothiazide for the initial treatment of hypertension: I. Results 
of short term titration with emphasis on racial differences in response. JAMA 
1982;248:1996-2003.
34 Anonymous. Who needs nine Ace inhibitors? Drug Ther Bull 1995;33:1-3.
58 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 4
35  Cutler JA. Combinations of lifestyles modifications and drug treatment in management 
of mild moderate hypertension: a review of randomized clinical trials. Clin Exp 
Hypertens 1993;15:1193-204.
36 De Graeff PA, Van Gilst WH. ACE-remmers. Geneesmiddelenbull 1991;25:37-41.
37  Resnick LM. Cellular calcium and magnesium metabolism in the pathofysiology and 
treatment of hypertension and related metabolic disorders. Am J Med 1993;93:105-205.
38  Swales JD. Pharmacological treatment of hypertension. Lancet 1994;344:380-5.
39  Alderman MH. Non-pharmacological treatment of hypertension. Lancet 
1994;344:307-11.
40  Haynes RB, Lacourciere Y, Rabkin SW, Leenen FH, Logan AG, Wright N, et al. 
Report of the Canadian Hypertension Society consensus conference: 2 Diagnosis of 
hypertension in adults. Can Med Assoc J 1993;149:409-18.
41  Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence 
of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio 
Heart Study. Diabetes 1993;42:154-61.
42  Rosner B, Polk BF. Predictive value of routine blood pressure measurements in 
screening for hypertension. Am J Epidemiol 1983;117:429-42.
43  Anonymous. Standardized lung function testing. Report working party 
standardization of lung function tests, European Community for Coal and Steel. Bull 
Europ Physiopath Respir 1983;19 (Suppl):1-95.
44  Anonymous. Global strategy for asthma management and prevention. NHLBI/WHO 
report. National Institutes of Health. National Heart, Lung and Blood Institute. 
Publication number 95-3659, 1995.
45  Bottema B. Diagnostiek van CARA in de huisartspraktijk [Dissertatie]. Amsterdam: 
Universiteit van Amsterdam; 1993.
46  Commissie diagnostiek astma bronchiale en COPD NVALT. Standaard diagnostiek 
van astma bronchiale en COPD. Pulmoscript 1994;3:31-46.
47  Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung-
volumes and ventilatory flows. Official statement of the European Respiratory 
Society. Eur Respir J 1993;16 (suppl):5-40.
48  Sorgdrager B, Pal TM, Van der Lende R. Literatuurstudie naar beroepsmatige expositie 
en bronchiale hypereactiviteit. Leusden: Nederlands Astma Fonds; 1988.
49  Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 
1991. N Engl J Med 1994;331:1524-6.
50  Wiersma T. Overwegingen bij de NHG-standaard cholesterol. Huisarts en 
Wetenschap 1992;35(3):97-100.
51  Berg M, Klazinga N, Van Hout B. Goede zorg is niet altijd passende zorg. Van 
evidence-based naar value-based. Med Contact 1999;54(29/30):1040-43.
52  Leape LL, Park RE, Kahan JP, Brook RH. Group judgements of appropriateness: the 
effect of panel composition. Qual Assur Health Care 1992;4(2):151-9.
Do ethnic specific differences in 
treatment of asthma, diabetes, and 
hypertension in general practice exist?
DR Manna, WK Redekop, HGA Mokkink, AE Vlug, 
M. Berg, and MA Bruijnzeels 
5
Submitted.
60 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 5
61STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
do EthnIc SPEcIfIc dIffErEncES In trEatMEnt ExISt?
IntroDuCtIon
Evidence shows worse outcomes of care in chronic conditions like asthma, diabetes mellitus 
type 2, and hypertension in ethnic minorities.1-3 Reasons for these ethnic differences are 
unclear and several theories have been proposed, like a greater burden of disease among 
ethnic minorities, disease severity, genetic predisposition and patient compliance. Other 
important possible explanations for ethnic disparities in health outcomes are inadequate 
access to health care facilities, and ethnic differences in treatment and quality of care4. 
Nowadays many studies confirming ethnic differences in treatment of chronic diseases 
are published.5-8 Many of these studies are limited to US and UK populations. Over the 
last years these ethnic differences in treatment in the US and UK have sometimes been 
explained by the existence of institutional racism.9 10 Institutional racism is described 
as “the collective failure of an organization to provide an appropriate and professional 
service to people because of the color, culture or ethnic origin”.11 Many expressions of 
institutional racism have been provided in the USA and UK.11
On the European continent ethnic differences in outcome of care are also found, 
although research on possible explanations is still limited.2 12 Furthermore, the discussion 
on institutional racism in health care has not yet reached the European continent, 
probably partly because scientific information regarding ethnic differences in treatment 
of chronic conditions is scarce. The demographic and ethnic composition, and the 
specific historical background and political context of the ethnic minority population 
on the European continent differs from that in the USA and to a lesser extent the UK. 
Furthermore there are large differences in the structure and financing of health care 
between the US, UK, and the European continent. Given these differences evidence 
found in the USA or even the UK does not automatically apply to populations of the 
European continent. Therefore, the question arises whether institutional racism in health 
care in fact also occurs on the European continent. 
In the Netherlands, chronic diseases are treated for a large part in general practice. GPs 
have a central and important role in the Dutch health care system as gatekeepers for 
specialist care. Research has shown that the management of chronic conditions in Dutch 
general practices seems more difficult in ethnic minorities with worse health outcomes 
as a consequence.12 It is often stated that because of cultural and language differences 
many GPs experience difficulties in delivering optimal care to patients from ethnic 
minority groups, especially in the treatment of chronic conditions.16 If so, institutional 
racism could also be present as a potential problem in Dutch health care. Our aim was 
to assess whether ethnic differences in the treatment of chronic conditions exist and 
thereby contribute to the discussion of the explanations of worse health outcomes in 
ethnic minorities and the existence of institutional racism. 
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MethoDs
General Practices
Treatment data was electronically extracted from patient records in general practices. 
Because the software used to extract the patient records was only compatible with one 
type of GP information system i.e. Elias®, we approached general practices that used 
Elias®. At the moment Elias® was one of the most widely used GP information systems. 
These general practices were also located in or near a deprived neighborhood because 
of their relatively high share of ethnic minorities. We asked the general practices to 
participate in this project, which consisted of a retrospective analysis of patient records 
and prospective data collection.
Patients
Patients were included in several steps. First, a computerized search in the GP information 
system identified patients with asthma, diabetes mellitus type 2 and hypertension, 
using codes of the International Classification of Primary Care (ICPC), the Anatomical 
Therapeutic Chemical (ATC) classification of drugs, or free text (table 1). The search 
was restricted to patients under treatment over the last two years (from March 2000 to 
March-June 2002). During the second step ethnic background of identified patients was 
assigned, based on their surnames, by research assistants from corresponding ethnic 
groups. This method is proven valid for most ethnic groups in the Netherlands.17 In 
case of doubt, GPs were asked to check our assignment. Subsequently, we selected 
patients from the three largest ethnic minority groups in the Netherlands, i.e. Moroccan, 
Turkish, and Surinamese and from a Dutch comparison group. In the Surinamese group 
a distinction was made between African-Surinamese and Hindustani-Surinamese, 
because of large and important ethnic differences within the Surinamese group. 
To enhance validity of our identification process we reviewed the records of patients 
identified on the basis of free text. In case of a false positive identification patients 
were excluded. False positive identification could occur when the selection text term: 
1. was part of a negation (e.g. “patient does not have diabetes”); or 2. referred to a 
family member of the patient (e.g. “patient’s father has diabetes”); or 3. referred to 
another disease (e.g. “patient has cardiac asthma”). Finally, all identified patients from 
the selected ethnic minority groups were included in the sample, added with a random 
sample of Dutch patients per diagnosis per general practice. 
Data collection and measurements
The complete electronic patient records of study patients were extracted from the 
GP information systems. Data in two practices were only extractable from 2002. We 
obtained data on patient characteristics (i.e. sex, year of birth, and insurance state); 
dates and the journal text of all GP visits; dates and contents of all prescriptions; dates 
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and specification of all referrals to medical specialists, and patient specific prevalence 
of relevant co-morbidity. 
For our analysis, we selected GP visits, prescriptions, or relevant referrals if they contained one 
of the indicators regarding free text, ICPC coding, ATC-coding or the WCIA 12 specialist codes 
(which is a Dutch classification system of medical specialists) shown in table 2. According to 
the clinical practice guidelines of the Dutch College of General Practitioners the following 
referrals were defined as relevant: for asthma a referral to the lung specialist; for diabetes 
a referral to the internist, podiatrist, ophthalmologist, and dietician; and for hypertension a 
referral to the internist and cardiologist.18-20 Co-morbidity was defined as relevant when its 
presence had consequences for the treatment of the GP according to guidelines of the Dutch 
College of General Practitioners.18-20 The following conditions were defined as relevant: in 
diabetes: hypercholesterolemia, hypertension, kidney problems, and obesity; in hypertension: 
angina pectoris, arrhythmia, ankle oedema, asthma/COPD, diabetes, gout, heart failure, 
hypercholesterolemia, stroke, myocardial infarction, kidney problems, obesity, and peripheral 
arterial disease. In asthma the presence of other conditions does not interfere with treatment 
and therefore co-morbidity had no relevance for asthma in this study. 
To enhance validity, all selected contacts, prescriptions and referrals were manually 
checked by screening the patient records. False positive selections (of treatment data) 
were excluded. An example of a false positive selection concerned GP visits that 
were identified as an asthma visit because the journal text contained the term “pf” (a 
frequently used abbreviation of “peak flow”), while in some cases “pf” represented the 
first characters of the word “Pfeiffer”. 
 ICPC AtC free text
Asthma R96* R03AB* ASTMA
  R03AC02 ASTHMA
  R03AC03
  R03AC04
  R03AC05
  R03AC12
  R03AC13
  R03AK02
  R03B*
  R03CB03
  R03CC02
  R03CC03
  R03CC04
  R03DA04 
Type 2 diabetes T90.0 A10B* DIAB*
 T90.2 
Hypertension K86.0 † HYPERTE*
* Truncated from here 
† In hypertension the ATC-classification was not used because of the large numbers of false-positives.
tAble 1
Terms used to identify asthma-, type 2 diabetes- and hypertension patients from the GP information system 
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Data analysis
We retrospectively followed patients from March 1st 2000 to March 1st 2004. In two 
practices patients were followed from March 1st 2002 to March 1st 2004. For patients 
referred, died or deleted from the register, the date of referral, death or deletion from 
the register meant the end of follow-up. Patients were excluded from the analysis if they 
had been referred to a relevant specialist one year prior to the study period, because we 
assumed the patient could still be under treatment of the specialist. 
To compare the number of GP visits and prescriptions between the different ethnic 
groups we computed contact- and medication frequencies per person-year by dividing 
the number of contacts during follow up by the length of the follow up period. Patients 
with a follow up of less than six months led to outliers of contact and medication 
frequencies, and were therefore excluded from the analysis. We also compared the 
number of prescriptions of specific medications. Regarding referrals we calculated the 
percentage of patients per ethnic group referred to relevant specialists. 
We first performed t-tests to detect differences in the number of visits and prescriptions 
between ethnic minority groups and the indigenous Dutch group. Subsequently we 
 AtC* free text† specialist codes‡
Asthma R03- astma-   015: lung specialist
  asthma- 
  R96-
  piek- 
  Pf-
  fev- 
  peak-
  pkf- 
  fvc- 
  pef-
 
Type 2 diabetes A10- diab-  012 : internist
  dm-  045 : internist
  d.m.- 017 : ophthmalogist
  gluc-  049 : dietician
  hba1c-  POD : podiatrist‡‡ 
  glyhb- 
  gly hb- 
  T90-
Hypertension C02- hyperte- 003: cardiologist
 C03- K86- 012: internist
 C07- rr- 045: internist
 C08-
 C09-
* used to identify study contacts and prescribed medication
† used to identify study contacts
‡ WCIA 12: used to identify referrals
‡‡ There is no numeric code in the WCIA12 for a podiatrist. This was coded with the abbreviation POD.  
tAble 2
Terms used to identify GP visits, prescribed medications and referrals
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performed multivariate regression analyses to control for differences in age, sex, and 
insurance status (because in the Netherlands GPs receive an annual capitation fee for 
their public insured patients, while they receive a fee for service from their private insured 
patients), and relevant co-morbidity. In the analysis of the number of prescriptions, the 
number of visits, was also added as an confounder. Since our patient sample differed 
between general practices we used a random effects model in which we controlled for 
differences between GPs.
Analyses were performed in SPSS 12.0 and SAS 8.1.  
    hindustani- African- Moroccan turks Indigenous  total
    surinamese surinamese   Dutch
    (n = 151) (n = 20) (n = 109) (n = 163) (n = 262) (n = 705)
Asthma (N=230) 52 0 45 62 61 220
 Males (%) 21 (40) 0 (0) 19 (42) 25 (40) 26 (43) 91 (41)
 Mean age (SD) 48 (15) xx 45 (16) 42 (13) 53 (19) 47 (16)
 Insurance by sick benefit fund (%) 45 (87%) xx 37 (82) 51 (82) 42 (69) 175 (80)
 Mean follow-up period 2.60 (1.20) xx 2.71 (1.28) 3.13 (1.05) 2.78 (1.25) 2.82 (1.20)
Diabetes (286) 58 11 44 60 95 268
 Males (%) 26 (45) 5 (45) 25 (57) 35 (58) 38 (40) 139 (52)
 Mean age (SD) 59 (10) 63 (11) 55 (10) 58 (10) 68 (12) 61 (12)
 Insurance by sick benefit fund (%) 47 (81) 11 (100) 41 (93) 57 (95) 68 (72) 224 (84)
 Comorbidity N (%)
  - kidney 2 (3) 1 (9) 3 (7) 1 (2) 2 (2) 9 (3)
  - hypertension 9 (16) 4 (36) 7 (16) 8 (13) 40 (42) 68 (25)
  - hypercholesterolemia 5 (9) 3 (27) 7 (16) 9 (15) 21 (22) 45 (17)
  - obesity 3 (5) 1 (9) 3 (7) 10 (17) 18 (19) 35 (13)
 Mean follow-up period 2.77 (1.31) 2.33 (1.13) 2.88 (1.14) 3.04 (1.01) 2.70 (1.20) 2.81 (1.18)
 
Hypertension (217) 41 9 20 41 106 217
 Males (%) 17 (41) 6 (67) 16 (80) 15 (37) 47 (44) 101 (47)
 Mean age (SD) 61 (11) 56 (13) 59 (13) 59 (10) 66 (13) 63 (12)
 Insurance by sick benefit fund (%) 36 (88) 9 (100) 14 (70) 35 (85) 66 (62) 160 (74)
 Comorbidity  N (%)
  - angina pectoris 1 (2) 1 (11) 2 (10) 4 (10) 7 (7) 15 (7)
  - arrhythmia 1 (2) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1)
  - ankle oedema 1 (2) 0 (0) 0(0) 0 (0) 4 (4) 5 (2)
  - asthma/copd† 1 (2) 0 (0) 2 (10) 4 (10) 12 (11) 19 (9)
  - diabetes 7 (17) 3 (33) 6 (30) 6 (15) 30 (28) 52 (24)
  - gout 0 (0) 1 (11) 0 (0) 0 (0) 2 (2) 3 (1)
  - heart failure 0 (0) 0 (0) 0 (0) 0 (0) 2 (2) 2 (1)
  - hypercholesterolaemia 2 (5) 2 (22) 3 (15) 3 (7) 13 (12) 23 (11)
  - stroke 1 (2) 0 (0) 0 (0) 0 (0) 6 (6) 7 (3)
  - myocardial infarction 0 (0) 0 (0) 0 (0) 1 (2) 2 (2) 3 (1)
  - kidney problems 2 (5) 0 (0) 2 (10)  1 (2)  3 (3) 8 (4)
  - obesity 2 (5) 1 (11) 3 (15) 3 (7) 16 (15) 25 (12)
  - peripheral artery disease 2 (5) 0 (0) 0 (0) 2 (5) 5 (5) 9 (4)
 Mean follow-up period (SD) 2.45 (1.26) 3.09 (1.31) 2.67 (1.31) 2.80 (1.23) 2.62 (1.23) 2.65 (1.24)
* Statistical significant differences between Dutch and other groups are mentioned in bold (α =  0.05) 
† COPD = Chronic Obstructive Pulmonary Disease
tAble 3
Characteristics of patients in analysis* 
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results
We approached 145 general practices of which 16 (11%) practices with 30 GPs 
agreed to participate in this study. Main reasons for refusal were the lack of a sufficient 
number of ethnic minorities in the practice, the high workload, and the perceived time-
consuming character of the prospective data collection. 
Table 3 shows some characteristics of the study population. A total of 705 patients were 
included in the analysis. The mean number of included patients per practice was 62 
(sd. = 23). Sex distribution differed between ethnic groups and between diseases. Mean 
age was lower in ethnic minorities compared to indigenous Dutch in all three conditions. 
The relative share of patients with private insurance was higher in Dutch than in ethnic 
minorities, although most of the Dutch were also insured through a public sick-benefit 
fund. Mean follow up period did not differ between the different ethnic groups and 
fluctuated between 2.45 and 3.13 years. In the diabetes and hypertension groups, 
Dutch patients had more frequent registered co-morbidity than Hindustani-Surinamese, 
Moroccan and Turkish patients. 
GP visits
Table 4 shows that all ethnic groups visited their GP less often compared to the Dutch. 
Differences were statistically significant in Turks with asthma (2.3 visits compared to 3.4 
in Dutch), and Hindustani-Surinamese diabetes patients (7.0 visits versus 8.6 in Dutch). 
After controlling for confounders and differences between GPs ethnic differences in 
mean number of GP visits no longer were significantly different, although the number of 
visits remained lower in all ethnic minority groups. The relative covariance estimate of 
the GP factor shows that the distribution of mean number of GP visits per ethnic group 
did not differ much between GPs.
 
Prescriptions
The yearly number of prescriptions was significantly lower in Turks with asthma 
compared to Dutch with asthma (2.5 compared to 3.9). The same applied to Moroccans 
with hypertension (2.1 compared to 4.3 in Dutch hypertension patients). We did not find 
any other statistically significant differences regarding the mean number of prescriptions. 
The analysis of specific medication shows that Hindustani-Surinamese asthma patients 
received more prescriptions of a beta2sympathicomimetica (74% versus 54% in Dutch), 
and received fewer prescriptions of corticosteroids (20% versus 35%). Turkish asthma 
patients received fewer prescriptions of anticholinergica as compared to Dutch (2% 
versus 10%). The relative share of metformin of the total medication was higher in African-
Surinamese diabetes patients compared to Dutch (71% versus 35%). African-Surinamese 
received a beta-blocker less often than Dutch (5% versus 31%), but more often a calcium 
antagonist (52% versus 15%). These differences were all statistical significant.
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    hindustani- African- Moroccan turks Indigenous  total
    surinamese surinamese   Dutch
Mean number GP visits 
per person-year (sD)      
 - asthma 3.4 (4.0) xxxxx 2.5 (2.0) 2.3 (1.8)* 3.4 (3.1) 2.9 (2.9)
 - diabetes mellitus 7.0 (3.7)* 7.1 (3.4) 7.7 (4.6) 8.1 (4.3) 8.6 (4.5) 8.0 (4.2)
  type 2
 - hypertension 4.1 (2.4) 5.4 (3.4) 4.0 (3.2) 4.4 (3.2) 5.0 (3.4) 4.6 (3.2)
Multivariate regression       relative 
model GP visits β       covariance
(95%-CI)*      estimate GPs
 - asthma -0.290  xxxxxx -0.654  -0.433  Reference  5%
    (-1.446 , 0.865)  (-1.843 , 0.536) (-1.631 , 0.766) group
 - diabetes mellitus -1.034  -1.773  -0.993  -0.264  Reference 8%
  type 2 (-2.567 , 0.499) (-4.325 , 0.779) (-2.653 , 0.668) (-1.807 , 1.278) group
 - hypertension -0.879  0.235  -0,777  0,050  Reference 11%
    (-2.127 , 0.369) (-1,979 , 2.448) (-2.359 , 0.804) (-1.224 , 1.323) group
* In this analysis was controlled for differences in age, sex, insurance status, and the presence of relevant comorbidity (added 
with the number of visits in the analysis of the number of prescriptions).
tAble 4
GP visits per ethnic group
    hindustani- African- Moroccan turks Indigenous  total
    surinamese surinamese   Dutch
Mean number of 
prescriptions per 
personyear (sD)
 - asthma 4.3 (5.4) xxxxxx 3.1 (3.0) 2.5 (2.3)* 3.9 (4.4) 3.4 (4.0)
 - diabetes mellitus  4.3 (3.1) 4.8 (4.0) 4.8 (3.6) 3.9 (3.1) 4.5 (3.6) 4.4 (3.4)
  type 2
 - hypertension 3.5 (3.5) 6.1 (7.9) 2.1 (2.1)* 3.6 (3.9) 4.3 (3.8) 3.9 (3.9)
Multivariate regression        relative  
model prescriptions β       covariance
(95%-CI)*      estimate GPs
 - asthma 0.004  xxxxxx -0.533  -0.344  Reference  4%
    (-1.563 , 1.572)  (-2.174 , 1.080) (-1.970 , 1.282) group
 - diabetes mellitus  0.541  0.296  0.815  0.087  Reference 0%
  type 2 (-0.811 , 1.893) (-1.952 , 2.544) (-0.646 , 2.276) (-1.270 , 1.445) group
 - hypertension -0.395  2.168  -1.540  0.235  Reference  15%
    (-1.926 , 1.135) (-0.547 , 4.883) (-3.480 , 0.400) (-1.328 , 1.797) group
* In this analysis was controlled for differences in age, sex, insurance status, and the presence of relevant comorbidity.
tAble 5
Prescriptions per ethnic group
After controlling for confounders and differences between GPs, ethnic differences in 
general became smaller and were not statistically significant. The most pronounced 
remaining difference in prescription rate concerned Moroccan and Dutch hypertension 
patients, in which the prescription rate remained 1.5 times lower in the former. The 
relative covariance estimate of the GP factor shows that the distribution of mean number 
of prescriptions per ethnic group did not differ much between GPs.
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referrals
Although none of the differences were statistically significant, table 6 shows that Dutch 
asthma patients were more frequently referred to the lung specialist than ethnic minority 
asthma patients, and ethnic minorities with diabetes were more frequently referred to 
the internist compared to Dutch patients. Referrals in Dutch hypertension patients were 
almost equally divided between the internist and cardiologist, while ethnic minorities 
were more often referred to the internist. 
After controlling for confounding and differences between GPs, ethnic differences in 
referrals were still not statistically significant. However, the odds of a referral to the 
lung specialist are lower in ethnic minorities with asthma compared to Dutch patients. 
Furthermore the odds of a referral to the internist was 2.5 times higher in Moroccan 
hypertension patients compared to Dutch, while the odds of getting referred to the 
cardiologist was 0.37 in Moroccan hypertension patients.
The relative covariance estimate of the GP factor shows that the distribution of referrals 
regarding diabetes, and to a lesser extent hypertension, differed somewhat between GPs. 
 
DIsCussIon
Our aim was to assess whether ethnic differences exist in the treatment of chronic 
diseases in Dutch general practices. In general we conclude that when differences in 
age, sex, insurance status and the prevalence of co-morbidity between the different 
ethnic groups are taken into account, ethnic differences in the number of GP visits and 
prescriptions do not exist in the treatment of patients with asthma, diabetes mellitus type 
2, and hypertension. Furthermore, the chance of referral to a specialist does not differ 
between Dutch and ethnic minorities. Particularly demographic differences between 
ethnic minorities and indigenous Dutch in our sample explained ethnic differences 
found in the univariate analyses. 
Although evidence of ethnic differences in treatment in primary care is well established in 
the US and UK, our study did not show these differences in Dutch general practices. This 
is in line with Agyemang et al. who found that treatment received by Dutch hypertension 
patients by the GP was similar in different ethnic groups, and with Uitewaal et al. who 
did not find any ethnic disparities in treatment of diabetes in Dutch general practices.2 12 
Because health care treatment is the same, this implies that institutional racism is not 
apparent in primary care in the Netherlands. However equal treatment is only one part 
of equal access. In research the access of health care is normally defined by objective 
and quantitative indicators of use and treatment. Both Agyemang et al. and Uitewaal 
et al. found that although treatment was similar in different ethnic groups, the clinical 
outcome of treatment was worse in ethnic minorities. This could be explained by other 
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less objective indicators of access such as poorer mutual understanding between the 
GP and the ethnic minority patient, resulting in a lower patient compliance in ethnic 
groups.21 This suggests that the same treatment by the GP does not mean the same level 
of access and quality of care and the conclusion that institutional racism does not occur 
in Dutch primary care is still too premature. Furthermore, in the introduction of this 
paper institutional racism is described as “the collective failure of an organization to 
provide an appropriate and professional service to people because of the color, culture 
or ethnic origin”. It is proven in several studies that asthma, diabetes and hypertension 
are more prevalent and more aggressive in ethnic minorities2 6 22 23. It seems therefore 
that the specific need for care differs between ethnic groups, while treatment is the 
same, resulting in worse health outcomes. So one could argue that Dutch health care 
has failed to deliver appropriate services to ethnic minorities and institutional racism 
    hindustani- African- Moroccan turks Indigenous  total
    surinamese surinamese   Dutch
Percentage referrals       
Asthma      
 - to lung specialist 15 xxxxxx 18 15 25 18
Diabetes      
 - to internist 28 27 23 27 15 22
 - to chiropodist 2 0 5 7 5 4
 - to ophthalmologist  60 73 75 72 66 68
 - to dietician 28 18 30 30 28 28
hypertension        
 - to internist 32 22 45 39 26 31
 - to cardiologist 24 11 15 24 23 22
 - to internist  44 22 45 54 44 45
  or cardiologist
Multivariate regression       relative  
model referrals odds       covariance
ratios (95%-CI)      estimate GP’s 
   
Asthma      
 - to lung specialist 0.617  xxxxx 0.771  0.620  Reference  0%
    (0.226 , 1.686)  (0.278 , 2.136) (0.231 , 1.665) group
Diabetes      
 - to internist 1.094 1.978  0.945  1.236  Reference  50%
    (0.406 , 2.944) (0.395 , 9.894) (0.314 , 2.843) (0.463 , 3.302) group
 - to chiropodist 0.408  xxxxx 0.806  1.136  Reference  58%
    (0.059 , 2.807)  (0.161 , 4.029) (0.289 , 4.462) group
 - to ophthalmologist  1.087 1.366 1.716  1.841  Reference  56%
    (0.451 , 2.625) (0.302 , 6.173) (0.635 , 4.639) (0.745 , 4.550) group
 - to dietician 1.164 0.896  1.007  1.000  Reference  55%
    (0.466 , 2.907) (0.157 , 5.107) (0.373 , 2.714) (0.401 , 2.492) group
hypertension        
 - to internist 0.800  0.788  2.412  1.508  Reference  38%
    (0.308 , 2.074) (0.308 , 2.074) (0.804 , 7.237) (0.606 , 3.751) group
 - to cardiologist 1.383  0.146 0.371  1.129  Reference  47%
    (0.502 , 3.812) (0,001 , 2.285) (0.067 , 2.051) (0.401 , 3.177) group
 - to internist or  0.826  0.195  0.928  1.262  Reference  32%
  cardiologist (0.326 , 2.092) (0.024 , 1.577) (0.286 , 3.015) (0.505 , 3.159) group
tAble 6
Referrals per ethnic group
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could be in fact present. Research on the reasons for the worse health outcomes in 
ethnic minorities should give more insights in the presence of institutional racism in 
Dutch health care.
The fact that ethnic differences in health do not lead to differences in treatment while 
health outcomes are worse in ethnic minorities has implications for the concept of 
standardization and clinical practice guidelines in a multicultural setting. Guidelines 
assume a standard or preferred treatment for the whole (patient) population, unless 
exceptions in specific subgroups are scientifically justified. Research has shown that the 
Dutch GP guidelines mention less ethnic specific information compared to their British, 
American, and Canadian counterparts.24 Dutch guidelines could therefore propagate 
a lack of awareness in Dutch GPs about important ethnic differences, resulting in the 
same treatment but worse outcomes. Studies on the adherence to guidelines in different 
ethnic patient groups and the effect of adherence on the outcome of treatment should 
provide valuable insight into the (external) validity of clinical practice guidelines in a 
multicultural setting. 
There are some limitations to this study. First, because only 12% of the GPs we approached 
participated in this study, our study population could be an unrepresentative sample 
of all GPs. Although a high workload was the main reason for refusal to participate 
in this study, there are in fact no indications of a lower workload in the practices of 
participating GPs. To our knowledge, the participating practices do not differ in practice 
characteristics or in patient population from the non-participating practices. Our 
participating GPs are probably more research minded and/or have a special interest in 
the topic of ethnic disparities in treatment. Therefore they may put more effort into the 
treatment of their ethnic minority patients. However, because our results are in line with 
results from other studies we assume that our sample of GPs did not affect our results.
Second, the data used are not registered for research purposes, so incompleteness and 
consequently the quality of the data could lead to validity problems. However, since 
we expect that this will apply equally to all ethnic groups under study, we assume that 
these problems did not influence our comparison.
ConClusIons 
In this study we did not find any ethnic differences in treatment in Dutch general 
practices. However, research has shown that despite the same treatment the 
clinical outcome in ethnic minorities is worse. Therefore, further research on the 
relationship between treatment and health outcomes should provide more more 
insights into the reasons for these worse health outcomes in ethnic minorities and 
on whether institutional racism is an issue in Dutch health care.
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AbstrACt
background: In western countries, much of the evidence on ethnic disparities in the 
quality of care indicates a lower quality of care amongst ethnic minorities. Clinical practice 
guidelines (CPGs) can be an important tool in the effort to rectify these disparities.
Aim: To assess whether ethnic disparities exist in adherence to guideline recommendations 
from GPs in the Netherlands.
Design: Cross-sectional study with prospective data collection.
setting: General practices in and around deprived neighbourhoods in large cities in 
The Netherlands
Methods: Adult patients with asthma, diabetes mellitus type 2 or hypertension were 
selected from the GP information systems of 17 general practices (31 GPs). All ethnic 
minority patients were included in this study plus a random sample of Dutch patients 
for each diagnosis. A contact registration form was created to assess adherence to the 
recommendations of the guidelines. This form was implemented into the GP information 
systems and linked to the records of the study patients. After every visit by a patient for 
the disease of inclusion, the GP was asked to complete the form.
results: 1149 patients were included and 402 forms were completed (regarding contacts with 
238 patients). This study found no statistically significant ethnic differences in adherence. 
With an adherence rate of about 75%, our study showed that GPs generally treat their 
patients according to guidelines. Furthermore adherence differed a great deal between GPs, 
while the differences in adherence were smaller between patients and ethnic groups. 
Conclusion: This study did not reveal any ethnic disparities in adherence to CPG by 
GPs. Moreover, because CPGs are assumed to be quality instruments, it seems that 
there are no ethnic disparities in the quality of care.
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IntroDuCtIon                           
Ethnic disparities in health status have been documented extensively. Much of the 
evidence suggests a health gap to the disadvantage of ethnic minorities in western 
countries. Established ethnic differences in health extend over a large spectrum and 
includes differences in morbidity and mortality of type 2 diabetes, hypertension, asthma, 
end-stage renal disease and many others.1-6 Reasons for these ethnic disparities in health 
are complex. Socio-economic-, cultural-, behavioural-, genetic- and other factors are 
often used to explain this. Recently the US Institute of Medicine (IOM) reported, based 
on an analysis of several studies, that ethnic disparities in quality of care also play an 
important role in the existence of the health gap.7 These ethnic disparities in quality of 
care exist in many aspects of the health care process, such as diagnostic and therapeutic 
procedures, the intensity of medical care received, and pain control, and still remain 
after adjustment for socio-economic differences and other health care access-related 
factors.7 Thus, one could argue that physicians differ in their treatment depending on 
the ethnicity of the patient in front of them. 
Clinical practice guidelines (CPGs) play an important role in improving quality of 
care. As defined by the IOM, CPGs are “systematically developed statements to assist 
practitioners and patient decisions about appropriate health care for specific clinical 
circumstances”.8 According to this definition CPGs are developed for, among other 
things, defining appropriate care and therefore quality assurance in care. Furthermore, 
by standardising care according to the principles of evidence-based medicine, (ethnic) 
variation in treatment is discouraged, and therefore guidelines could be an important 
tool in the struggle with ethnic disparities in the quality of health care.9 To determine 
the potential of guidelines in reducing ethnic variation in treatment and quality of 
care, it is important to determine whether GPs differ in their adherence to guideline 
recommendations in the treatment of patients from different ethnic groups. It is often 
hypothesised that cultural differences between GPs and ethnic minority patients 
negatively affect the quality of care.10, 11 In the Netherlands guidelines for general 
practice are issued by the Dutch College of General Practitioners. Studies focussing on 
ethnic differences in adherence to guidelines are rare, and have mostly been based on 
analyses of patient records and therefore suffer from several validity problems.12 The 
aim of this study was to assess whether ethnic disparities exist in adherence to guideline 
recommendations from GPs in the Netherlands, using a methodology and a validated 
data collection and –analysis instrument specifically developed to measure adherence 
to guideline recommendations in general practice. 
 
6 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 6
MethoDs
In this study we focussed on three chronic health problems with known ethnic 
differences in morbidity, which are highly prevalent in general practice and the 
corresponding guidelines of those health problems, i.e. asthma in adults, type 2 
diabetes mellitus and hypertension.13-15 
General Practices
Practices were selected on the basis of their GP information system, because the data 
collection was computerised and the data collection instrument was only compatible 
with one type of GP information system (i.e. Elias®). We approached (by mail and 
telephone) 145 general practices using Elias® (one of the most used GP-information 
systems) and located in or near a deprived neighbourhood (because of the relatively 
high share of ethnic minorities). 
Patients
Patients were included in several steps. First, a computerised search in the GP-
information system identified patients with asthma, diabetes mellitus type 2 and 
hypertension, using codes of the International Classification of Primary Care (ICPC), 
Anatomical Therapeutic Chemical (ATC) classification of drugs, or free text (table 1). The 
search was restricted to patients under treatment in the last two years (from March 2000 
to March-June 2002). In the second step ethnic background of identified patients was 
assigned, based on their surnames, by research assistants from corresponding ethnic 
groups, which is a valid method for most ethnic groups16 In case of doubt, GPs checked 
our assignment. The selection of patients was limited to the largest ethnic groups in 
the Netherlands, i.e. Dutch, Moroccan, Turkish, African-Surinamese, and Hindustani-
Surinamese. Subsequently, the patient records of patients identified on basis of text 
terms were analysed and in case of a false positive identification patients were excluded. 
False positive identification could occur when the selection text term: 1. was part of a 
negation (e.g. “patient does not have asthma”), or 2. referred to a family member of 
the patient (e.g. “patient’s father has diabetes”), or 3. referred to another disease (e.g. 
“patient has cardiac asthma”). Finally, all identified patients from the selected ethnic 
minority groups were included in the sample, added with a random sample of Dutch 
patients per diagnosis per general practice. 
Data-collection and measurements
We used a validated instrument developed by the Dutch College of General Practitioners 
and the Centre for Quality of Care to measure adherence.17 Adherence means that 
the care was given according to the recommendation of the guideline. The instrument 
consists of two parts:
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1  For the data collection, a contact registration form, which comprised questions 
about the patient’s clinical situation (including relevant co-morbidity) and the 
treatment (in the present as well as the past) by the GP of the patient, was used. A 
computerised design was used to facilitate data collection in which the form was 
linked to the patient number of the included patients. Every time the GP closed the 
electronic patient file of an included patient the form popped up on the computer 
screen asking him to answer the questions of the data collection instrument. 
However, the GP always had the opportunity to cancel a form. Information on 
the gender and year of birth from the included patients was also collected from 
the GP information systems. Data was collected over 6 to 9 months per practice 
between14-4-2003 and 15-9-2004. 
2  For the data analysis, key recommendations of the specific guidelines were 
determined by an expert panel and indicators for adherence were formulated. 
The adherence indicators consist of a clinical action and none, one, or more 
relevant clinical details or circumstances. For the three guidelines a total of 39 
adherence indicators were constructed (11 for asthma; 16 for type 2 diabetes; 12 
for hypertension). Since recommendations are intended to guide clinical decisions 
by defining how to act under specific case conditions or existent clinical details, 
each adherence indicator was constructed by relating clinical actions to relevant 
and specific clinical details using “if then” algorithms. In this way different cases 
meet different, yet more specified, criteria and thus certain aspects of case-mix 
are accounted for. Specific software calculated the adherence score by comparing 
 ICPC AtC free text
Asthma R96* R03AB* ASTMA
  R03AC02 ASTHMA
  R03AC03
  R03AC04
  R03AC05
  R03AC12
  R03AC13
  R03AK02
  R03B*
  R03CB03
  R03CC02
  R03CC03
  R03CC04
  R03DA04 
Type 2 diabetes T90.0 A10B* DIAB*
 T90.2 
Hypertension K86.0 † HYPERTE*
* Truncated from here 
† In hypertension the ATC-classification was not used because of the large numbers of false-positives.
tAble 1
Terms used to identify asthma-, type 2 diabetes- and hypertension patients from the GP information system 
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clinical action of the GP with the adherence indicators (1 = adherence, 0 = non 
adherence). So in every patient-GP contact 11, 16 or 12 (respectively for asthma, 
type 2 diabetes, and hypertension) adherence scores could be calculated.
Furthermore, a distinction is made between positive and negative recommendations, in 
which positive means the GP has to do something and negative means the GP has to 
refrain from a specific action, because GPs are more likely to adhere to negative- than 
to positive recommendations18.
non-response analysis
The workload in general practices in deprived neighbourhoods is relatively high and to 
get GPs to participate in this study we left them the opportunity to withhold from filling 
in a form.
Every time a patient record of an included patient was opened, the software used for 
computerising the data collection registered, the date, GP-code, patient number, and the 
answer of the GP regarding the request to fill in the data collection form for this included 
patient now (yes or no). So all contacts between included patients and the GPs during the study 
period were registered. We performed a non-response analysis to get insight in the number of 
times and reasons a GP did not complete a form. This is necessary for determining the external 
validity of this study. We compared all contacts registered by the software with the content of 
the patient records of the included patients. For the non-response analysis we focussed on the 
study contacts. These were the contacts for the diseases for which the patient was included 
(e.g. a patient included for asthma who comes to the GP for his asthma). In this we compared 
    Contacts with  Contacts without  total 
    completed forms completed forms 
Disease of inclusion (%)   
 - Asthma 47   (17) 258 (20) 305 (19)
 - Diabetes mellitus type 2 128 (45) 558 (43) 686 (43)
 - Hypertension 108 (38) 481 (37) 589 (37)
   
ethnic group (%)   *
 - Hindustani-Surinamese 49 (17) 304 (23) 353 (22)
 - African-Surinamese 19 (7) 48 (4) 67   (4)
 - Moroccan 61 (22) 210 (16) 271 (17)
 - Turkish 61 (22) 299 (23) 360 (23)
 - Dutch 93 (33) 436 (34) 529 (33)
   
Gender (%)   *
 - Male  145 (51) 518 (40) 663 (42)
 - Female 138 (49) 779 (60) 917 (58)
   
Mean age (sD) 59,1 (13,1) 61,2 (13,2) 60,8 (13,2)
total    283 1297 1580
* Chi² p<0.05
tAble 2
Comparison of patient-GP contacts for non-response analysis  
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the contacts in which a form was completed with the contacts in which was not, regarding 
patient characteristics, i.e. ethnic group, age, and gender and the disease of inclusion.
Data analysis
In the data analysis we performed analyses of variances to detect differences in mean 
adherence between ethnic groups and in case of a statistical significant outcome, we 
performed t-tests to detect differences in mean adherence between specific ethnic 
minority groups and the Dutch group. A multivariate multilevel logistic regression 
analysis was performed to adjust for differences in disease-, age-, and sex distribution 
between the different ethnic groups (Dutch group was reference) and in which patient- 
and GP random effects were taken into account.
    Asthma  type 2 diabetes  hypertension  total
    (n=83) (n=198) (n=121) (n=402)
number of forms per ethnic group    
 - Hindustani-Surinamese 13 36 15 64
 - African-Surinamese 2 6 11 19
 - Moroccan 23 51 18 92
 - Turkish 24 45 25 94
 - Dutch 21 60 52 133
 - Total 83 198 121 402
number of forms of males (%)    
 - Hindustani-Surinamese  (n=64) 5 (39) 7 (19) 5 (33) 17 (27)
 - African-Surinamese (n=19) 0 (0) 3 (50) 10 (91) 13 (68)
 - Moroccan (n=92) 11 (48) 32 (63) 16 (89) 59 (64)
 - Turkish (n=94) 7 (29) 31 (69) 3 (12) 41 (44)
 - Dutch (n=133) 7 (33) 32 (53) 21 (40) 60 (45)
 - Total (n=402) 30 (36) 105 (53) 55 (46) 190 (47)
Mean age per form (sD)    
 - Hindustani-Surinamese  (n=64) 51 (16) 63 (11) 57 (9) 59 (13)
 - African-Surinamese (n=19) 77 (0,7) 71 (2) 59 (6) 65 (8)
 - Moroccan (n=92) 52 (13) 54 (9) 52 (14) 53 (11)
 - Turkish (n=94) 48 (24) 57 (10) 54 (9) 54 (11)
 - Dutch (n=133) 59 (21) 68 (11) 67 (13) 66 (13)
 - Total (n=402) 53 (15) 61 (12) 60 (13) 59 (13)
Mean number of forms per GP (range)    
 - Hindustani-Surinamese  (n=64) 0,4 (0-2) 1,2 (0-11) 0,5 (0-4) 2,1 (0-12)
 - African-Surinamese (n=19) 0,07 (0-2) 0,2 (0-5) 0,4 (0-6) 0,6 (0-11)
 - Moroccan (n=92) 0,8 (0-6) 1,7 (0-18) 0,6 (0-14) 3,1 (0-35)
 - Turkish (n=94) 0,8 (0-7) 1,5 (0-15) 0,8 (0-10) 3,1 (0-29)
 - Dutch (n=133) 0,7 (0-4) 2,0 (0-13) 1,7 (0-11) 4,4 (0-22)
 - Total (n=402) 2,8 (1-17) 6,6 (1-52) 4,0 (1-38) 13,4 (1-102)
number of clinical decisions in analyses (missings)    
 - Hindustani-Surinamese 135  (0) 402 (26) 129 (25) 666 (51)
 - African-Surinamese 24 (0) 68 (4) 91 (21) 183 (25)
 - Moroccan 219 (3) 583 (25) 162 (28) 964 (56)
 - Turkish 238 (11) 525 (15) 217 (36) 980 (62)
 - Dutch 222 (2) 671 (34) 444 (68) 1337 (104)
 - Total (number missing) 838 (16) 2249 (104) 1043 (178) 4130 (298)
tAble 3
Characteristics of completed data collection forms by GPs  
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To pinpoint the potential ethnic differences in adherence we further explored our 
findings by testing the models per diagnosis and per field of decision making of the 
GP. The latter is categorised into seven areas: physical examination, instrumental 
examination, evaluation, prescribing medicine, giving information, giving advice, and 
referrals. Because of too little observations, we focussed in this explorative analysis only 
on total adherence. 
Analyses were performed in SPSS 12.0 and SAS 8.1. 
 
results
Seventeen general practices (12%) with 31 GPs, were willing to participate in this 
project. The main reasons for refusal were the high workload in the practices and the 
alleged time-consuming character of the project.
Because of technical problems data from one practice (with one GP) could not 
be extracted. Therefore data was obtained from 16 general practices (30 GPs) in 
which a total of 1149 patients were included and 402 forms were completed. 
These 402 forms were completed for 238 patients (mean form per patient = 1,68; 
SD = 1,2). The 238 patients consisted of 40 (17%) Hindustani-Surinamese, 8 (3%) 
African-Surinamese, 50 (21%) Moroccans, 57 (24%) Turks, and 83 (35%) Dutch. 
During the study period a total of 8435 patient-GP contacts were registered. 1580 (19%) 
of the patients-GP contacts were study contacts. During those 1580 study contacts, 283 
data-collections forms were completed. Table 2 gives information on the 1580 study 
contacts and shows that response was relatively poor and that there were differences 
between the contacts with filled in forms and without filled in forms in the relative 
distribution of ethnic group, and gender. 
Table 3 shows characteristics of the completed forms and patients. The most forms 
concerned type 2 diabetes, and the least asthma. 64 Forms concerned the treatment of 
Hindustani-Surinamese patients, 19 of African-Surinamese patients, 92 of Moroccan, 
94 of Turkish, and 133 of Dutch patients. Dutch patients were older than patients from 
other ethnic groups, except the African Surinamese. The African-Surinamese- and 
Moroccan group contained more men than women contrary to the other ethnic groups. 
The mean number of questionnaires completed by the 30 GPs is 13,4, with a range of 1 
to 102. A total of 4130 clinical decisions (838 for asthma, 2249 for type 2 diabetes, and 
1043 for hypertension) were used in the analyses of adherence. 
Table 4 shows the influence of the patient’s ethnic group on GP’s adherence to the 
guidelines. The univariate analysis shows that the mean percentage of the number of 
clinical decisions in which the GPs were adherent to the guideline is equal in the 
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    number of  GP’s adherence  Multivariate model 
    clinical decisions by ethnic group  ‡ or (95%-CI)
     (sD)
total adherence   
 - Dutch 1337 74% (.44) Reference group
 - Hindustani-Surinamese 666 75% (.43) 0,85 (0,64-1,11)
 - African-Surinamese 183 81% (.39) † 1,50 (0,90-2,49)
 - Moroccan 964 75% (.43) 0,86 (0,65-1,12)
 - Turkish 980 76% (.43) 0,83 (0,63-1,09)
 - Total 4130 75% (.43) xxxx
Relative covariance estimate (%)   
 - GP xxxx xxxx 30%
 - Patient xxxx xxxx 17%
Adherence positive 
recommendations   
 - Dutch 928 71% (.45) Reference group
 - Hindustani-Surinamese 422 70% (.46) 0,86 (0,60-1,25)
 - African-Surinamese 135 80% (.40)† 1,26 (0,64-2,49)
 - Moroccan 649 67% (.47) 0,74 (0,52-1,06)
 - Turkish 659 71% (.45) 0,74 (0,52-1,06)
 - Total 2793 71% (.46)* xxxx
Relative covariance estimate   
 - GP xxxx xxxx 20%
 - Patient xxxx xxxx 8%
Adherence negative recommendations   
 - Dutch 409 81% (.39) Reference group
 - Hindustani-Surinamese 244 84% (.37) 1,05 (0,57-1,96)
 - African-Surinamese 48 83% (.38) 2,37 (0,70-8,08)
 - Moroccan 315 91% (.29) † 1,73 (0,90-3,33)
 - Turkish 321 85% (.35) 1,14 (0,61-2,14)
 - Total 1337 85% (.36)* xxxx
Relative covariance estimate   
 - GP xxxx xxxx 12% 
 - Patient xxxx xxxx 42%
* Significant result analysis of variances between groups (α = .05).
† Significant difference with Dutch; Independent sample T-test (α = .05)
‡  Y(adherence) = x1(ethnic group) + x2(disease) + x3(patient’s age) + x4(patient’s gender) + ε, with random effects for GPs 
and patient
tAble 4
Association of patient’s ethnic group with GP’s adherence to the guidelines  
different ethnic groups (around the 75%), except for the African-Surinamese (81%). 
GPs were adherent to the guideline in 71% of the clinical decisions when it concerned 
positive recommendations in Hindustani-Surinamese, Turkish, and Dutch. This is 
lower in Moroccan patients (67%), although not statistically significant, while this is 
higher in African-Surinamese (80%). Mean adherence to negative recommendations 
is comparable in Hindustani-Surinamese (84%), African-Surinamese (83%), Turkish 
(85%), and Dutch (81%), while it is higher in the Moroccan group (91%). Adherence 
to positive recommendations is lower than adherence to negative recommendations in 
all ethnic groups.  
In the multivariate multilevel model we adjusted for confounders and the effect of 
differences between GPs and between patients and the relative covariance estimate 
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shows what part of the variances in the outcome is explained by these differences. 
Differences between GPs are larger than differences between patients except concerning 
adherence to negative recommendations. Although total adherence and adherence to 
positive recommendations is worse (except in the African-Surinamese) and adherence 
to negative recommendations is better in the different ethnic minority groups than in 
Dutch, none of the findings are statistically significant. 
Disease-specific exploration of these results shows no statistically significant differences 
in adherence or adherence to positive recommendations. 
Analysis of the different phases of the patient’s consultations indicates no ethnic 
differences in adherence, except regarding the instrumental examination in Turkish 
patient (OR (95%-CI) = 0,28 (0,09-0,91)) and giving information in Moroccan patients 
(OR (95%-CI) = 0,22 (0,05-0,99)), which are statistically significant lower than in 
Dutch patients. 
 
DIsCussIon
summary of main findings
Overall, GPs treat their patient to a large extent according to existing guidelines. 
Our prior hypothesis that GPs would have more difficulties adhering to guideline 
recommendations in the treatment of ethnic minorities is not supported by our findings. 
However, some differences were found in the instrumental examination in Turkish 
patients and giving information in Moroccan patients. However, because these findings 
concerned very small subgroups, further exploration is needed. This study also showed 
that, although patients are often treated according to guidelines, ethnic differences in 
adherence between GPs are relatively large. 
strengths and the limitations of this study
To our knowledge, this is the first study that has ever assessed ethnic disparities in 
guideline adherence using a specifically developed and validated instrument instead 
of retrospectively analysing patient records. To increase the willingness of GPs to 
participate in this study and to facilitate data collection, we implemented a data 
collection instrument in the GP information systems and we allowed GPs to elect not to 
complete a form. Therefore, in the situation of - for instance - a crowded waiting room, 
a GP could choose not to complete a form, so patients would not have to wait any 
longer than necessary. However, this strategy resulted in a relatively small number of 
completed forms and probably some selection bias. Our non-response analysis showed 
some ethnic differences in the number of times a contact led to a completed form. 
Differences were found in the Hindustani-Surinamese and Moroccan patients, although 
these differences were relatively small and therefore probably did not affect our results 
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very much. Differences in gender were also found when comparing contacts, resulting 
in a completed form with contacts that did not. However, gender was adjusted for in 
our analyses. Another important reason for the GP not to fill in a form could have been 
the clinical condition of the patient. However, because our measurement of adherence 
took into account the specific clinical condition of the patient, we did not include this 
in the non-response analysis.
Because only 12% of the GPs we approached participated in this study, our study 
population could also be an unrepresentative sample of all GPs. Although a high 
workload was the main reason for refusal to participate in this study, there are in fact 
no indications of a lower workload in the practices of the participating GPs. To our 
knowledge, the participating practices do not differ in practice characteristics or in 
patient population from the non-participating practices. Our participating GPs are 
probably more research minded and/or have a special interest in the topic of ethnic 
disparities in the quality of care. They probably also put more effort into the treatment 
of their ethnic minority patients by trying to treat them as much as possible according to 
the guidelines, in spite of the many challenges surrounding care for ethnic minorities. 
This could have resulted in a higher adherence to guidelines in ethnic minorities in our 
participating GPs compared to other GPs. 
This study shows the many difficulties with a prospective data collection in general 
practices in deprived neighbourhoods. The number of completed forms was relatively 
small and GPs mentioned a crowded waiting room, and therefore a lack of time, as the 
main reason for not completing forms. However, this study provides valuable insight in 
the quality of GP care in ethnic minorities.
Comparison with existing literature
Because clinical practice guidelines are often used as quality improvement instruments 
by defining appropriate health care, our results suggest that the quality of GP care is 
comparable in ethnic minority and indigenous patients. This conclusion is not in line 
with many other studies showing that ethnic minorities are substantially less likely to 
receive either key diagnostic procedures or effective therapies after adjustment for 
important clinical conditions19, 20 However, most of the scientific information on ethnic 
disparities in health care quality comes from the USA, and to a lesser extent the UK, and 
mostly does not concern GP-care. Studies from the Netherlands are scarce. Stronks and 
her colleagues found that access to the general practice in the Netherlands is equal for 
different ethnic groups21 Once in the general practice it seems that patients with different 
ethnic backgrounds are treated alike. Agyemang et al. found that the treatment received by 
Dutch hypertension patients by the GP was alike in different ethnic groups.22 The study by 
Uitewaal and colleagues was the first and only other study focussing on ethnic disparities 
in GP’s adherence to guidelines and it also found no ethnic disparities in treatment and 
adherence.12 However both Agyemang et al. and Uitewaal et al. found that although 
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treatment was alike in different ethnic groups, the clinical outcome of the treatment was 
worse in the ethnic minority groups.12, 22 This could be explained by a lower compliance 
with treatment in ethnic minorities caused by a lower mutual understanding between 
the GP and the patient from the ethnic minority group.23 So, it seems that adherence 
to the guidelines is not enough in the treatment of ethnic minorities. However, another 
explanation for the worse clinical outcome (of a similar treatment) in ethnic minorities is 
given by the recent debate on the external validity (generalisability) of CPGs.24, 25 One of 
the issues in this debate is whether guidelines take into account the specific circumstances 
of health care for ethnic minorities.25, 26 Research has shown that Dutch GP-guidelines 
mention less ethnic specific information than their British, American, and Canadian 
counterparts25 Dutch guidelines could therefore preserve a lack of awareness in Dutch 
GPs about important ethnic differences, resulting in a worse outcome of their treatment.
Implications for future research or clinical practice
Because of the relatively small numbers it would be worthwhile to repeat this study. 
Especially because we tend to see some ethnic differences in our results in the 
multivariate model. Although the odds ratios of the ethnic minority groups differ from 
the indigenous Dutch, the confidence intervals are too large to make the differences 
statistically significant. Furthermore, when focussing on special phases in a contact, 
ethnic differences in adherence become more likely to appear. When repeating this study, 
it would be important to get a larger GP-sample and a larger share of contacts in which 
forms are completed. To achieve this, methods should be found to shorten the form or to 
make a more optimal use of the GP-information system, so the time needed to complete 
the forms could be reduced. This would also avoid problems with non participation. 
Furthermore, it would be interesting to assess whether the same treatment approach has the 
same effect on health outcomes in different ethnic groups. This will help to determine whether 
or not there are no ethnic disparities in the quality of Dutch general practices. Such a study 
should preferably be done with a data collection instrument like ours, because it gives a more 
valid estimate of adherence compared to retrospective analysis of patient records. 
 
ConClusIon
This study did not reveal any ethnic disparities in adherence to CPGs by general 
practitioners. Because CPGs are assumed to be quality instruments, it seems that there 
are no ethnic disparities in the quality of care. However, before making that conclusion, 
it is worthwhile to assess whether the same level of GP’s adherence in ethnic minorities, 
compared with the indigenous majority, leads to the same positive health outcomes. 
Only then will it be possible to conclude that a similar degree of adherence to guidelines 
seen amongst different ethnic groups is synonymous to a similar quality of care. 
 
85STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
do gPS In thE nEthErlandS dIffEr In adhErEncE...
referenCes
1  Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, et al. Racial/ethnic 
differences in hypertension and hypertension treatment and control in the multi-
ethnic study of atherosclerosis (MESA). Am J Hypertens 2004;10:963-970.
2  Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, et al. Ethnic 
variations in UK asthma frequency, morbidity, and health-service use: a systematic 
review and meta-analysis. Lancet 2005;365:312-317.
3  Agyemang C, Bhopal R. Is the blood pressure of people from African origin adults 
in the UK higher or lower than that in European origin white people? A review of 
cross-sectional data. J Hum Hypertens 2003;17:523-34.
4  Uitewaal PJM, Manna DR, Bruijnzeels MA, Hoes AW, Thomas S. Prevalence of type 
2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease 
in Turkish and Moroccan immigrants in North West Europe: a systematic review. 
Preventive Medicine 2004;39:1068-1076.
5  Lane D, Beevers DG, Lip GY. Ethnic differences in blood pressure and the prevalence 
of hypertension in England. J Hum Hypertens 2002;16:267-73.
6  Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences 
in mortality, end-stage complications, and quality of care among diabetic patients: a 
review. Diabetes Care. 2005;28:2280-8.
7  Smedley BD, Stith AY, Nelson AR. Unequal treatment: confronting racial and ethnic 
disparities in healthcare. Washington DC: Institute of Medicine; 2003.
8  Field MJ, Lohr ML. Clinical practice guidelines: directions for a new program. 
Washington DC: National Academy Press; 1990.
9  Cabana MD, Flores G. The role of clinical practice guidelines in enhancing quality 
and reducing racial/ethnic disparities in paediatrics. Pediatric Respiratory Reviews 
2002;3:52-58.
10  Wieringen van JC, Harmsen JA, Bruijnzeels MA. Intercultural communication in 
general practice. Eur J Public Health 2002;12:63-68.
11  Horner RD, Salazar W, Geiger HJ, Bullock K, Corbie-Smith G, Cornog M, et al. 
Changing healthcare professionals’ behaviors to eliminate disparities in healthcare: 
What do we know? How might we proceed? The American Journal of Managed 
Care 2004;10:SP12-SP19.
12  Uitewaal PJ, Bruijnzeels MA, Bernsen RM, Voorham AJ, Hoes AW, Thomas S. 
Diabetes care in Dutch general practice: differences between Turkish immigrants 
and Dutch patients. Eur J Public Health 2004;14(1):15-8.
13  Geijger RMM, Van Hensbergen W, Bottema BJAM, et al. NHG-standaard Astma bij 
Volwassenen: behandeling. Huisarts Wet 2001;44:153-64.
14  Rutten GEHM, Verhoeven S, Heine RJ, et al. NHG-standaard Diabetes Mellitus type 
2 (eerste herziening). Huisarts Wet 1999;42:67-84.
86 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 6
15  Walma EP, Grundmeijer HGLM, Thomas S, et al. NHG-standaard Hypertensie 
(eerste herziening). Huisarts Wet 1997;4:598-617.
16  Bouwhuis CB, Moll HA. Determination of ethnicity in children in the Netherlands: 
two methods compared. European Journal of Epidemiology 2003;18:385-388.
17  Spies TH, Mokkink HGA, De Vries Robbe PF, Grol RPTM. Which data source in clinical 
performance assessment? A pilot study comparing self recording with patient records 
and observation. International Journal for Quality in Health Care 2004;16(1):65-72.
18  Spies TH, Mokkink HGA. Toetsen aan standaarden. Het medisch handelen van de 
huisarts in de praktijk getoetst [eindrapportage]. [Evaluating practice guidelines. 
Audit of clinical performance of general practitioners in practice: final report.]. 
Nijmegen: Centre for Quality of Care Research (WOK); 1999.
19  Felix-Aaron K, Moy E, Kang M, Patel M, Chesley FD, Clancy CM. Variation in quality 
of Men’s health care by race/ethnicity and social class. Medical Care 2005;43(3 
(Suppl)):I-72-I-81.
20  Bonds DE, Zaccaro DJ, Karter AJ, Selby JV, Saad M, Goff DC. Ethnic and racial 
differences in diabetes care. Diabetes Care 2003;26:1040-1046.
21  Stronks K, Ravelli ACJ, Reijneveld SA. Immigrants in the Netherlands: Equal access 
for equal needs? J Epidemiol Community Health 2001;55:701-707.
22  Agyemang C, Bindraban N, Mairuhu G, Montfrans van G, Koopmans R, Stronks 
K. Prevalence, awareness, treatment, and control of hypertension among Black 
Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The 
Netherlands: the SUNSET study. J Hypertens 2005;23:1971-1977.
23  Harmsen H, Meeuwesen L, van Wieringen J, Bernsen R, M. B. When cultures meet 
in general practice: intercultural differences between GPs and parents of child 
patients. Patient Educ Couns. 2003;51:99-106.
24  Thompson AGH. Variation may be good for your health: the nature of evidence. 
International Journal for Quality in Health Care 2002;14:1-3.
25  Manna DR, Bruijnzeels MA, Mokkink HGA, Berg M. Ethnic specific recommendations 
in clinical practice guidelines: a first exploratory comparison between guidelines 
from the USA, Canada, the UK, and the Netherlands. Quality and Safety in Health 
Care 2003;12:353-358.
26  Maassen H. A neglected difference. Ethnicity in research and guidelines (in Dutch). 
Med Contact 2005;60:1204-1206.
Are clinical practice guidelines good for 
your health? Ethnic disparities explored.
DR Manna, WK Redekop, HGA Mokkink, 
AE Vlug, M. Berg, and MA Bruijnzeels
7
Submitted. 
88 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 
89STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
arE cPgS good for your hEalth? EthnIc dISParItIES ExPlorEd. 
IntroDuCtIon
Clinical practice guidelines (CPGs) could be an important tool to achieve better health 
outcomes and represent a potentially powerful tool to reduce ethnic diifferences 
in health outcomes. While adherence to CPGs by Dutch GPs is relatively high and 
comparable between patients of different ethnic groups, the clinical outcome of care 
is often worse in ethnic minorities compared to indigenous Dutch patients.1 2 In this 
study we assessed whether adherence to CPGs has a positive effect on the clinical 
outcome of asthma, diabetes, and hypertension treatment, and we explored whether 
this relationship between adherence and clinical outcome differs between different 
ethnic groups.
 
PArtICIPAnts, MethoDs, AnD results 
The study design and methods are described in detail elsewhere.1  
We prospectively collected data in 17 general practices (with 31 GPs) for 6 to 9 months 
per practice between April 2003 and September 2004. We included all ethnic minority 
adult patients receiving treatment in the previous two years for asthma, diabetes 
mellitus type 2 or hypertension. A random sample of Dutch patients per diagnosis and 
per general practice was added.  
Adherence to guidelines was assessed by comparing clinical actions of the GPs with 
key recommendations of the CPGs, as measured by an electronic validated contact 
registration form that took into account the patient’s specific clinical condition.3 
Clinical outcome of care was measured for hypertension using systolic blood pressure 
(SBP) and diastolic blood pressure (DBP), for diabetes using blood glucose level and for 
asthma the GP was asked whether optimal lung capacity was reached or maintained. 
In addition, we constructed dichotomous outcome variables indicating whether the 
treatment target was reached. We did this overall and for all the three conditions 
separately. For hypertension, the treatment target was reached when the DBP was ≤95 
mmHg and the SBP was ≤ 160 mmHg for hypertension, and for diabetes mellitus type 2, 
the treatment target was reached when the fasting blood glucose level was < 8 mmol/l 
or the non-fasting blood glucose level was <10 mmol/l. The target in asthma treatment 
was reaching or maintaining an optimal lung capacity. To determine the relationship 
between mean adherence and the outcome of care we used a multivariate multilevel 
regression model in which we controlled for the covariates of patient gender and 
age and for variation at the patient and GP level. To explore ethnic disparities in the 
relationship between adherence and outcome, we performed the analyses for Dutch 
patients and ethnic minorities separately (Dutch versus non-Dutch, and Dutch versus 
the specific ethnic groups). 
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    Mean  treatment target  odds ratio (95%CI)* relative covariance
    adherence (%) reached (%)  (%GP / %patient)
Total (n = 401) 75 63 28.2 (3.8, 211.6) † 6/78
Hypertension (n = 120) 75 57 109.2 (2.7, 4421.2) 12/74
Diabetes (n = 198) 79 70 110.0 (3.59, 3369.3)  13/65
Asthma (n = 83) 66 52 0.5 (0.0, 88.2) 36/5
    
Dutch (n = 132) 75 67 149.7 (2.6, 8487.0) 0/86
Non-Dutch (n = 269) 75 61 21.8 (1.8, 268.7) 0/85
Difference between Dutch patients 
 and other patients (per ethnic minority)
 - Hindustani-Surinamese (n = 64) 0   -7 10.2 (0.0, 3230.2) 0/69
 - African-Surinamese (n = 19)  +6   +1 Not computable Not computable
 - Moroccan (n = 92) 0 -14 55.7 (0.5, 6690.7) 32/61
 - Turkish (n = 94) 0   +1 26.8 (0.1, 5113.8) 14/82
* Multivariate multilevel model: Y(treatment target reached) = x(mean adherence) + x(patient’s age) + x(patient’s gender) + ε, with 
random effects for GPs and patients. (α = .05)
† In this regression model, the diagnosis was included to adjust for differences between hypertension, diabetes and asthma.
tAble 1
Association between mean adherence and reaching treatment targets   
The GPs completed a total of 401 forms, regarding 238 patients, consisting of 40 (17%) 
Hindustani-Surinamese, 8 (3%) African-Surinamese, 50 (21%) Moroccans, 57 (24%) 
Turks, and 83 (35%) Dutch patients. 
We observed a strong relationship between adherence to the guidelines and reaching 
the treatment target overall, in hypertension, and diabetes mellitus type 2, but not in 
asthma (see table 1). We found a statistically significant relationship between adherence 
and blood glucose level with a β-coefficient of –5.01 (95%CI = -9.23, -0.80). The 
relationship between adherence and blood pressure was not statistically significant with 
β-coefficients of –11.52 (95%CI = -38.39, 15.34) for systolic BP and –4.17 (95%-CI = 
–17.78, 9.44) for diastolic BP. 
The table shows that while adherence rates did not differ between Dutch patients and 
patients in other ethnic groups, the treatment target was more often attained in Dutch 
patients. The relationship between adherence and attainment of treatment target was 
stronger in Dutch patients compared to non-Dutch patients, illustrated by the larger odds 
ratios seen for the Dutch patients than for the non-Dutch patients (see table 1, OR=149.7 
vs. 21.8). However, the confidence intervals for these odds ratios overlap. Analyses 
using the specific ethnic minority groups showed considerably lower likelihoods of 
achieving treatment targets compared to the Dutch, although no statistically significant 
odds ratios were observed. 
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CoMMent
This study shows that treatment targets are more often reached when GPs adhere to 
guidelines. This effect was particularly evident in the effect of adherence on blood 
glucose levels. Adherence to guidelines leads to better clinical outcomes in Dutch 
patients as well as in ethnic minorities. Given the explorative nature of this study and 
the lack of statistical significant differences, one could argue that there is a lack of any 
true ethnic variation in the effect of adherence to guidelines on treatment outcomes. 
Therefore, further research is necessary to test our conclusions. However, the results of 
this study suggest that the positive effect of adherence to guidelines on clinical outcomes 
is stronger in Dutch patients compared to ethnic minorities. If this is the case, the next 
step would be to determine why this is so. The differences might be explained by a 
mismatch between the content of the guidelines and the treatment acquired by ethnic 
minorities.4 Another explanation might be a difficulty in communication between GP 
and patient, leading to a poorer mutual understanding and ultimately reduced patient 
compliance.5 If our findings are true, further research would be invaluable in explaining 
why these ethnic disparities exist.
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IntroDuCtIon
Guidelines of the Dutch College of General Practitioners (NHG) are an integral part 
of general practice nowadays. The clear and scientific procedures laid down in the 
guidelines of the NHG have earned them not only acceptance by GPs, but also respect 
both at home and abroad. Nonetheless, from the moment they were introduced, 
the guidelines also met opposition. It was thought they would not do justice to the 
complexities of medical treatment and would lead to “cookbook medicine”.1 
Several years ago we posed the question: to what extent are guidelines valid in a multicultural 
society such as the Netherlands? In many deprived areas of large cities for example, the 
immigrant population is far greater than that of the native Dutch. The increasing immigrant 
population has resulted in GPs being confronted more frequently with an ethnically diverse 
patient population in which relatively large contrasts exist regarding the prevalence and 
incidence of certain illnesses and complications, the reactions to medical treatment, how 
people experience and react to an illness and its cause, and often language.2 3 Analyses 
of American, English, Canadian and Dutch primary care guidelines and their scientific 
justifications have shown that guidelines of the NHG include relatively little information on 
relevant ethnic differences.4 Moreover, although the scientific justifications for the guidelines 
of the NHG did describe a number of ethnic differences, these were not incorporated into 
the final guidelines.5 The publication of this information provoked a discussion with the 
NHG regarding the extent to which the guidelines fulfil the requirements for ethnic minority 
patient care.6 7 However, GPs with a multicultural patient population, specialists dealing 
with ethnic minorities, and others who use these guidelines have not yet been given their 
say in this discussion. We interviewed a number of GPs in order to gain insight into the 
extent to which those working in deprived areas consider the guidelines relevant when 
treating patients from ethnic minority groups. Their insights can help the discussion on the 
relevance of guidelines of the NHG in a multicultural setting.
 
MethoD
We asked nine GPs for an interview for this study. The nine GPs were selected from 30 
GPs who had participated in a study entitled “NHG guidelines and the care of ethnic 
minorities”. This study examined whether a patient’s ethnic origin influences the extent 
to which GPs follow the recommendations in the guidelines of the NHG, and whether 
the relationship between acting according to the guideline and the clinical results of the 
treatment given is affected by a patient’s ethnic origin. The selection of these nine GPs 
was based on the amount of data they had delivered for the study, and their relatively 
large immigrant patient population. These GPs could therefore be described as experts in 
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this field. Seven of the nine chosen GPs were prepared to be interviewed. One GP had 
already retired and the other was too busy due to the fact that a large number of GPs were 
on strike at the time of the interviews. The interviews took place in May and June 2005.
In this study we opted for a qualitative exploratory design, and an open interview 
technique. The interviews began by asking whether the current guidelines of the NHG 
were useful in the multicultural general practice. GPs were then asked if they deviated 
from certain specific recommendations for certain specific ethnic minority groups.
All interviews were recorded first on tape and then in writing. Due to the exploratory 
nature of this study, a method of analysis was chosen in which the written texts were 
categorised according to a number of central themes. Relevant results were presented 
in the GPs own words as far as possible. 
 
results
Almost all interviewed GPs said they treated immigrant patients no differently than 
native Dutch patients, nor did they always deviate from the recommendations in the 
guidelines for particular ethnic groups. On further questioning about ethnic differences 
that potentially affect treatment, one important point was mentioned by all interviewees: 
the significant difference in the effect of treatment. GPs often find immigrant patients 
more difficult to regulate than native Dutch patients. In their opinion, there are three 
essential differences: 1. Compliance and attitude to illness 2. Diet and exercise 3. 
Unfamiliarity with the concept of general practice. Although these three aspects are 
interlinked, they are discussed separately below. Opinions regarding the value of the 
guidelines of the NHG in the treatment of ethnic minorities will also be discussed. 
Compliance and attitude to illness
Diabetes and hypertension are disorders that do not cause immediate distress, but do 
carry risk factors for life-threatening complications and illnesses such as cardiovascular 
disease. According to the GPs interviewed, poor understanding of the concepts “chronic 
illness” and “risk factor” is partially due to the fact that immigrant patients have often had 
a poorer education than their native Dutch counterparts. The patients do not feel ill and 
therefore do not realise the seriousness of the situation. This also applies to native Dutch 
patients, but to a lesser extent, even if only due to the fact that information is more easily 
communicated. This attitude to illness causes significant problems regarding compliance. 
Compliance presents a greater a problem with immigrant patients because they do not 
understand that, even though they do not feel ill at present, they could become seriously 
ill in the future. Why should they take medication if they do not feel ill? 
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“They	do	not	understand	the	relation	between	risk	factors	in	the	present	and	potential	
illness	in	the	future.	Nor,	therefore,	do	they	understand	that	they	need	treatment	now	
in	order	to	prevent	problems	in	the	future.	This	results	in	very	poor	compliance	and	
a	vague	disposition.	The	concept	of	“I	feel	good	so	why	should	I	take	medication”	is	
therefore	prevalent	in	such	groups,	particularly	with	Turkish	and	Moroccan	patients”.
“My	biggest	problem	with	my	immigrant	diabetic	patients	is	that	they	do	not	really	
consider	diabetes	an	illness	which	requires	treatment.	It	is	an	illness	with	few	perceptible	
symptoms,	yet	one	for	which	patients	constantly	have	to	take	medication.”
The GPs also reported having difficulty in responding to such situations, for instance 
when patients say they have taken their medication but the GP doubts this to be the 
case, perhaps because the patient has not requested a new prescription for some time. 
The patient’s understanding of the illness remains poor, but the GP does not dare to 
respond by increasing the dose of medication. 
“The	patient	collects	the	prescribed	medication,	but	I	have	my	doubts	as	to	whether	
it	is	taken.	I	have	several	patients	who	return	3	months	later	with	the	entire	prescribed	
dose	and	yet	say	they	have	been	taking	it.	Their	compliance	is	definitely	worse.”
“Immigrant	 patients	 often	 present	with	 increased	 blood	 pressure	 or	 blood	 sugar	
levels,	but	I	dare	not	increase	their	medication	as	I	do	not	know	whether	it	is	being	
taken	properly	at	home.	Then	there	is	a	real	danger	that	the	patient	will	experience	
a	hypo.	I	would	rather	that	my	patient	has	 increased	glucose	levels	than	become	
hypoglycaemic.	It	is	very	difficult	to	judge	how	a	patient	deals	with	the	illness	when	
he	is	at	home.	That	leaves	me	feeling	helpless.”	
The GPs also reported that these patients sometimes deal well with their illness 
and take their medication as prescribed whilst in the Netherlands, but forget this 
as soon as they are on holiday in their native country. Patients then feel fine and 
no longer stick to their diet and medication. When they return, the patients tell 
their GP that they felt fine on holiday, suffered no stress (which they often consider 
to be the cause of high blood sugar levels or high blood pressure), and that their 
blood sugar levels were normal. What the patients often do not realise is that their 
blood sugar levels and/or blood pressure have been rising significantly during 
their holiday, and that the GP then has to do all he possibly can to get them back 
under control. 
In addition to compliance with medication, compliance with appointments is also 
worse among immigrant patients. This is often due to some groups’ unfamiliarity 
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with the concept of general practice. General practitioners enjoy an important 
position within health care in the Netherlands. In many other countries, and 
particularly those countries from which immigrants in the Netherlands originate, 
the concept of a “general practitioner” and his role as ‘gatekeeper’ to secondary 
health services, are unknown. In the Netherlands, patients suffering from diabetes 
or high blood pressure have to visit their GP every three months, even though they 
experience no symptoms. And the lack of symptoms is the reason they so often fail 
to keep follow-up appointments. 
“The	health	care	system	is	very	different	in	the	countries	these	immigrants	come	
from.	If	a	patient	is	ill,	he	goes	to	the	hospital.	If	not,	he	stays	at	home	and	there	
is	 no	need	 to	 contact	 a	doctor.	 If	 diabetes	 is	 diagnosed	 in	 those	 countries,	 the	
patient	 is	 not	 called	back.	The	 initiative	 lies	much	 less	with	 the	physician,	 and	
more	with	the	patient.	For	this	reason,	patients	receive	medical	care	much	later.	
And	you	 see	 that	here	 too.	People	 from	other	 cultures	 think	 it	 is	 strange	when	
asked	to	return	every	three	months	to	have	their	blood	sugar	levels	checked.	They	
have	no	symptoms,	so	why	see	a	doctor?	They	would	rather	do	something	else,	
and	that	has	become	a	habit.	They	are	not	familiar	with	general	practice.	That	is	
a	big	problem.	And	 if	a	patient	does	come	with,	 for	example,	a	headache,	 they	
immediately	ask	to	be	referred	to	a	specialist	or	for	a	CT	scan.”
“Immigrant	patients	also	avoid	check-ups,	do	not	have	their	blood	tested	regularly	
or	 simply	do	not	 take	 their	medication	 as	 prescribed,	 or	 in	 the	prescribed	dose.	
They	sometimes	decrease	the	prescribed	dose	without	consultation	because	they	
are	feeling	better.”
“Immigrants	do	not	understand	that	they	have	an	appointment	so	they	often	do	
not	turn	up.	I	think	that	is	a	problem	that	receives	little	attention	in	health	care.	
They	do	not	understand	that	hey	have	to	come	back	to	the	doctor	in	three	months	
because	they	do	not	feel	ill.	They	think	it	is	only	necessary	to	see	a	doctor	if	they	
are	feeling	unwell.”
Another important cultural difference concerns what we refer to as the “Health Locus 
of Control”. People from western countries generally have an internal health locus of 
control, whilst many ethnic minority groups in the Netherlands have an external health 
locus of control. Patients with an internal locus of control take responsibility for their 
illnesses and the effect of the treatment. Patients with an external locus of control place 
the cause of, and responsibility for, their illness beyond themselves. They often seek 
explanations in supernatural phenomena such as the ‘evil eye’, or God in the event of 
diabetes or hypertension, which results in noncompliance.8 
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“I	 once	 spent	 half	 an	 hour	 explaining	 to	 a	 patient	 that	 he	 had	 to	 take	 his	 own	
responsibility.	He	nodded	pleasantly	with	 a	 glazed	 look	 in	his	 eyes.	When	 I	 had	
finished	he	said:	“Yes,	but	doctor,	yesterday	I	had	a	dream	that	two	men	tried	to	kill	
me,	then	Allah	came	between	us	and	said	it	was	not	yet	my	time.	So	what	you	are	
saying	is	not	true.	As	a	human	being,	you	can	do	nothing.”	
Poor compliance can also result in GPs deviating from the guidelines more often with 
their immigrant patients. 
“You	 accept	 more	 from	 immigrant	 patients.	 If,	 for	 example,	 they	 return	 from	 a	
holiday	with	highly	abnormal	blood	sugar	 levels,	you	don’t	 immediately	 increase	
their	medication	because	you	know	the	patient	has	probably	not	been	 following	
your	instructions.
Diet and exercise
“Just	try	to	get	an	overweight,	traditional,	burqua-clad	immigrant	mother	of	five	
to	adapt	her	lifestyle	to	include,	for	example,	aquarobics.	They	all	see	swimming	
lessons	as	an	amusing	 idea,	but	none	take	them.	Sport	 is	not	an	option,	so	you	
have	to	 try	 to	get	 them	to	 take	walks.	But	 it	 is	difficult	 to	get	Dutch	patients	 to	
change	from	a	sedentary	lifestyle,	let	alone	immigrant	patients.”
This quote reflects the problems of overweight, diet and exercise. The GPs reported that 
diabetes and hypertension often go hand in hand with obesity in immigrant patients, 
particularly women. 
“My	immigrant	patients	are	significantly	heavier.	The	specific	problem	is	that	they	do	
not	want	to	exercise.	They	experience	aching	legs	because	they	are	overweight,	and	
do	not	take	exercise	because	of	the	pain	in	their	legs.”	
The GPs described a cultural difference in the degree to which patients exercise. Sport 
is part of the Dutch culture, in which everyone cycles and many people regularly 
visit a sport club. The same does not apply to immigrants. It is therefore more difficult 
to motivate them to exercise. The effect is, of course, strengthened by their lack of 
compliance and their beliefs surrounding illness, which have already been described. 
“Many	 immigrant	patients	are	heavily	overweight	and	have	been	for	many	years.	
This	applies	less	often	to	native	Dutch	patients.”
“Men	in	particular	are	terrified	that	their	heart	will	stop	if	they	start	to	exercise.	This	
again	is	due	to	lack	of	understanding.	I	also	get	the	impression	that	in	the	subcultures	
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I	deal	with,	the	car	is	a	kind	of	holy	cow	to	be	worshipped	together.	To	travel	by	bike	
is	a	sign	of	poverty.	You	can’t	get	immigrants	to	leave	the	car	at	home.”	
To some extent, not wanting to exercise explains their worse regulation. The quotes 
below show that GPs for this reason often deviate from guidelines.
“Yes,	sport	is	of	course	a	Dutch	pastime.	I	don’t	think	I	would	even	consider	suggesting	
it	to	immigrant	patients.	They	wouldn’t	do	it	anyway,	so	there	is	no	point.”
“I	treat	my	immigrant	diabetic	patients,	particularly	the	youngsters,	with	medication	
straight	away	because	if	I	didn’t,	I	think	they	would	be	back	in	six	months	and	then	
need	it	anyway.	You	cannot	get	a	40-year	old	Turkish	woman	with	abnormally	high	
blood	sugar	levels	to	exercise	her	way	back	to	health.	I’ve	seen	that	fail	all	too	often.	
Sooner	or	later,	those	patients	all	die	of	an	infarct,	so	for	heaven’s	sake	let	them	have	
medication	straight	away.”
nhG guidelines and the care of ethnic minorities
Almost all participating GPs thought that information on ethnic and/or cultural 
differences should only be included in guidelines once it has been scientifically 
proven. The moment we no longer strictly adhere to that requirement, NHG guidelines 
can no longer be taken seriously. According to the interviewees, the fact that little 
regarding ethnic differences has yet been proven in the Netherlands, unlike in the 
United States and Great Britain, explains why information on ethnic differences 
in the guidelines is limited. Moreover, these GPs expect the guidelines to include 
more on ethnic differences in the future due to the slow but sure increase in the 
scientific results available. It did strike them that in the last update of the guideline 
on hypertension no mention was made of the reduced effectiveness of medication on 
patients of African origin. According to the GPs, the proven differences that should 
be included in the guideline are those regarding the higher prevalence of diabetes, 
also regarding Turkish and Moroccan people, and the increased prevalence of 
hypertension in Creole Surinamese and Ghanese patients. Some physicians consider 
that differing perceptions of illness described in the study entitled “Hee Broedoe” 
should be included in the guideline on hypertension.9
“An	article	was	published	recently	in	Huisarts	&	Wetenschap		on	hypertension	
in	 Surinamese	 patients	 and	 their	 perceptions	 of	 the	 condition.	 It	was	 all	 very	
familiar	to	me.	For	example,	Creole	Surinamese	patients	who	say:	it	is	stress;	no	
more	stress,	no	more	hypertension.	These	patients	will	not	take	medication	if	you	
prescribe	it.	The	ideas	that	circulate	among	the	Surinamese	should	be	included	
in	the	guideline.”
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However, GPs expect to face difficulties if cultural differences are included in guidelines. The 
question remains: Where do you start? There are often fewer cultural differences between 
ethnic groups than within them, and is it possible to take all the differences into account?
“It	would	be	a	very	complex	 task	 to	outline	 the	perceptions	of	specific	 illnesses	per	
ethnic	group	and	include	these	in	the	guideline.	There	are	many	different	ways	in	which	
Dutch	people	perceive	specific	illnesses.	That	also	applies	to	persons	of	all	ethnicities.”
“A	guideline	must	be	succinct	and	specific,	and	it	makes	no	difference	whether	the	
patient	was	born	in	Casablanca	or	Amsterdam.	They	all	need	equal	conscientious	
medical	care.	What	we	know	about	the	various	cultural	backgrounds	is	not	a	topic	
for	the	guideline.	That	would	make	the	guideline	far	too	complex.”
One GP had trouble accepting the NHG’s passive attitude regarding the study of ethnic 
and cultural differences. 
 
“I	am	irritated	by	the	passive	attitude	taken	by	the	guidelines.	It	is	already	a	well-
known	fact	that	diabetes	is	often	diagnosed	at	a	late	stage,	and	statistics	show	that	
half	of	all	diabetics	do	not	even	know	they	have	it.	Postponing	the	diagnosis	instead	
of	 anticipating	 these	 statistics	 is	 highly	 dangerous.	 This	 applies	 in	 particular	 to	
immigrant	patients.	Patients	should	therefore	be	screened	much	sooner.	
I	am	also	concerned	about	the	way	the	guidelines	generalise,	just	because	evidence	
is	found	within	one	particular	group.	Further	research	must	be	carried	out	in	which	a	
differentiation	is	made	between	ethnic	groups.	I	also	think	that	evidence	from	abroad	
could	be	put	to	good	use	in	the	Dutch	situation.	If	you	see	that	everything	is	the	same,	
why	repeat	everything?	It’s	not	that	different	in	the	Netherlands.	The	main	problem	is	
that	the	NHG	is	waiting	for	information	that	is	solely	applicable	to	the	Netherlands.	It	
will	be	many	years	before	we	have	that,	while	we	already	know	the	difference.	
The	guideline	is	no	use	to	me	whatsoever.	Screening	at	the	age	of	50	is	far	too	late.	I	prefer	
‘anticipatory’	medicine	whilst	the	NHG	prefers	prevention	for	the	majority.	No-one	needs	
to	know	that	some	groups	think	differently,	and	what	you	don’t	know	can’t	hurt	you.”	
 
DIsCussIon
In this study, we asked GPs for their opinions regarding the value of guidelines of the NHG 
in a multicultural setting. Apart from a few exceptions, the GPs interviewed considered 
that NHG guidelines do pay sufficient attention to the ethnic differences between patients. 
The GPs also reported that they do not treat immigrant patients differently to native Dutch 
patients, nor do they deviate more often from the guidelines when treating people from 
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ethnic minority groups. This information was based on the results of their own studies 
into ethnic differences regarding adherence to guidelines and treatment given by general 
practitioners.10 Nevertheless, certain situations were described that appear to be more 
prevalent among immigrant patients and in which the GPs did deviate from the guideline. 
The GPs were less apt to increase medication if immigrant patients remained unwilling to 
cooperate, or were unwilling to cooperate following a holiday. Some also reported making 
less effort to change the patient’s behaviour in favour of starting medication earlier. These 
examples, however, show that the information in the guideline is, although correct, more 
difficult to implement for immigrant patients. 
The GPs mentioned that immigrant patients often fail to adjust to their illness. This 
was generally assumed to be due to the patient’s poor understanding and the cultural 
differences affecting lifestyle and compliance. 
However, our method does appear to have certain shortcomings. The GPs we interviewed 
were all from a select group that had participated in a study of NHG guidelines and the 
care of ethnic minorities. This group may well be particularly interested in improving the 
quality of care for ethnic minorities and therefore have a different opinion to GPs who 
had not taken part in the study. This study, however, did not aim to make generalisations 
based on the views of a typical GP working in the Netherlands. The GPs interviewed 
in this study were all experts, in other words they all had many years of experience in 
treating patients from various ethnic backgrounds. No, on the contrary, the aim of this 
study was to gain the views of these experts, as they could probably best determine 
whether the guidelines of the NHG suffice in multicultural general practice.
The interviews had an open character and no topic list was used. This was done 
deliberately so that the GPs were influenced as little as possible, and to give the 
interviewees the opportunity for own input. Almost all the GPs interviewed reported 
no differences in the care given to different ethic minority groups. Nevertheless, further 
questioning did reveal issues that are discussed in this article. It is possible that the 
GPs, through further questioning, revealed problems that were rather exceptions than 
rules. To present the information in this way could give an incorrect and unfavourable 
impression of the care received by ethnic minority groups in general practice. However, 
since all the GPs interviewed reported the same ethnic differences mentioned in this 
article, it would seem that the problem has by no means been overestimated. In fact, 
we think that GPs have become so used to dealing with the “problems” described here 
that they did not even mention them at first. We do recommend, however, that future 
studies examine the extent of the problems outlined in this article.
The comments made by the GPs in this study are comments that have been made in 
health care since the 1980s.11 12 One could even regard these comments as immigrant 
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patient “stereotyping”. These GPs do, however, have practices in deprived areas and/or 
have many immigrant patients and therefore wide experience in this subject. In addition 
to a variety of stereotype problems still faced on a regular basis, the GPs stated that 
immigrant patients are more difficult to treat, which leads to poorer clinical results. 
It is remarkable that all these years later the same problems surrounding the care of 
immigrant patients in general practice still exist, and it poses doubts about the health 
care policies over the last decades. These policies appear to have had little effect on 
patient care in multicultural general practice. The problem GPs still encounter is a 
continuing lack of communication with immigrant patients, which causes much distress 
and high expenditure as a result of secondary complications. As primary care provider 
and gatekeeper, the GP faces these problems on a daily basis yet has few resources with 
which to solve them adequately. Political attention is therefore still essential. 
Despite the problems outlined above, the GPs did consider the NHG guidelines to be 
more than adequate, also for the treatment of ethnic minorities. But how tenable is 
this viewpoint if they admit deviating from the guidelines due to problems of treating 
immigrant patients, and while research shows that the care given yields poorer results?13 14 
The GPs felt that more specific attention for ethnic differences would only be indicated 
if more Dutch evidence becomes available, and even then should be limited so as 
not to undermine the value of the guidelines. This is a very valid consideration that is 
also being argued by the NHG. We do feel, however, that ethnic differences must be 
recognised in view of the fact they have been an issue in general practice for so many 
years now. Dutch policy has largely ignored the problem so far, and therefore new or 
other ways must be found to assist GPs in providing care for ethnic minorities. The 
guidelines can be highly instrumental in this regard. The NHG guidelines are accepted 
and respected everywhere. A more pro-active attitude towards specifying the relevant 
ethnic differences could therefore improve the care given to ethnic minority groups. The 
government should also continue to stimulate research and intervention with a view to 
improving the medical treatment of these patients in the Netherlands. This will result not 
only in a better quality of care for ethnic minorities, but will also save on expenditure 
by preventing many unnecessary illnesses and complications. Fortunately, the NHG 
has devoted regular attention to ethnic differences, which is evident for example in the 
recent publication of the NHG guideline on diabetes mellitus type 2.15 However, the 
fact that no mention has been made of ethnic differences in the recently published NHG 
Guideline on Cardiovascular Risk Management shows that the problem is still not being 
acknowledged, even though many ethic differences have already been established.16 
There is, therefore, still much to be gained.
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ConClusIon
NHG guidelines are an important, respected and accepted instrument in improving the 
quality of care provided by general practitioners in the Netherlands. Little has changed 
over the last decades regarding the problems surrounding immigrant patient care in general 
practice. For this reason, the NHG would be justified in taking a more proactive attitude 
towards acknowledging ethnic differences in their guidelines. The NHG is now giving 
more structured attention to ethnic differences in the development of its guidelines. 
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overAll ConClusIon
This thesis was focussed on the question whether guidelines of the Dutch College of 
General practitioners should pay more attention to ethnic differences between adult 
patients with diabetes mellitus type 2, hypertension and asthma. This question was 
divided into five sub questions: 
1.  Is there any reason or evidence for paying attention to ethnic differences in these 
chronic conditions?
2. Do GPs’ treatment differ between patients of different ethnic origin
3.  Is GPs’ adherence to the guidelines associated with the ethnic background of 
their patient?
4.  Are there any ethnic differences in the association between treatment and 
clinical outcome of treatment?
5.  What is the opinion of GPs with many ethnic minorities in practice, regarding 
the usefulness of the current guidelines in the treatment of ethnic minorities?
Based on the studies described in this thesis I conclude that much relevant evidence 
on ethnic differences exist which mostly does not lead to ethnic specific remarks or 
recommendations in the Dutch guidelines. Furthermore, although GPs do not differ 
in the degree of adherence to guidelines or treatment between ethnic groups, the 
association between the GPs’ adherence to guidelines and the patients’ positive health 
outcomes is stronger in Dutch patients. Finally, almost all GPs indicated that the current 
guidelines were adequate for the treatment of ethnic minorities. 
With answering all five sub-questions an overall conclusion regarding the question 
whether the guidelines of the Dutch College of General Practitioners should pay 
more attention to ethnic differences can be made. Given the relatively large ethnic 
disparities in health, the evidence based character of the guidelines and the relatively 
large number of relevant available evidence the guidelines should pay more attention 
to ethnic differences. Especially because it seems that the same treatment and the 
same degree of adherence to the recommendations of the guidelines have a smaller 
association with reaching treatment targets in ethnic minorities compared to in Dutch 
patients. Our findings that in the participating GPs’ opinion the current guidelines 
are as useful in ethnic minority patients as in Dutch does not negatively affect this 
conclusion. First, because the GPs point out that if evidence is available it should be 
taken into consideration in the development of the guidelines and second, because they 
experience differences in outcome and explain it with patient factors, which of course 
also could be addressed in the guidelines.  
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lIMItAtIons of thIs stuDy
Considering all analyses performed in this thesis the question arises whether selection 
bias is a relatively large problem in some of the studies. In this thesis selection bias could 
have occurred through the sample of GPs or the completed data collection forms. 
GP sample and selection bias
In this study 145 practices using a specific type of information system (Elias) and located 
in or near deprived neighbourhoods were approached to participate in this study. Only 
17 practices out of the 145 agreed to participate. Participation implied extracting 
patient records (which were made anonymous) from the GP information system, and 
more importantly prospectively filling in a data collection form after visits of selected 
patients. Especially the alleged time-consuming character of the prospective part of this 
study led to the low participation rate of GPs. 50 general practices should be included 
according to the project proposal, while only 17 did. This selection of GPs could have 
been a source of bias with consequences for the results in two ways. First because only 
GPs using Elias were approached, and second, because only 12% of the approached 
GPs agreed to participate.
The reason why “only” practices using Elias were approached is explained by the 
collaboration with the Department of Medical Informatics of the Erasmus MC. The 
Department of Medical Informatics has much experience in writing software tools 
for computerised data-collection. They developed and installed software in the GP 
information systems for the computerised data collection of this study. However, at 
that time their experience was limited to one type of GP information system, e.g. Elias. 
Although at that time Elias had one of the largest market shares in the Netherlands, only 
around 25% of all GPs used this information system. There are no indications that the 
GPs using Elias differ from other GPs in such a way that it could influence the findings 
presented in this thesis. Therefore we do not expect that the selection of GPs using Elias 
negatively affected the external validity of this study. 
Only 12% of the approached practices finally participated in the study. As mentioned, 
the main reason for refusing participation was the alleged time consuming character 
of this study. The participating practices seemed not to differ from other practices. The 
participating practices were located in or near deprived neighbourhoods in different 
cities in the Netherlands, like The Hague, Rotterdam, Amsterdam, Utrecht, Delft and 
Arnhem. Furthermore the participating GPs consisted of males as well as females and 
were distributed proportionally over different age categories. The practices also ranged 
from solo-practices to practices with two or three GPs and large health centres. So 
it seemed that neither the practices nor their patient population differed from non-
participating practices. The reason for participation could therefore be found in the 
participating GPs being more research-minded and/or being more interested in the 
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topic of the quality of care for ethnic minorities. However, I did not perform a proper 
non-response analysis, so I can not make any scientifically grounded conclusion in this 
regard. However, in my opinion it was a source of bias, because it is not unthinkable 
that research-minded GPs with special interest for ethnic minorities pay more attention 
to the care given to ethnic minorities. This type of bias could have led to for instance 
an underestimation of the ethnic differences in health outcomes found in this thesis, 
because they put special care in their treatment of ethnic minorities. It has to be noted, 
however, that the interviews with the GPs did not seem to confirm this. The GPs did not 
feel the guidelines should give more specific attention to ethnic differences. Nor was 
there any hint of a different approach in their work vis-à-vis ethnic minorities compared 
to other GPs.  
Completed data collection forms and selection bias
To asses differences in adherence to guidelines and the association between adherence 
and health outcomes, we used a data collection form, which we implemented in the 
GP-information systems. After every visit of an included patient the GP was asked 
whether the visit concerned the disease for which the patient was included in this 
study. If so, the GP was asked whether he would like to fill in the data collection form. 
If the GP answered one of these two questions with NO the data collection form 
did not appear on his computer screen. After the data collection period it turned out 
that a disappointingly small number of forms was completed in the practices. When 
confronting the GPs with this low response they all mentioned the high workload as the 
only reason for not completing the forms more frequently. 
The low number of completed forms led to problems with statistical power (see below) 
and could have caused selection bias, because the completed forms are a selection 
of the forms potentially completed. Bias could have arisen when a GP would have 
not completed forms when s/he doubted whether appropriate care was delivered. 
Consequently, the completed forms could concern those visits that the GPs were 
willing to have reviewed, because of perceived high adherence to the guidelines. This 
bias could obviously be a large problem when GPs excluded forms because of the 
perceived high or low adherence more often in one or more specific ethnic group or 
the Dutch reference group. Because GPs indicated that the high workload was the 
main reason for not completing a form and a high workload is often associated with 
care for ethnic minorities there is a strong probability that selection bias could had an 
effect on our findings. To estimate this effect a non-response analysis was performed, 
which is partly described in chapter six. The Chi²-analyses in the non-response analysis 
showed differences in visits with and without completed forms between ethnic groups. 
However further t-test analyses showed that the differences between the ethnic groups 
did not concern differences between the Dutch reference group and the different ethnic 
minority groups. Also not when focussing on the specific diseases. What is also important 
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and is not mentioned in chapter 6 is that we also included the number of prescriptions 
in the non-response analysis to see whether characteristics of visits in which a form was 
completed differed from visits without a completed form. No differences were found. 
So, based on this analysis of non-response I conclude that the visits do not seem to 
differ from each other in a relevant way and therefore it seems that visits with completed 
forms are comparable with visits without completed forms. 
The clinical condition of the patient could also be an important reason for GPs for not 
completing a form. This clinical condition (i.e. the existence of relevant co-morbidity) 
is not included in the non-response analysis, because it is an integral part of the data-
collection form. The clinical situation of the patients determines the specific action 
(according to the guidelines) required by the GP. And this was taken into account in 
the data collection and –analysis instrument. Therefore we conclude that the clinical 
situation is not a factor of relevance for this non-response analysis.
So, although the low number of completed forms and therefore non-response was an 
important issue in the prospective part of this study, the non-response analysis did not 
reveal large difference. Therefore I conclude that our results are probably not biased. 
Although the low numbers of completed forms in this study I think that data collection 
forms integrated in the GP’s information system for research purposes can be a powerful 
way to gather data. It is however important that such an integrated data collection form 
does not intervene with the GP’s work. So, the question the GP has to answer should be 
kept to a minimum. One way to do that is to copy data which the GP filled in his patient 
file automatically in the form. 
statistical power and effect on results
The relatively low numbers of participating GPs and completed forms led to 
problems with statistical power in the analyses presented in the chapters six and 
seven of this thesis. This lack of statistical power in all subgroups led to relatively 
wide confidence intervals. This partly explains why no ethnic differences in the 
results were found. When closely considering the different confidence intervals some 
appear to approach statistical significance. For instance the analysis of adherence to 
positive recommendations in guidelines presented in chapter six show ORs of 0.74 
in Moroccan and Turkish patients. The confidence intervals were between 0.52 and 
1.06. It is plausible that statistical significance is not reached because of the lack 
of statistical power. In all analyses in this thesis two-sided hypothesis testing was 
done in which a significance level of 0.05 (and 95% confidence intervals) was used, 
which is common in epidemiology and health services research. However, two-
sided hypothesis testing is often automatically chosen because of this commonness. 
It is rather questionable whether two-sided hypothesis testing should always be the 
standard. Actually, two-sided hypothesis testing should only be performed when 
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prior hypotheses regarding the direction of the expected differences or associations 
do not exist. In one-sided hypotheses testing prior hypotheses of differences and 
associations exist.  It can be argued that in many analyses presented in the scientific 
literature including in our own analyses one-sided hypothesis testing should be 
preferred. In this thesis for example prior hypotheses were that adherence to guideline 
recommendations, the association between adherence and outcome, and treatment 
would be better in Dutch patients. Therefore, one-sided testing is defendable in this 
thesis. Figure 1a. and 1 b. shows the effect of the choice between one-sided and 
two-sided hypothesis testing on the confidence intervals and therefore the results 
of the analysis. 
 
Both figures indicate that one-sided testing would more often yield statistically 
significant differences, also regarding the analyses presented in this thesis. Realising 
this is relevant because of the differences between statistical significance and 
clinical relevance. All of the (not statistically significant) ethnic differences found 
in this study indicate the same finding which is that adherence, treatment and 
association between adherence and outcome is worse in (some) ethnic minority 
groups. If the hypotheses were tested one-sided some differences would probably 
be statistically significant 
However a 95% confidence interval was chosen in this study and therefore our 
conclusion still remains that there are little statistically significant ethnic differences in 
adherence and treatment. Although it would be worthwhile to repeat this study with an 
improved design in which more GPs should be included and more completed forms 
should be obtained.
Figure 1a  two-sided hypothesis testing Figure 1b one-sided hypothesis testing 
α /2 α /2
t1-α /2 tα/2µ0=0
α = 0.05
tα= 95%µ0= 97%
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GenerAl DIsCussIon
Ethnic disparities in health are nowadays extensively described in the scientific literature. 
Evidence of this ethnic health gap is particularly present in the diseases under focus 
in this thesis. In diabetes and hypertension a higher prevalence in ethnic minorities, 
earlier onset, and more (severe) complications are proven. It is not totally clear whether 
asthma is more prevalent in ethnic minorities, although the risk of hospitalisation and 
the number of department visits are higher.1 Explanations for these ethnic disparities 
in health are complex. Health outcomes can be considered as the outcome of the 
interaction between the physician and the patient. One of the many forces influencing 
this doctor-patient interaction are the guidelines. In the following part of this chapter I 
will focus on the validity of guidelines as a possible explanation for ethnic inequalities 
in health outcomes. 
validity of guidelines 
The international scientific literature is filled with evidence of ethnic disparities in 
the quality of health care. It is proven in the US and UK that ethnic disparities in 
the quality of care are an important potential explanation for ethnic inequalities in 
health outcomes.2 3 Standardisation and guidelines are considered important quality 
improving concepts and instruments. This thesis implicitly explored the validity 
of the concept of standardisation in a multicultural setting and how guidelines in 
a multicultural society are related with the ethnic health gap. Opinions on this 
matter can be classified along the continuum between two perspectives. First, the 
perspective that the concept of standardisation in Western medicine is in contrast 
with the Western world becoming more and more ethnically divers. And second, 
standardisation of care according to the principles of evidence-based medicine 
discourages ethnic variation in treatment, and therefore could be an important 
tool to diminish ethnic disparities in the quality of health care and consequently 
in ethnic disparities in health. The results of this thesis confirm earlier findings that 
treatment and adherence to guidelines of Dutch GPs do not differ between ethnic 
groups and that the same treatment does lead to relatively worse heath outcomes 
in ethnic minorities.4 5 So, the question arises whether standardisation and clinical 
practice guidelines could overcome these worse health outcomes. 
The history of guidelines goes back to the industry in the 1930’s where it became 
apparent that variation in processes should be reduced as much as possible.6 In 
the last 20 years this management wisdom called “standardisation” has entered 
health care services. The reason for this was a need for better quality health 
services. The explicit belief was that many, if not most, professionals were working 
sub-optimally through not practising with the best evidence available to their 
particular discipline. Examples of wide variations in outcomes between hospitals 
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or treatment units were often quoted in support of the general condemnation, 
fuelled by comparisons with other sectors, service and manufacturing, where 
often such variation has been successfully brought under managerial control.7 The 
principle of standardisation and guidelines aims on defining the best treatment for 
the average population based on the best available evidence. Exceptions between 
patients should only be made when these exceptions seem necessary and are 
proven with scientific evidence. Obviously physicians still retain their autonomy 
and therefore can deviate from the recommendations of the guidelines when 
necessary in best interest for their patients. 
The concept of standardisation and guidelines are by now a legitimate and 
structural part of health care and medicine. However, when developing a 
guideline stating the best treatment practice based on the best available evidence 
the users of the guidelines should be certain whether the guideline is indeed the 
best-practice for the patient in front of him. This is not always the case. Apart 
from human considerations such as inadvertent oversights by busy or weary 
members of the guideline group, guideline developers may err in determining 
what is best for patients for several reasons.8 For instance, scientific evidence 
about what to recommend is often lacking, misleading, or misinterpreted and 
recommendations are influenced by the opinions and clinical experience and 
composition of the guideline development group. Flawed clinical guidelines harm 
practitioners by providing inaccurate scientific information and clinical advice, 
thereby compromising the quality of care.8 The greatest danger of flawed clinical 
guidelines is to patients. Recommendations that do not take due account of the 
evidence can result in sub-optimal, ineffective, or harmful practices. What is 
best for patients overall, as recommended in guidelines, may be inappropriate 
for individuals or specific subgroups, like ethnic minorities.8 Thus the frequently 
touted benefit of clinical guidelines e.g. more consistent practice patterns and 
reduced variation, may come at the expense of reducing individualised care for 
patients with special needs.8 
To determine whether guidelines could be a reason or a solution for ethnic differences 
in health outcomes the question on validity of the guidelines should be addressed. 
Graham et al. (2000) created an conceptual framework to explain variances in clinical 
outcomes.9 Figure 2 shows that the internal as well as the external validity of guidelines 
can have an effect on ethnic differences in clinical outcome.
In figure 2, the level of scientific evidence and experience of the expert panel determines 
the internal validity. The external validity is determined by patient characteristics and 
the clinical setting in which the guideline is used. Patient characteristics refer to the 
possibility that personal factors, e.g., social, physiological, and economic, of patients 
may affect relationships between guidelines and care outcomes, thus limiting their 
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generalisability to specific patients. Clinical setting refers to limitations in extrapolating 
from guideline-related circumstances in one clinical context to another.
Internal validity
As stated above, according to the conceptual framework of Graham et al. the internal 
validity of guidelines is based on the level of evidence or the level of experience of the 
guideline developers.9 The guidelines used in this study are developed according to 
the principles of evidence-based medicine. The guideline development process of the 
Dutch College of General Practitioners serves as a worldwide example of an evidence 
based medicine standard setting procedure.10 The expert panels responsible for the 
specific guidelines are in general experts in the specific health problems in general 
practice. The (most recent updates of the) guidelines on the health problems under 
study in this thesis are also developed by panels with members with much expertise on 
the specific subjects, also concerning these health problems in ethnic minorities. The 
guideline development process has a comment phase in which 50 randomly selected 
GPs can give feedback on a draft of the new guideline. Finally the standard development 
procedure ends with an authorisation procedure that consists of a session in which the 
External validity
Internal validity
Experiential
Expert
opinion
Experimental
Scientific
Evidence
clinical Setting Patient characteristics
Figure 2 Explaining variances in clinical outcome by the validity of guidelines9
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expert panel has to defend its’ product before a critical committee of wise men and 
women. Their wisdom is derived from various academic chairs of general practice or 
a long experience in general practice.11 So, in conclusion one should be confident in 
the expertise of the guideline developers. However, parts of this thesis emphasise the 
importance of the role of normative values in the development process. Guidelines are 
highly influenced by the human factor, i.e. feelings, behaviour, values, needs, rationality 
and subjectivity.11 The whole guideline development process takes place in a normative 
and subjective context. The choice of the members of the expert panel, the topics in the 
guidelines, and the search and selection of evidence are all partly based on normative 
powers and values. 
The guidelines under study in this thesis were very reserved with giving attention to ethnic 
differences. In chapter three and four I concluded that despite the existence of relevant 
evidence about ethnic differences most of these differences were not mentioned in the 
guidelines. This could refer to problems with the internal validity of the guidelines. In a 
reaction, the developers of the guidelines (the Dutch College of General Practitioners) 
mentioned different arguments for this reservation, which all seemed valid.12 First, 
they mentioned that the evidence of ethnic differences in care or health found in the 
Netherlands does not make ethnic specific recommendations necessary. Furthermore, 
evidence found in other settings or countries could not be deemed to be necessarily 
applicable on the Dutch context. 
Second, they mentioned that relevant ethnic differences are implicitly already 
incorporated in the guidelines. For instance, it is well known that people from African 
descent are more sensitive to sodium restrictions. The guideline states that the GP has 
to inform all of his patients to cut down on salt, so this will automatically benefit the 
patients of African descent as well.  
Third, they mentioned that the treatment by the GP is based on clinical values rather 
than social constructs (like ethnicity). This means that for example the blood glucose 
level or the (lack of) success of the treatment should influence the actions of the GP. 
When a specific medication does not work in a specific ethnic subgroup, the blood 
pressure will not be controlled and the GP will automatically reconsider his treatment 
according to the guideline. 
Their first argument, the alleged lack of Dutch scientific evidence on ethnic differences, 
is only partly true. Although in general evidence is still limited, ethnic differences in 
some health problems are by now fully established. Differences in prevalence, severity, 
ages of onset, and effectiveness of treatment are found in diabetes and hypertension. 
However, even in the most recent updates of the guidelines on diabetes and hypertension 
ethnic differences are scarcely or not mentioned. Furthermore, evidence found in other 
western countries with the same ethnic groups should not be disregarded. It's not 
defensible that while evidence found in white men in the USA or UK is automatically 
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applied to the entire population in western society and therefore the Netherlands, 
evidence on ethnic differences should only be considered when found in the own 
country. Ethnic differences found in other countries should surely be considered with 
caution. Evidence found in the USA for instance cannot automatically be applied on the 
Dutch situation, because of the relative large differences between the ethnic groups and 
to a lesser extent their position in the host country. However, some ethnic groups with 
the same background are scattered over different (European) countries, like the Turks, 
Ghanaians, South East Asians and Moroccans. So evidence found in Turks in Germany, 
for example, can surely be used in the Dutch setting. 
Not everything stated in the guideline, as we argued before, is evidence based. On 
some specific issues evidence is lacking or not straightforward. In those situations often 
a minimum intervention philosophy is followed in the Netherlands or the expert panel 
will decide on the content of a specific recommendation based on their expertise. A 
minimum intervention philosophy is probably often a preferable strategy to resist for 
instance medicalisation or to control costs. But when scientific evidence is lacking or 
is not so strong while many experts or signs are pointing to a large health problem in 
ethnic minorities, a more pro-active attitude could be desirable. When recommendations 
are based on the expertise of the panel the composition of the panel becomes a very 
important determinant for the content of the guideline. Therefore it is important that the 
expert panel should always be a reflection of all users. 
There are many problems surrounding the second argument of the Dutch guideline 
developers. First, research has shown that Dutch GPs adhere to approximate 70% 
of the recommendations in the guideline.13 So 30% of the recommendations are not 
followed because of several reasons. It is never assessed whether the salt restriction 
recommendation is followed or not but it is not unthinkable that this particular 
recommendation is not followed by every GP every time. It is known that salt 
restriction has a larger blood pressure lowering effect in black people, who have much 
larger problems regarding hypertension than the general population. So the specific 
mentioning in the guideline of the effect of salt restriction in blacks could enlarge the 
adherence to this specific recommendation in the treatment of blacks and could have 
a positive effect on their hypertension burden. Not mentioning this ethnic specific 
information could lead to an unnecessary lower quality of care. Second, one of the 
most important objectives of the guidelines is to provide GPs with a quick-reference-
guide regarding the current scientific knowledge on a specific subject. It is only fair that 
proven ethnic differences should be stated in this reference book. It alerts GPs to pay 
attention to specific circumstances regarding care to ethnic minorities, like compliance 
or difficulties in the management of diabetes or hypertension. The mentioning of the 
higher burden of these diseases could lead to GPs treating more actively in stead of 
trying and waiting on the effect.
The third argument that the treatment of the GP is based on clinical outcome 
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measures like the blood glucose or blood pressure levels, and therefore ethnic specific 
recommendations would not be necessary because GPs automatically will react 
(according to guidelines) when a positive effect stays away, is odd. It would mean that 
inaccurate information is knowingly stated in the guideline. The guideline developers 
know that the treatment recommended would probably not have an effect in a specific 
ethnic group, but it remains the first preferred treatment. Only after some months, when 
the treatment does not have the intended effect, GPs will start an alternative treatment.
The above briefly described discussion is very interesting and it is not easily determined 
who is right in this matter. However, the purpose of illustrating this discussion is to show 
that the above-described arguments of the guideline developers can be categorised as 
mainly normative and subjective (as are mine) with large consequences for the content 
and the internal validity of the guidelines. This normative and subjective context cannot 
be eliminated, because guidelines are still developed by humans. Guidelines could 
even also benefit from the human factor. So is the possibility of reaching consensus on 
a multitude of questions which are important for the day to day functioning of GPs, one 
of the most prominent benefit of the human factor.11 The potentially negative sides of the 
human factor such as subjectivity can be curtailed by a rigid development procedure.11 
Perhaps the greatest challenge to guideline developers is making explicit the values used in 
formulating recommendations. This would improve the internal validity of the guideline. 
Because of the relevance of ethnic inequalities in health I suggest to make this an 
integral part of the guideline development process or of the guideline. The first means 
that ethnic differences should always be one of the important topics that need to be 
considered in the update of the guideline. The second means that standard a box is 
reserved in the guideline that addresses the topic of important differences between 
ethnic groups. Although the topic of ethnic inequalities in health can still vanish in 
the subsequent development process, the chance it will be properly discussed will 
probably be larger.
External validity
The external validity of guidelines is as stated above determined by the usefulness of the 
guideline in all patients and all clinical settings. 
Professor Thompson wrote “In the same way that no one can be against quality, no 
right-minded person can be against evidence. What is at stake is the nature of that 
evidence, how it was created and how it will be used”.7 This summarises the main 
problems regarding external validity. Many authors question whether clinical guideline 
recommendations of demonstrated efficacy (internal validity) within epidemiological 
research can be generalised to general practice.9 
Evidence based medicine weighs the strength of the evidence (see box 1). As shown 
120 STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
chaPtEr 9
box 1
Evidence weighing in the North of England evidence based guideline development project15
Strength of recommendation
A Directly based on category I evidence
B  Directly based on category II evidence or extrapolated recommendation from category I 
evidence
C  Directly based on category III evidence or exptrapolated recommendation from category I or II 
evidence
D Based on the group's clinical opinion
Categories of evidence
I  Based on well designed randomised controlled trials, meta-analyses, or systematic reviews
II Based on well designed cohort or case control studies
III Based on uncontrolled studies or external consensus
in box 1 randomised controlled trials (RCTs) are considered to be the best available 
evidence. The evidence found in RCTs is considered to be the best available evidence 
and is the most important input for guidelines. However, care in general practices has 
its specific needs for research. For instance, Mant et al. assessed differences in the 
characteristics between participants of a large RCT (which served as the main basis for a 
guideline for stroke in the UK) and patients in English general practices. They concluded 
that these populations were not sufficiently similar to warrant widespread use of the 
guidelines.14 Problems arise because of the specific rules of RCTs. The study population 
in RCTs, for example, are generally kept as uniform as possible to be able to determine 
the effect of the study.
In practice, this means that evidence found in a very small subgroup of mostly white, 
middle aged men is used to describe the best treatment for the average population. 
This focus on RCTs can lead to problems with the external validity of guidelines. 
These problems are especially large in general practices in deprived neighbourhoods, 
which is a setting contextually very complex. The patient population of GPs in 
deprived neighbourhoods is very different from the study populations of the RCTs 
and even from the average population targeted by the guidelines. General practices 
in deprived neighbourhoods are often confronted with patients with different ethnic 
backgrounds and lower social economic status with specific consequences for the 
health status of the population. 
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Because ethnic minorities are seldom included in RCTs, evidence in ethnic minorities 
of the highest quality is very scarce. So the question is whether to structurally generalise 
RCT evidence to the whole (average) population (including ethnic minorities) or to use 
evidence of ethnic inequalities in health of lower strength. The answer depends on the 
specific context, e.g. the health problem, the RCT, the potential existence of relevant 
differences in ethnic groups and so forth. Guideline developers should realise that while 
the current guidelines state the preferred treatment for the average patient population 
in the Netherlands, the patient population in deprived neighbourhoods is one of the 
extremes in that continuum and therefore deviates significantly of the average. 
My suggestion is the same as described above to improve the internal validity: make 
the care for ethnic minorities an integral part of the guideline development process or 
the guideline. Furthermore I would suggest that guideline developers should not be too 
careful with mentioning relevant ethnic differences in guidelines. A more pro-active 
attitude is desirable. Evidence of a lower quality (than RCTs) and opinions of experts 
are also a very important source of input for the guideline, especially when combined 
with common sense. 
The caution with or reluctance against ethnic diversity in the Dutch guidelines is in my 
opinion not a main reason of the existing ethnic differences in health and specifically in 
diabetes and hypertension, because the standard treatment is probably not very harmful 
for ethnic minorities and otherwise GPs probably would react upon that by deviating 
from the guidelines in the treatment of ethnic minorities. However the current guidelines 
are also not a solution to the ethnic health gap, whereas they potentially could be. A 
more pro-active attitude towards the mentioning of important ethnic differences could 
be an important and powerful tool in the struggle against ethnic inequalities in health. 
Doctor-patient interaction and patient compliance
So far the focus on explanations of the worse health outcomes was sought in the 
guidelines. But explanations could also be found in the interaction between the GP and 
the patients and (its consequences for) the patients’ compliance with treatment. Harmsen 
showed in his thesis the importance of the cultural background of patients for the mutual 
understanding between the GP and the patient.16 The main outcome of his work was 
that the patient’s cultural background is a very important patient characteristic, because 
of its consequence for the mutual understanding, communication and perceived quality 
of care. Furthermore, mutual understanding proved to be the best predictor for medical 
compliance.16 GPs studied in my thesis point out that compliance is worse in ethnic 
minorities, which seems to be confirmed by other research.17 Problems with compliance 
in ethnic minorities are mostly explained by a lack of knowledge and therefore for a 
large part by the inability of the GP to explain his treatment. Although one can argue 
to what point physicians can be held responsible for the compliance of their patients, 
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they do play a vital role in improving compliance. It has been shown that compliance is 
associated with health outcomes.18-20 In my opinion, reducing the knowledge gap and 
improving compliance in ethnic minorities will yield the most benefit in reducing ethnic 
health inequalities. This should therefore be an important focus in health care research 
and policy. Physicians and the health care system should take their responsibility and 
do their best to tackle this problem. Guidelines could play a role in this by stating 
information to support the GP in not only improving the treatment but also patient 
compliance. For instance the health locus of control of ethnic minority patients or the 
social normative values of ethnic groups are important for compliance and therefore the 
treatment. Informing GPs about these issues can help in improving health outcomes. 
However, stating such information would probably not be the most effective or feasible 
way. There are other ways to inform GPs than by guidelines, although guidelines are 
highly valued by the GPs and therefore one of the most powerful tools to reach GPs. It 
is more important to educate physicians in the cultural backgrounds of patients as one 
of the most important aspects of the patient’s context.16 This education should already 
begin at the university where future doctors are being prepared. 
In this respect, the patients’ responsibility should also not be forgotten. The improvement 
of health literacy (especially knowledge about chronic diseases and its treatment) and 
knowledge about Dutch health care system and especially the role and communication 
style of the general practitioners are important. GPs could play an important role in this. 
However, studies showed that to provide culturally competent care and to meet the 
individual needs of immigrant patients a particular set of skills is required, including, 
adapting communication patterns, modifying diabetes education programmes, and 
eliciting information about the patient’s logic on non-compliance.21 It is difficult for 
GPs to obtain all these skills. In my suggestion community intervention strategies with 
intercultural mediators or peer health educators can play an important role in this. 
Culturally tailored intervention programmes delivered by intercultural mediators or 
peer health educators are proven effective.22
Another potentially effective way to improve the compliance and health status of 
chronically ill ethnic minorities, which should be further explored, are combination 
pills. In diabetes and hypertension treatment for instance co-morbidity is a large problem 
and for every chronic condition patients have to take several pills. This has negative 
consequences for an already low compliance. When the effect of different pills can be 
combined in one pill, this could result in a better effect on health, perhaps despite other 
negative consequences of combining different pills into one.
standardisation in a multi-ethnic world: a paradox?
To give an answer to the title of this thesis one should first establish the role of clinical 
practice in health care. In Dutch health care there is a development towards a structure in 
which health care becomes more transparent and providers become more accountable 
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for the delivered (quality of) care. In many health care organisations quality of care 
is measured by scores on a broad range of clinical performance indicators based on 
adherence rates to clinical practice guidelines. Furthermore, higher adherence rates 
to guidelines performance measures is often considered to be evidence of improved 
quality of care.23 However, many pitfalls exist when converting guidelines into quality 
measures.24 The most important pitfall in this context is extracting indicators from 
guidelines that are based on RCTs, which at best allow generalised statements about 
population averages, not what to do in individual cases or specific ethnic subgroups. 
Treatment according to the guidelines leads to relatively worse health outcomes in ethnic 
minorities. Deviation from the guidelines should therefore not automatically indicate 
a lower quality of care in ethnic minorities, because deviation could be good for their 
health. This brings us again to the question of the role of clinical practice guidelines. 
When they are considered to be just one of the many instruments to support physicians 
in daily practice and therefore comprehend just a small part of health care, guidelines 
and the multi-ethnic population probably do not refer to a paradox. However when the 
role of guidelines is enlarged by deriving national indicators from them to evaluate the 
quality of health care providers or health care sectors, as described above, guidelines 
and the multi-ethnic society are becoming paradoxical. 
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De ontwikkeling van medische standaarden heeft de laatste decennia een vogelvlucht 
genomen. Standaardisatie was het antwoord op de grote praktijkvariatie die er tussen 
artsen bleek te bestaan. Het idee was dat veel artsen suboptimale zorg leverden, omdat 
niet volgens het best beschikbare wetenschappelijk bewijs werd behandeld. Het in kaart 
brengen van de best mogelijke behandeling op basis van wetenschappelijk bewijs of de 
meningen van experts levert uiteindelijk de standaard op. Deze standaard is de aanbevolen 
behandeling voor een type klacht waarin rekening wordt gehouden met specifieke klinische 
karakteristieken van de patiënt. Tegelijk met deze tendens van standaardisatie is de gehele 
westerse wereld vanwege allerlei migratiestromen (met verschillende redenen) steeds etnisch 
diverser geworden. In deze dissertatie staat deze ogenschijnlijk paradoxale situatie centraal. 
Valt standaardisatie te rijmen met een steeds diverser wordende (patiënten)populatie? Hoe 
valide en bruikbaar zijn richtlijnen daardoor in de praktijk? De centrale vraag van deze 
dissertatie is: “Dienen standaarden meer rekening te houden met etnische verschillen tussen 
patiënten?” Deze centrale vraag is opgedeeld in vijf subvragen:
1.  Is er ‘wetenschappelijke bewijs’ dat wijst op de noodzaak van verschillende 
aanbevelingen op het gebied van diagnostiek en/of behandeling voor diverse 
etnische groepen? Deze vraag komt aan de orde in de hoofdstukken 2, 3 en 4.
2.  Verschilt de verleende huisartsenzorg aan patiënten van verschillende etnische 
afkomst? Deze vraag komt aan de orde in hoofdstuk 5.
3.  Is de mate van adherentie aan standaarden van huisartsen verschillend naar gelang 
de etniciteit van de patiënt? Deze vraag wordt besproken in hoofdstuk 6.
4.  Bestaat er een etnisch verschil in de associatie tussen het volgen van de standaard 
en de klinische uitkomst van de behandeling? Deze vraag komt aan de orde in 
hoofdstuk 7.
5.  Wat is de mening van huisartsen over de bruikbaarheid van standaarden in de 
behandeling van patiënten met verschillende etnische achtergronden? Deze vraag 
komt aan de orde in hoofdstuk 8.
Omdat dit onderzoek is uitgevoerd bij huisartsen is in dit onderzoek gefocust op de 
standaarden van het Nederlands Huisartsen Genootschap (NHG). Vanwege hun 
veel voorkomende en chronische karakter focust deze dissertatie zich verder op de 
aandoeningen diabetes mellitus type 2, hypertensie en astma bij volwassenen.
In dit onderzoek is gebruik gemaakt van verschillende kwantitatieve en kwalitatieve 
onderzoeksmethoden.
Na de beschrijving van de achtergrond van deze dissertatie en de introductie van de 
onderzoeksvragen in hoofdstuk 1 wordt in de hoofdstukken 2 tot en met 8 een antwoord 
gegeven op de bovenstaande vragen.
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Hoofdstuk 2 beschrijft de resultaten van een systematische review van de 
wetenschappelijke literatuur naar de prevalentie van diabetes type 2, andere 
cardiovasculaire risicofactoren en cardiovasculaire morbiditeit en mortaliteit bij 
Turkse en Marokkaanse immigranten in Noordwest-Europa. De meeste bestudeerde 
studies baseren hun metingen op zelfrapportage en zijn daarom ontoereikend om de 
“werkelijke” prevalentie van diabetes, andere cardiovasculaire risicofactoren en de 
aanwezigheid van cardiovasculaire ziekte te schatten. De bestudeerde onderzoeken 
boden daarom onvoldoende materiaal voor een kwalitatief goede schatting van het 
cardiovasculaire risico bij Turkse en Marokkaanse immigranten en de autochtone 
bevolking. Niettemin toont het beschikbare bewijs voldoende aan dat: diabetes mellitus 
vaker voorkomt bij zowel Turkse als Marokkaanse immigranten, dat Turkse mannen 
vaker roken, en Marokkaanse vrouwen zelden roken. Gegevens over cardiovasculaire 
sterftecijfers zijn schaars: in een studie was het sterftecijfer opvallend lager bij Turks-
Duitse immigranten in vergelijking met de Duitse bevolking. 
In hoofdstuk 3 worden de resultaten gepresenteerd van een vergelijking van de 
aandacht aan etnische verschillen in Nederlandse, Britse, Amerikaanse en Canadese 
standaarden. De Amerikaanse standaarden schonken verreweg de meeste aandacht aan 
etnische verschillen, gevolgd door de Britse en Canadese standaarden. De Nederlandse 
standaarden schonken de minste aandacht aan etnische verschillen. Alleen de 
Nederlandse diabetes standaard schonk aandacht aan etnische verschillen in de 
prevalentie en voegde daar een aanbeveling aan toe om op jongere leeftijd te screenen 
naar diabetes bij bepaalde etnische groepen. Opvallend was dat de Nederlandse 
hypertensie standaard geen enkele aandacht schonk aan etnische verschillen, terwijl 
de andere standaarden hier uitvoerig op in gingen. In deze standaarden werden 
verschillende empirische verschillen in het voorkomen van hypertensie bij bepaalde 
groepen beschreven en werden verschillende aanbeveling gedaan om de behandeling 
meer toe te spitsen op deze groepen. 
In hoofdstuk 4 wordt dieper ingegaan op de Nederlandse standaarden en wordt 
bekeken of er in de wetenschappelijke onderbouwing van de standaarden etnische 
verschillen besproken worden. Verschillende relevante etnische verschillen worden 
genoemd in de wetenschappelijke onderbouwing van de NHG-standaarden. Voor 
diabetes zijn dat prevalentieverschillen en verschillen in het klinische beloop. Voor 
astma zijn dat longinhoudverschillen en voor hypertensie verschillen in prevalentie, 
klinisch beloop, respons op medicatie en gevoeligheid voor zout beperking. De 
NHG-standaarden noemen een hogere prevalentie van diabetes bij Hindoestanen 
en adviseren eerdere screening bij deze groep. De astma standaard meldt dat de 
longinhoud etnisch bepaald is en de hypertensie standaard noemt geen etnische 
verschillen. Verreweg de meeste publicaties uit de wetenschappelijke onderbouwing 
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zijn verzameld met een ander doel dan het onderbouwen van etnische verschillen 
en het betekent dus niet dat de NHG de meldingen van etnische verschillen uit die 
publicatie bewust heeft gewogen en terzijde heeft gelegd. Desondanks toont deze 
studie dat er wel relatief veel bekend is over etnische verschillen en dat dit bewijs 
betrokken moet worden in het richtlijnontwikkelingsproces.
In hoofdstuk 5 worden de resultaten besproken van een analyse van patiëntendossiers. De 
historische dossiers van 705 patiënten met diabetes, hypertensie of astma van 30 huisartsen 
zijn onderzocht in de periode tussen 2000 en 2004 op het aantal huisartsenbezoeken, 
het aantal recepten en het aantal verwijzingen naar de specialist. Turkse astmapatiënten 
gingen gemiddeld minder vaak naar de huisarts en kregen gemiddeld minder vaak een 
prescriptie mee. Marokkaanse hypertensiepatiënten kregen ook gemiddeld minder 
medicijnen voorgeschreven. Deze verschillen verdwenen echter als er gecorrigeerd werd 
voor verschillen in leeftijd, geslacht, verzekeringsstatus en co-morbiditeit. Er bleken ook 
geen etnische verschillen in het aantal verwijzingen uit deze studie.
In hoofdstuk 6 is door middel van een dwarsdoorsnede onderzoek met een prospectieve 
dataverzameling onderzocht in hoeverre de mate waarin de huisarts de standaard volgt 
afhankelijk is van de etniciteit van de patiënt voor hem. Hiervoor is in 17 huisartspraktijken 
(met 31 huisartsen) in en rond achterstandswijken in verschillende grote Nederlandse 
steden een meetinstrument in het huisartsinformatiesysteem geïnstalleerd die bij een 
aselect geselecteerde groep patiënten de huisarts confronteerde met een lijst met vragen 
over de behandeling van de patiënt. Met die lijst vragen is bepaald in welke mate de 
standaard is gevolgd. Uiteindelijk zijn er 402 volledige lijsten door de huisartsen ingevuld 
over in totaal 238 patiënten. Het bleek dat huisartsen over het algemeen redelijk goed 
de aanbevelingen uit de standaarden volgen (rond 75% van de aanbevelingen wordt 
opgevolgd). Dit verschilde echter veel tussen de verschillende huisartsen. Het bleek 
dat huisartsen geen verschil maakten in het volgen van de standaard bij patiënten van 
verschillende etnische groepen. 
Omdat aanbevelingen in standaarden gebaseerd zijn op het beste wetenschappelijke 
bewijs is de verwachting dat het volgen van standaarden een gunstig effect heeft op de 
klinische uitkomst van de behandeling. In hoofdstuk 7 wordt een antwoord gegeven op 
de vraag of deze associatie tussen het volgen van de standaard en de klinische uitkomst 
van de behandeling verschilt bij patiënten uit verschillende etnische groepen. In het 
bovengenoemde meetinstrument dat geïnstalleerd is in de huisartsinformatiesystemen 
werden naast vragen over de behandeling door de huisarts ook klinische uitkomstmaten 
gevraagd. Voor diabetes betrof dat de bloedglucosewaarde, voor hypertensie de 
systolische- en diastolische bloeddruk en bij astma werd gevraagd of een optimale 
longcapaciteit bereikt of gehandhaafd was. 
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Er bleek een sterk verband te bestaan tussen de mate van adherentie aan de standaard 
door de huisarts en een positieve klinische uitkomst bij de patiënt. Dit gold voor 
diabetes en hypertensie en niet voor astma. Zowel in de behandeling van autochtone 
Nederlanders als etnische minderheden had het volgen van de standaard een sterke 
associatie met een positievere klinische uitkomst. Deze associatie was alleen aanzienlijk 
groter bij autochtone Nederlanders in vergelijking met de etnische minderheden (odds 
ratio van 150 bij autochtone Nederlanders versus een odds ratio van 22 bij etnische 
minderheden). Omdat de aantallen waarnemingen in deze studie laag waren, bleek 
het verschil tussen de twee odds ratio’s niet statistisch significant te verschillen. Uit 
toekomstig onderzoek zal moeten blijken of dit etnische verschil in de associatie tussen 
het volgen van de standaard en de klinische uitkomst echt aanwezig is.
In hoofdstuk 8 worden de resultaten weergegeven van een kwalitatief onderzoek bij 
een aantal huisartsen waarbij data voor de eerdere hoofdstukken is verzameld. Deze 
huisartsen zijn gekozen op basis van het aantal ingevulde lijsten en het aandeel 
etnische minderheden in hun praktijk. Het grote aandeel etnische minderheden in hun 
praktijk maakt deze huisartsen met recht deskundig als het gaat om huisartsenzorg aan 
etnische minderheden. Negen huisartsen zijn benaderd en uiteindelijk 7 huisartsen zijn 
geïnterviewd. Deze huisartsen is gevraagd of de huidige standaarden bruikbaar zijn in 
de behandeling van etnische minderheden en of ze het gevoel hebben vaker af te wijken 
van de standaard bij patiënten met een specifieke etnische achtergrond. De huisartsen 
gaven bijna allen aan dat de huidige standaard bruikbaar was in de behandeling van 
etnische minderheden en dat ze niet het gevoel hadden vaker af te wijken bij bepaalde 
etnische minderheden. Unaniem waren ze wel in hun mening dat de behandeling van 
etnische minderheden moeizamer is en zij ook moeilijker goed in te stellen zijn. Hiervoor 
gaven zijn ook haast unaniem 3 redenen: 1. ziektebeleving en therapietrouw; 2. dieet 
en beweging; 3. onwennigheid met huisartsenzorg. Bij doorvragen bleken huisartsen 
overigens wel degelijk vaker af te wijken van aanbevelingen uit standaarden bij etnische 
minderheden, maar dit werd niet veroorzaakt doordat de aanbevelingen onjuist zijn, maar 
doordat ze moeilijker implementeerbaar/ uitvoerbaar zijn bij etnische minderheden. 
Opvallend in dit onderzoek was dat de opmerkingen die de huisartsen maakten over de 
problematiek betreffende de zorg aan etnische minderheden (in achterstandswijken), 
opmerkingen zijn die 25 jaar geleden ook al gemaakt werden. Deze conclusie zet dan 
ook kanttekeningen bij het effect van het minderhedenbeleid van de laatste decennia.
Uit de resultaten van de onderzoeken gepresenteerd in deze dissertatie concludeer ik 
dat relatief veel relevant bewijs bestaat over etnische verschillen wat tot op heden over 
het algemeen nog niet leid tot etnisch specifieke opmerkingen of aanbevelingen in de 
Nederlandse (NHG-)standaarden. Verder concludeer ik dat ondanks dat huisartsen niet 
verschillen in hun behandeling of het volgen van de standaard bij etnische minderheden 
131STANDARDISATION IN A MULTI-ETHNIC WORLD: A PARADOx?
SaMEnvattIng
in vergelijking met autochtone Nederlanders, de associatie tussen het volgen van de 
standaard en positieve klinische uitkomsten kleiner lijkt in de behandeling van etnische 
minderheden. Tot slot concludeer ik dat volgens de huisartsen zelf de huidige standaard 
voldoet in de behandeling van etnische minderheden. 
Met deze conclusies kan een antwoord geformuleerd worden op de hoofdvraag van deze 
dissertatie: Dienen standaarden meer rekening te houden met etnische verschillen tussen 
patiënten? Gezien de relatieve grote etnische verschillen in gezondheid en uitkomsten 
van zorg, het evidence-based karakter van standaarden en de relatief grote hoeveelheid 
bewijs over etnische verschillen, dienen standaarden meer rekening te houden met etnische 
verschillen. Vooral omdat het erop lijkt dat dezelfde behandeling en dezelfde mate van 
volgen van de standaard tot minder positieve uitkomsten van zorg leiden. De mening van de 
deelnemende huisartsen dat de huidige standaarden bruikbaar zijn in de behandeling van 
etnische minderheden hoeft niet tegenstrijdig te zijn met deze conclusie. Allereerst omdat 
de huisartsen zelf aangeven dat als er bewijs bestaat over etnische verschillen deze zeker 
meegenomen moeten worden in de standaard. En omdat de huisartsen duidelijk aangeven 
dat ze moeite hebben goede behandelingsuitkomsten te behalen bij etnische minderheden. 
Ook al denken zij dat het laatste vooral aan patiënt factoren ligt en niet aan de standaard, 
kunnen relevante patiënt factoren natuurlijk ook benoemd worden in de standaard. 
Is standaardisatie in een multi-etnische wereld een paradox? Om hierop een antwoord te 
kunnen geven dient eerst bepaald te worden wat nu eigenlijk de rol is van standaarden. In 
de Nederlandse gezondheidszorg is er een ontwikkeling gaande naar meer transparantie. 
Aanbieders van zorg moeten meer verantwoording afleggen over hun presteren dan in 
het verleden. In verschillende gezondheidszorg organisaties wordt de kwaliteit van zorg 
gemeten door zogenaamde prestatie indicatoren die deels gebaseerd zijn op het volgen van 
standaarden. Het is zelfs zo dat het beter volgen van standaarden wordt beschouwd als bewijs 
voor een verbeterde zorgverlening. Maar deze dissertatie maakt duidelijk dat er verschillende 
valkuilen bestaan als standaarden worden omgezet naar kwaliteitsindicatoren. Een belangrijke 
valkuil in deze is dat in deze context indicatoren worden opgesteld vanuit standaarden die 
gebaseerd zijn op RCT’s, welke op zijn best generaliserende statements voor de gemiddelde 
populatie opleveren. En zeker niet voor individuele patiënten of specifieke etnische groepen. 
Het behandelen volgens deze standaarden levert relatief slechtere uitkomsten op bij etnische 
minderheden. Afwijken van de standaard is in dit geval dus niet hetzelfde als het leveren van 
mindere kwaliteit van zorg, aangezien afwijken van de standaard een positiever effect op 
de gezondheid van de patiënt kan hebben. Dit brengt ons weer op de rol van standaarden. 
Worden zij ‘slechts’ beschouwd als een van de instrumenten die de arts tot zijn beschikking 
heeft ter ondersteuning van het dagelijks handelen, dan hoeft standaarden in een multi-
etnische populatie niet op een paradox te wijzen. Maar als de rol van standaarden belangrijker 
wordt gemaakt door bijvoorbeeld als basis te dienen voor landelijke kwaliteitsindicatoren dan 
worden standaarden in een multi-etnische wereld wel degelijk paradoxaal. 
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